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1. Summary 
In every living organism amino acids are pivotally important multifunctional molecules. Single amino 
acids drive mayor intracellular signaling pathways controlling growth and proliferation, and enable 
neuronal communication in the synaptic cleft. Apart from signaling, their oxidative break down in the 
citric acid cycle provides energy and metabolic substrates for the cell. When several single amino 
acids are covalently linked and correctly folded, they form a functional protein. This certainly 
describes one of the most important processes in biology. All these vital functions depend on the 
availability of amino acids. Not surprisingly, amino acid pools are maintained within a physiological 
range by complex regulatory feedback mechanisms – a process termed homeostasis. A homeostatic 
challenge is to refill the amino acid pools without perturbing amino acid homeostasis, which might 
cause severe side effects. The temporal regulation of transport protein expression may solve this 
problem in single cell organisms, whereas eating behavior has to be balanced with the homeostatic 
needs and the specific available nutrient source in higher species. How this is achieved is currently 
under active research, but little is known in the context of individual amino acids.  
One reason might be, that ingested proteins are broken down to twenty different individual amino 
acids leading to large complexity. Not only do they differ in their chemical structure, but some are 
also nutritionally essential. We hypothesize that, based on these structural differences; they may 
have distinct roles in the control of food intake and gastrointestinal function. We systematically 
assessed the impact of all 20 individual proteogenic amino acids on food intake and gastric function. 
These two functional readouts are particularly relevant in the short-term regulation of nutrient 
intake. Food intake determines the maximal achievable intake of nutrients, and gastric function i.e. 
gastric emptying and secretion dictates the concentration and the timing of nutrient release into the 
small intestine. Both have a direct impact on plasma nutrient concentration and the timing of 
nutrient appearance in plasma.   
Here, we show that short-term food intake was most potently reduced by oral L-arginine, L-lysine 
and L-glutamic acid compared to all other 17 proteogenic amino acids in the rat. As feeding 
behavior is controlled by neuronal circuits located in specific brain areas, we tested for neuronal 
activity using immunohistochemistry after L-arginine, L-lysine and L-glutamic acid application. An 
increased number of cFOS positive cells were detected in the blood-sensing area postrema and the 
nucleus of the solitary tract. To test whether circulating amino acids can directly signal to the brain to 
induce their anorectic effect, we administered L-arginine, L-lysine and L-glutamic acid intravenously. 
All three amino acids induced an anorectic response that was similar to the one induced after oral 
application. Surgical lesion of the area postrema abolished the anorectic responses of L-arginine and 
L-glutamic acid but not of L-lysine. The nucleus of the solitary tract is the main projection site of the 
vagus nerve which innervates the gastrointestinal tract. Surgical lesion of vagal afferents did not alter 
the anorectic effect of L-arginine and L-glutamic acid but of L-lysine. We presume that L-arginine and 
L-glutamic acid act in the area postrema to cause their anorectic response, while L-lysine stimulates 
hepatic vagal afferents projecting to the nucleus of the solitary tract. Interestingly, in the 
gastrointestinal tract all three amino acids induced gastric distension. L-arginine and L-lysine induced 
gastric secretion detected by changes in the alkaline tide. Gastric emptying, measured by stomach 
phenol red retention, was delayed after L-lysine and L-glutamic acid treatment. At the level of the 
small intestine, L-arginine and L-lysine accelerated phenol red dye passage into the cecum. The 
gastrointestinal effects of L-lysine were shown to be dose dependent in the rat and were analogously 
observed in healthy human subjects. The highest L-lysine dose caused self-limiting diarrhea in 
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humans, but no other side effects were reported. The gastrointestinal effect induced by L-arginine 
and L-lysine was dissociated from their effect on food intake and induced conditioned taste aversion 
in the rat. Hence, L-arginine, L-lysine and L-glutamic acid had a remarkable specific impact on 
mechanism important for food processing in the gastrointestinal tract and on food intake in rats and 
humans. This may suggest that they act as direct sensory input to assess dietary protein content and 
quality in vivo.  
Here, we show that L-cysteine, L-lysine, L-arginine and L-tryptophan most potently delayed gastric 
emptying and that L-arginine and L-lysine most potently stimulated gastric secretion compared to 
all other proteogenic amino acids in the rat. The systematic assessment of these two key stomach 
functions was only feasible, because we established and validated a quantitative non-invasive high-
throughput computed tomography based method. This novel method can measure simultaneously 
gastric emptying and secretion in rats in vivo. Future efforts aim to assess if gastric secretion and 
emptying induced by the candidate amino acids are conducted by a shared control mechanism, to 
identify its localization and potential effector molecules i.e. gastrointestinal hormones.  
In conclusion, we revealed remarkable amino acid specificity for two critical nutritional functions, 
namely food intake and gastric function. The main question arising from this work is the cellular 
mechanism enabling the remarkable amino acid specificity. This might give insights into how 
individual amino acids contribute to the control of protein intake, and how protein quality is assessed 
at a molecular level.  
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2. Zusammenfassung 
In jedem lebenden Organismus sind Aminosäuren wichtige multifunktionale Moleküle. Einzelne 
Aminosäuren regulieren wichtige intrazelluläre Signalwege, die für die Steuerung des Wachstums 
und die Proliferation verantwortlich sind. Ausserdem ermöglichen sie die neuronale Kommunikation 
im synaptischen Spalt. Neben ihrer Signalfunktion können sie durch den oxidativen Stoffwechsel im 
Citratzyklus in wichtige metabolische and energetische Substrate für die Zelle umgewandelt werden.  
Die kovalente Verknüpfung von mehreren einzelnen Aminosäuren und deren korrekte Faltung führt 
zur Bildung eines funktionellen Proteins. Dies sind mit Sicherheit einige der wichtigsten Prozesse in 
der Biologie. Alle diese lebenswichtigen Funktionen hängen von der Verfügbarkeit von Aminosäuren 
ab, weshalb diese in einem physiologischen Bereich durch komplexe Rückkopplungsmechanismen 
gehalten werden. Eine Herausforderung besteht darin, die Verfügbarkeit der Aminosäuren 
aufrechtzuerhalten, ohne die Homöostase des biologischen Systems stark zu erschüttern. In 
einzelligen Organismen kann die Regulierung der Transportproteine an der Zelloberfläche bereits 
dieses Problem lösen. Diese Aufgabe ist in höheren Arten komplexer, da das Essverhalten, die 
Verfügbarkeit von spezifischen Nährstoffen und der Bedarf koordiniert werden müssen. Wie dies 
erreicht wird, ist derzeit Bestandteil aktiver Forschung. Leider ist im Rahmen von Aminosäuren sehr 
wenig bekannt.  
Ein Grund dafür ist, dass gegessene Proteine zu zwanzig verschiedenen einzelnen Aminosäuren 
verdaut werden, was zu einer grossen Komplexität führt.  Sie unterscheiden sich nicht nur durch ihre 
chemische Struktur sondern auch ob sie essenziell sind. Unsere Hypothese besagt, dass aufgrunde 
ihrer strukturellen Unterschiede einzelne Aminosäuren unterschiedliche Rollen für die Kontrolle 
der Nahrungsaufnahme und Magenfunktion haben. Diese Hypothese wurde durch die erstmalige 
systematische Beurteilung der individuellen Einflüsse von Aminosäuren auf die Nahrungsaufnahme 
und die Magenfunktion in der Ratte getestet. Diese zwei Funktionen sind besonders in der 
kurzfristigen Regulation der Aminosäuren-Versorgung relevant. Die Nahrungsaufnahme bestimmt die 
maximal mögliche Aufnahme von Nährstoffen. Die Magenfunktion, hier die Sekretion und die 
Entleerung, bestimmen die Konzentration und den Zeitraum der Freisetzung von Nährstoffen in den 
Dünndarm und haben dadurch direkten Einfluss auf den Nährstoffgehalt im Blut und das zeitliche 
Erscheinungsbild nach der Aufnahme einer Mahlzeit.  
In dieser Arbeit zeigen wir, dass die kurzfristige Nahrungsaufnahme in der Ratte durch oral 
appliziertes L-Arginin, L-Lysin und L-Glutaminsäure im Vergleich zu allen anderen 17 proteinogenen 
Aminosäuren am stärksten reduziert wird. Da das Fressverhalten durch Neuronen in bestimmten 
Hirnregionen gesteuert wird, haben wir getestet, wo L-Arginin, L-Lysin und L-Glutaminsäure 
neuronale Aktivität induzierten. Eine erhöhte Anzahl von cFOS positiven Zellen wurde in der Area 
Postrema und dem Nucleus Tractus Solitarii nachgewiesen. Die Area Postrema ist nicht von der Blut-
Hirn-Schranke geschützt.Um zu testen, ob zirkulierende Aminosäuren das Fressverhalten 
beeinflussen, haben wir L-Arginin, L-Lysin und L-Glutaminsäure intravenös verabreicht. Alle drei 
Aminosäuren induzierten einen anorektischen Effekt, der eine ähnlich Stärke wie der nach einer 
oralen Applikation hatte. Eine chirurgische Läsion der Area postrema verhinderte den anorektischen 
Effekt von L-Arginin und L-Glutaminsäure, nicht aber den von L-Lysin. Der Nucleus Tractus Solitarii ist 
die primäre Projektionsregion des Vagus Nervs, welcher den gesamten Gastrointestinaltrakt 
innerviert. Eine chemische Läsion der afferenten vagalen Nervenfasern verhinderte den 
anorektischen Effekt von L-Lysine, nicht aber den von L-Arginin und L-Glutaminsäure. Wir gehen 
davon aus,  dass L-Arginin und L-Glutaminsäure über die Area Postrema den anorektischen Effekt 
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verursacht, während L-Lysin diesen Effekt über vagale afferente Nervenfasern auslöst. 
Interessanterweise induzieren alle drei Aminosäuren eine Ausdehnung des Magens. L-Arginin und L-
Lysin verursachen Magensäuresekretion, detektiert durch die Veränderung des alkalischen 
Gleichgewichts. Die Magenentleerung, gemessen durch die Retention von Phenolrot im Magen, ist 
verlangsamt durch L-Lysin und L-Glutaminsäure.  Im Dünndarm beschleunigen L-Arginin and L-Lysin 
den Transit eines Farbstoffes in den Blinddarm. Die Wirkung von L-Lysin im Magen sowie im 
Dünndarm ist dosisabhängig in der Ratte, und wurde analog im Menschen beobachtet. Diese 
peripheren gastrointestinalen Mechanismen sind von ihrem anorektischen Effekt unabhängig und 
führen zu einer Geschmacksaversion. Zusammenfassend hatten L-Arginin, L-Lysin und L-
Glutaminsäure eine bemerkenswerte, spezifische Auswirkung auf die wichtigen Mechanismen für die 
Verdauung im Magen-Darm-Trakt und auf die Nahrungsaufnahme. Dies deutet darauf hin, dass sie 
als direkte sensorische Signale wirken, um den totalen Proteingehalt und  die Qualität der Nahrung 
zu messen, und daher besonders relevante Signale für das Erhalten der Aminosäure-Homöostase 
sind.  
In dieser Arbeit zeigen wir, dass L-Cystein, L-Lysin, L-Arginin und L-Tryptophan die 
Magenentleerung am stärksten verzögern, und dass L-Arginin und L-Lysin die Magensäuresekretion 
am stärksten induzieren im Vergleich zu allen anderen proteinogenen Aminosäuren in der Ratte. 
Die systematische Beurteilung dieser zwei zentralen Funktionen des Magens war nur möglich, weil 
wir eine quantitative und nicht invasive Computertomographie-Methode entwickelt und validiert 
haben. Diese neue Methode erlaubt es, gleichzeitig die Magenentleerung und -sekretion in der 
lebenden Ratte zu messen. Zukünftige Bemühungen beabsichtigen zu entschlüsseln, ob die 
Magenentleerung und Magensäuresekretion,induziert durch die Aminosäuren, von einem  
gemeinsamen Kontrollmechanismus gesteuert werden, wo dieser Mechanismus lokalisiert ist und 
welche Effektormoleküle, z. B. gastrointestinale Hormone, sekretiert werden.  
Zusammenfassend zeigen wir hier für zwei zentralen Funktionen in der kurzfristige Kontrolle der 
Nährstoffaufnahme, nämlich dem Fressverhalten und der Magenfunktion, ein bemerkenswerte 
Spezifität für bestimmte Aminosäuren. Die wichtigste Frage, die sich aus dieser Arbeit ergibt, ist nach 
den zellulären Mechanismen, die diese bemerkenswerte Aminosäuren-Spezifität ermöglichen. Die 
Antwort auf diese Frage ermöglicht Einblicke, wie diese einzelnen Aminosäuren auf genaueste Weise 
die Proteinaufnahme steuern, und wie Proteinqualität auf molekularer Stufe wahrgenommen wird.  
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3. Introduction 
3.1 Nutrient Homeostasis 
Homeostasis describes a state where a system maintains its internal variables within a relative 
constant range.  In honor of the inventor of this concept – Claude Bernard – one often speaks of “la 
fixité du milieu intérieur” (156, 157). Homeostasis is a characteristic conserved in all organisms from 
single-cell microbes to mammals. Genes stabilizing internal variables were presumably selected 
because they enable other vital processes to function under stable intracellular conditions in the ever 
changing environment. Thereby enzymatic processes such as metabolism, gene expression, etc. can 
evolve towards high efficiency and are protected from the large changes in the encountered 
environment. The number and precision of variables regulated, and the complexity of the system 
regulating them increase with complexity of an organism. Single cells regulate crucial variables such 
as the membrane potential, pH or volume, whereas higher species in addition control the 
extracellular compartment (milieu intérieur) that contains a number of interlinked organs and cells. 
Impairments of these regulatory mechanisms often lead to imbalances causing disease. In sum, 
homeostasis enables life in the dynamic environment encountered on earth from the freezing-polar 
regions to the hottest Vulcan reefs. 
Figure 1 – Nutrient 
homeostasis. The central 
nervous system modulates 
food intake to maintain stable 
nutrient stores. Long-term 
signals (red) inform about 
current storage size and short-
term signals (blue) about 
immediate meal-related 
information. Figure was 
adapted from (104). 
 
 
 
Systemic homeostasis encounters several challenges such as the regulation of cell volume, body 
temperature and nutrient supply. The concept of nutrient homeostasis describes an elaborated 
process, which adjusts food intake over time to promote stability in the amount of stored nutrients 
(8, 104, 167). The central nervous system controls this balance by integrating different blood born 
and neuronal signals. They can be roughly separated in long- and short-term signals. The latter relays 
immediate signals from an on-going meal and the long-term signals mediate information related to 
nutrient stores (Fig. 1). For instance, leptin plasma concentrations correlate with adiposity stores, 
whereas CCK release with food intake. However, this separation of signals is an over simplification 
and functional overlaps exist as well for leptin. Importantly the current knowledge is most advanced 
in the field of energy intake based on its mayor implication for the current obesity epidemics. 
Nevertheless there are experimental indications that homeostatic control as well exists for muscle 
and bone mass. Next, I’ll review the current understanding with a specific focus on the interaction of 
muscle mass and amino acid/protein intake. Amino acids are the macronutrients my research 
focuses on and therefore a more detailed understanding complements my thesis.  
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3.2 Amino Acids 
Amino acids as building blocks of proteins are the most abundant component in the lean human 
body other than water. There are 20 proteogenic amino acids varying in size, charge, polarity and 
atomic composition. The main source of amino acids for metazoans is ingested protein, which are 
digested to individual amino acids prior to their release into portal circulation from intestinal 
enterocytes. The liver filters the portal blood prior entering systemic circulation and elaborated re-
absorptive machinery located in the proximal tubules prevents excess excretion of amino acids into 
the urine (155). Depending on the specific cell types involved amino acids can either serve as signals 
for growth control, neurotransmission and others or simply be utilized for enzyme synthesis or as 
metabolic substrates. Importantly, microbe metabolism can synthesize all amino acids de novo, 
however, this trait was lost in the course of evolution and therefore certain amino acids must be 
ingested to support normal growth and reproduction (169). Alternatively muscle catabolism can 
provide vital amino acids in times of shortage. However, this autophagy process is only observed 
under specific conditions. Critically there is no amino acid storage site analogous to adipose tissue 
providing energy whenever needed. Hence, there is a homeostatic need for protein ingestion.  
Ingestion of proteins and nutrients in general is a regulatory challenge, because efficient absorption 
must be performed while maintaining amino acid respectively nutrient concentration within the 
homeostatic range. In the next chapters I’ll review the current understanding of amino acid 
homeostasis starting with long-term signals regulating of amino acid intake.   
3.3 Long-term Signals affecting Amino Acid Intake 
The brain ultimately tunes food intake with the requirements of the body (Fig. 1). This would suggest 
that a difference in protein demand would stimulate specific amino acid intake. For instance, an 
increased protein synthesis is required to drive cell proliferation and differentiation during 
development. Consequently one would expect a higher protein demand in young animals compared 
to old. Indeed young rats consume a larger amount of high protein diets compared to mature 
individuals if given the choice (74, 165). Even in humans it is generally recommended to nurture 
young infants with additional proteins to support normal growth and development (77). In the same 
line of argumentation, animals with a high muscle mass due to growth hormone treatment or 
increased physical activity manifested an enhanced selection for protein enriched diets (29, 119, 
130).  Inversely, specifically restricting protein intake in animals induces an increased protein 
demand, and therefore a specific appetite for protein rich diets is observed following this 
experimental perturbation (41, 79, 166). Hence, a higher protein demand induced by different 
physiological perturbations stimulates increased protein intake. Importantly, these behaviors are 
nutrient specific as modulating energy requirements for example by cold exposure selectively 
increased energy intake, whereas protein consumption remained constant (84). Generally these 
observations indicate the presence of a signal reflecting muscle mass similar to leptin and adipose 
tissue. Irisin was recently suggested to potentially play such a role, but remained heavily 
controversial (17, 146). The identification of such a signal is a key step for a better understanding of 
the regulation of protein intake and as well amino acid homeostasis. Taken together, the brain 
balances nutrient ingestion and requirements targeting homeostasis. Consequently blood amino acid 
levels are relatively constant throughout the day, while eating marks the exception (169). Long-term 
signals were only briefly discussed, because the here presented work is not related to alterations of 
them. All animals used within one experiment in this dissertation had a similar age and body weight 
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thereby minimizing a bias due to distinct body composition. Next, I’ll discuss the mechanism 
controlling short-term food intake, which are stronger related to the work in this thesis.    
3.4 The Effect of Proteins and Amino Acids on Food Intake  
Limiting food intake is key to minimize particularly large disruption of plasma nutrient homeostasis 
(167). The brain accomplishes not only this task through the integration of information related to the 
meal and its composition, but as well by taking other factors like stress, day-time, social situation or 
experience (learned) in to account (Fig.2). The main components of every diet are carbohydrates, fats 
and proteins. The “Bundesamt für Gesundheit” recommends a daily protein intake of 0.8-2.0 g/kg for 
a healthy adult, which reflects 10-20 % of the daily energy intake in an adult man (77). Of all three 
macronutrients, protein most potently delays food intake at an iso-caloric dose (92, 93). Data 
supporting these conclusions are abundant throughout the animal kingdom from insects, fish, 
rodents and humans (reviewed in (102)). Specifically a high protein diet inhibits food intake, a low 
protein diet increases food intake, and a very low protein diets induces a dietary rejection compared 
to a standard diet (7, 43, 75, 164). These findings encouraged the development of diets high in 
protein content (30% protein per total energy) for weight loss with the most prominent being the 
Atkins and Protein Power diet (reviewed in (3)). The initial concerns for a higher risk of osteoporosis, 
renal insufficiency or coronary artery disease were insufficient and the intake up to 35% protein per 
total energy is concerned as safe. Both diets stimulated significant weight loss and reduced several 
risk factors for cardiovascular disease in obese test persons. Particularly convincing was the 
observation that only fat mass was lost, but lean body mass and energy expenditure were 
maintained.  Still these and diets in general are not successful strategies for reducing body weight in 
many individuals mainly due to lack of compliance with the dietary paradigm.  
Unfortunately, how protein diets induce their potentially specific effect on adipose stores remained 
obscure. One reason might be that a diet rich in proteins is low in fats or/and in carbohydrates, 
thereby limiting conclusions as one or the other variable can contribute to the observed effect. 
Geometrical models were applied to tackle this key limitation, which enables the comparison of 
protein versus carbohydrates versus fat consumption in the 3D ingestive space (139). Analyses of a 
large number of experimental data showed, that feeding behavior can be best described in the 2D 
space. Therefore the energy providing macronutrients fats and carbohydrate are summed as the 
energy variable (65, 140). Interestingly, this approach indicates that several species regulate ingestive 
behavior around a specific protein:energy target (124). This concept was recently experimentally 
validated in mice and humans (59, 68, 94, 142). Interestingly it was even demonstrated that insects 
and rodents prioritize protein over energy intake, if they cannot reach their protein:energy target. 
This led to the formulation of the “obesity leverage” theory, which proposes that the decreased 
protein content relative to energy in the western diet provokes a substantial increase in energy 
intake causing the current obesity epidemic (140). However, a certain controversy exists as certain 
studies do not support an anorectic effect of a high protein diet in humans (13, 92, 93, 123). These 
differences might be due to the fact that not only total dietary protein quantity but as well quality 
differentially impacts on food intake. When protein quality was altered, differences in their anorectic 
effect were observed in rodents and humans (19). Exemplary in rats soy proteins do not alter food 
intake in the same magnitude as yeast proteins (44). As different protein sources have a different 
amino acid composition, these studies might indicate a role for individual amino acids in the control 
of food intake (6, 44, 121). In agreement, rats freely select from two diets, each alone deficient but 
together complementary in their amino acid profile, to meet balanced amino acids intake (49). 
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Critically these studies as well exclude the possibility that animals only consume proteins to fuel their 
nitrogen needs (79, 82, 100). The impact of individual amino acids on food intake was not studied 
systematically in the past. Of all the 20 proteogenic amino acids only 12 where tested and this under 
different experimental conditions thereby disabling comparison (4, 5, 12, 107). Hence, their 
individual significance remains unclear. In summary, protein quantity and quality has a profound 
impact on feeding behavior, whereas currently the precise role of individual amino acids for satiation 
remains unknown.  
The importance of individual essential amino acids was recognized already early based on the impact 
of an extreme dietary paradigm. If a diet is depleted completely of an individual essential amino acid, 
animals reject this diet within 20 min (reviewed (57)). When the missing amino acid is provided 
within another diet, animals consume the right proportion of both to reach their protein 
requirements (49). Alternatively this rapid rejection can be reversed by injecting the limiting amino 
acid into the anterior piriform cortex or infused into the carotid artery, whereas the injection into the 
jugular vein or application of the non-limiting amino acid has no effect (86, 131). This deficiency of a 
single essential amino acid is sensed by the accumulation of uncharged tRNA’s and activation of the 
highly conserved GCN2 pathway in the anterior piriform cortex (62). Lesion of the anterior piriform 
abolishes this selective rejection of a deficient diet, but does not alter the anorectic effect of high 
protein diets (85). Hence, there is a clear dissociation of the response to insufficiency and 
physiological variations in protein quantity therefore the importance of these findings for 
physiological conditions might be limited. 
Provocatively one can question whether the behavioral responses to proteins described above 
represent a specific effect to protein intake or alternatively whether they are a secondary effect to 
the macronutrient. The intake of a high protein diet might lead to toxic levels of amino acids in the 
blood stream and therefore provoke a protective mechanism leading to an unspecific avoidance of 
an unhealthy diet.  Vomiting or diarrhea reflect such an extreme physiological reactions to maintain 
or protect homeostasis either from nutrients or toxic elements in the diet. To test this hypothesis, 
conditional taste aversion tests were conducted in which rats were exposed to diets very high in 
protein content (>60%) (10, 87). However, animals failed to avoid these high protein diets. Quite the 
contrary was actually observed. A conditioned learned preference was elicited, when proteins or 
amino acids were infused directly into the gut (116, 117). This holds as well for sugar or fat infusion 
therefore potentially reflecting a general response to a gastrointestinal nutrient load. Furthermore if 
animals are allowed to self-select between diets different in dietary protein content, they do not 
show a preference for low or high proteins diets, but select randomly to meet their protein 
requirements. These data collectively suggest that there is a specific mechanism to regulate protein 
intake in terms of quantity and quality intake. In the next chapter I’ll discuss the current known 
signals induced by a protein meal. 
3.5 The Short-Term Control of Protein and Amino Acid Intake  
The brain integrates a large variety of signals to ultimately conduct nutrient intake within a 
homeostatic range. Meal born signals are extremely diverse, redundant and differentially induced by 
macronutrients (Fig. 2). They differ in the temporal occurrence, their origin and their reliability to 
predict the macronutrient or energy content of a meal. In the next few sections I’ll review the 
different signals following the anatomical travel route of a meal. This is not a statement of 
importance or priority but rather an approach to simplify the structure. Critically all these signals are 
12 3. Introduction 
  
 
induced in a narrow time window and consequently may overlap, which might provoke synergies or 
neutralization. 
Figure 2 – General 
information flow 
contributing to the 
neuronal control of 
food intake. 
Important is the 
circulatory nature of 
the diagram 
illustrating that a 
sequence of 
ingestion may be 
initialized or 
terminated by any of 
the nodes in 
diagram. The figure 
was adapted from 
(11).  
 
Taste, Smell, Sight and Texture 
Taste, smell, sight and texture of a meal are obvious signals related to food and might help to predict 
the protein content of a diet directly or based on learned association. Indeed the taste of several 
amino acids, termed umami, is tasty for animals and humans. The heterodimer G-protein coupled 
receptor T1R1/T1R3 mediates the umami taste in mammals and is expressed in taste cells distributed 
randomly over the tongue. This amino acid taste receptor is broadly tuned and responds not only to 
umami (Monosodiumglutamate) but also to most other 20 proteogenic amino acids (106). Excitingly 
the cell type solely determines the behavioral response (preference or rejection), whereas the taste 
receptor the selectivity to the taste (172). Hence, membrane transport or intracellular metabolism 
does not play a role for taste detection. However, T1R1/T1R3 knockout mice have a diminished but 
not an abolished behavioral and neuronal response to umami compounds indicating other forms of 
amino acid taste detection (38). Interestingly T1R1/T1R3 and other taste receptors are not only 
expressed in the oral cavity, but as well in the gastrointestinal tract among others. Recently it was 
shown that the intestinal sugar transport by SGLT-1 and CCK release is controlled by T1R1/T1R3 in 
the small intestine suggesting a broader physiological role for taste receptors (37). No data is 
currently available of the eating behavior of T1R1/T1R3-knockout mice exposed to a high protein 
diet. Nevertheless, altering dietary taste or texture did not prevent the anorectic effect of a high 
protein diet in rats suggesting post-oral mechanism in control of this behavior (88).  This might not be 
surprising as most proteins are still folded and located in their respective cellular compartment, 
thereby hidden from detection by tongue receptors. Obviously this only holds for uncooked food. In 
summary, taste, smell, sight and texture are essential for the binary decision – to eat or not to eat, 
whereas their importance to modulate specific protein intake might be limited. That said the 
underlying taste receptors might be a promising mechanism for nutrient detection, if expressed at a 
different localization. The broad amino acid specificity of the T1R1/T1R3 receptor, however, might be 
problematic to explain the behavioral responds to alterations in protein quality discussed above.  
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Stomach 
The stomach is a reservoir for ingested food and plays a key role for the primary digestion of 
nutrients. Gastric acid secretion mediates the denaturation of proteins and activates different 
digestive enzymes among them pepsin. Pepsin cleaves proteins into di/tri-peptide or single amino 
acids. This digestive process is continued in the duodenum by trypsin/chymotrypsin, which are 
secreted by the pancreas (157). Stomach function and its regulation will be discussed in a subsequent 
section with more detail; here the focus is given to its potential role within the context of food intake 
regulation.  Based on the nutrient digestion the stomach is the primary location where the body is 
exposed to single amino acids and therefore potentially the primary place for their detection. 
However, evidences supporting this are still lacking. Nevertheless mechano-sensitive receptors in the 
stomach where shown to relay neuronal signals via vagal or splanchnic afferent fibers to the 
hindbrain and other brain areas. These receptors were shown to be stretch and tension sensitive, 
hence, signaling gastric distension (137, 167). Obviously, gastric distension was then hypothesized to 
play a role in food intake regulation (reviewed in (73)). Pyloric cuff experiments in rats supported this 
hypothesis and gastric balloon inflation studies showed a significant correlation between inflation 
and perception of fullness, satiation and gastric discomfort in humans (40, 48, 64, 114, 158). If 
feeding behavior was assessed within balloon inflation studies, no effect was observed in humans 
(114). In rats only extensive gastric distension leads to food intake reduction, whereas small 
distension up to 4 ml had no effect (71). Therefore physiological gastric distension might play a role 
for the perception, but seems not to control food intake directly. Additionally it remains unclear, how 
a chemical signal (the amino acid profile of a meal) should be translated solely by mechanical 
distension. In summary the stomach enables chemical, enzymatic and mechanic digestion of food 
and relays mechanical stimuli to the brain.  
Small Intestine 
The small intestine is the primary site of nutrient absorption. Individual amino acids are absorbed by 
a large family of different transport proteins located at the apical membrane of enterocytes. 
Alternatively, di/tri-peptides are absorbed via PepT1 transporter and subsequently catabolized to 
individual amino acids. Importantly only individual amino acids are released into the portal blood by 
basolateral amino acid transporters. Hence, individual amino acids in the blood stream could elicit 
the behavioral response to a high protein diet as their concentration in circulation directly correlates 
with the amount of ingested proteins (118). Apart from enterocytes as well endocrine cells are 
located in the small intestine, which secret a large variety of gastrointestinal hormones involved in 
food intake regulation. STC1 cells, an in vitro model for intestinal endocrine cells, increase 
intracellular [Ca2+] upon stimulation with specific amino acids. [Ca2+] facilitates vesicle fusion to the 
plasma membrane, a mechanism common for neurotransmitter and hormone release (32, 170). 
Indeed, the release of the gut hormone GLP-1 from primary murine intestinal cells correlated with 
intracellular [Ca2+] fluctuation induced by specific individual amino acids (147). Similar amino acid 
specific findings were reported for the release of CCK (159). Hence, this demonstrates a remarkable 
amino acid specificity of the secretory function of endocrine cells ex vivo.  In vivo concentrations of 
CCK, GLP-1, amylin, grehlin, GIP, PYY, glucagon and insulin were altered after a high protein stimulus, 
but conflicting findings were as well reported (19, 20, 55, 83, 101, 113, 125, 141). Interestingly PYY 
knockout mice are selectively resistant to the satiation effect of a high protein diet indicating a 
specific role for PYY (9). However, these results have to be interpreted conservatively as the 
phenotype of PYY knockout mice varies largely between different labs under normal feeding 
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conditions (16, 134). Finally if one considers that fat and carbohydrates as well modulate the 
secretion of gastrointestinal hormones, it remains unclear how gastrointestinal hormones should 
mediate the macronutrient specific ingestive behavior described for proteins. Taken together the 
small intestine enables amino acid absorption into portal circulation and the secretion of a large 
variety of gut hormones.  
Hepatic Portal Vein 
The blood from the small intestine flows to the liver through the hepatic portal vein. Importantly, this 
blood is on the first passage still unfiltered by the liver and therefore thought to be particularly rich in 
nutrients and gastrointestinal hormones acutely after a meal. The blood gets diluted only after 
entering general circulation by the hepatic veins. Exceptions are the branch chain amino acids (L-
leucine, L-isoleucine, L-valine) which are thought not to be altered by liver metabolism (169). 
Importantly, blood amino acid levels change within 10 min after the intake of a meal and show a 
dose dependent increase correlating with the amount of ingested proteins (118). The rise in amino 
acid concentration in the blood plateaus within 30 min after ingestion. By the blood stream, changes 
in amino acid concentration reach all organs including the brain. Hence, acute amino acid changes in 
the blood stream correlate with protein intake. 
Vagus Nerve 
The vagus nerve links the gastrointestinal tract to the brain projecting mainly to the nucleus of the 
solitary tract. The vagus nerve splits after the diaphragm into three branches – the hepatic, cephalic 
and gastric (112). Importantly vagal dendritic ends reach close to the absorptive enterocytes in the 
small intestine, but not into the gastrointestinal lumen. Hence, nutrients must be absorbed for direct 
vagal activation or mediate their effect indirectly by a paracrine mechanism.  80 % of vagal fibers are 
afferents and thought to serve as mechano- or chemo-sensors. Mechanical stimulation of the 
stomach wall by intragastric balloon inflation stimulates gastric vagal firing in vivo and induces cFOS 
expression in the nucleus of the solitary tract (48, 137). Several ex vivo electrophysiological studies 
revealed the amino acid specificity of vagal firing as different amino acids excite or inhibit vagal 
afferent activity dependent on the exposed vagal branch (109–111, 145, 151). Interestingly of all 
amino acids tested only intragastric L-glutamic acid induces vagal signaling ex vivo (78, 154). Not 
surprisingly a duodenal milk protein infusion as well induces vagal afferent firing showing the 
importance of vagal firing under more physiological conditions (149).  Additionally to nutrients, 
several gastrointestinal hormones mediate their anorectic effect by vagal afferents. CCK, GLP-1, PYY 
and grehlin do not alter feeding behavior in animals with a lessioned vagus nerve (1, 52). To the 
contrary a high protein diets still reduces food intake in total vagotomized or capsaicin treated 
(lesion specific for vagal afferents) rats (89, 148). Hence, high protein diets induce vagal signals and 
the release of gastrointestinal hormones, but their relevance to regulate specific protein intake is not 
convincing. Their role might be to specifically adjust gastrointestinal digestive function (motility, 
secretion, pancreatic function, …) to the macronutrient composition of the ingested meal.  
Central Nervous System 
The central nervous system ultimately controls eating behavior. The large variety of cells, their 
connectivity and the high-temporal resolution of neuronal activity make the brain one of the most 
formidable and complex system to understand. Numerous neurons form anatomically defined brain 
areas which presumably are relevant for overlapping functions. Efforts to generate a functional brain 
map were conducted, but remain difficult to understand due to the extensive connectivity and 
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plasticity (11). In context of feeding behavior the hypothalamus received a large amount of attention 
presumably because the homeostatic long- and short-term signals interact at this brain region (Fig. 
1). Nevertheless the brain stem is of broader interest for short term signals, because the vagus nerve 
primarily projects to the nucleus of the solitary tract and the area postrema is thought to sense blood 
born signals. The most simple and direct mechanism to detect protein intake would be neurons 
sensing amino acids. Blood amino acid concentrations correlated with the amount of protein 
ingestion and with total brain amino acid concentrations (118). Even more elegant micro-perfusion 
studies revealed feeding dependent increases in brain amino acid concentrations in freely moving 
animals in different brain regions (25–28). This demonstrates that dietary and therefore circulatory 
amino acids have access to the brain in a reasonable time to contribute to the control of food intake. 
Alternatively amino acids could be detected within one of the circumventricular organs, which are 
not protected by the blood brain barrier for instance in the area postrema or the subfornical organ to 
mention two. Evidence that neurons can directly sense nutrients and thereby modulate food intake 
were first described for glucose and lipids, newer reports suggesting similar mechanisms for amino 
acids (34). The amino acid L-leucine was shown to modulate neuronal activity of hypothalamic cells 
by an mTOR (mammalian target of rapamycine) dependent mechanism (35). Similar mTOR 
dependent L-leucine detection was recently described in the nucleus of the solitary tract located in 
the brain stem (15). mTOR activation in both studies lead to a decrease in food intake. However, the 
role of this effect was challenged by the observation that physiological changes in plasma L-leucine 
concentration by dietary supplementation or genetically induced did not inhibit food intake (81, 102, 
105, 122, 171). Alternatively mTOR independent mechanisms for amino acid sensing by neurons 
were as well described. Hypothalamic orexin/hypocretin neurons were electrically more potently 
excited by non-essential amino acids than essential (76).  The authors suggested a dual mechanism 
for detection involving the inhibition of KATP-channels and the activations of system-A amino acid 
transporters. Taken together, dietary amino acids have direct and quick access to the brain and 
thereby may stimulate amino acid sensitive neurons. The physiological importance of this afferent 
route and their overlap with peripheral signals remains to be disentangled.  
In sum, throughout animal kingdoms a protein diet inhibits food intake more potently than 
carbohydrates or fats under isocaloric condition. Even though proteins can induce peripheral 
neuronal and endocrine mechanisms, there is no convincing data supporting this as the primary 
afferent pathways responsible for the anorectic effect. Currently evolving is the concept of direct 
amino acid detection in the central nervous system thereby enabling amino acid specific eating 
behavior presumably to detect protein quality. Most likely all signals can inhibit food intake, if they 
are experimentally specifically triggered and thereby empowered out of the temporal or 
physiological context. In reality, all of them might help to fine tune behavioral or other still unknown 
functions presumably inducing a selective advantage. If not evolution would have selected against 
them and their trait would have been lost.  
3.6 Gastric Function 
The stomach and its function receive in this thesis a larger attention, because a part of my project 
was devoted to the development of methods to measure its functions. The stomach is located 
between the esophagus and the small intestine and plays several important roles for nutrient 
digestion with its secretory, endocrine and motor functions (157). Nevertheless it must be noted, 
that the stomach is not required for survival. For instance total gastrectomy patients, providing a 
adapted diet, maintain adequate health and longevity (157). Less extensive but still substantial 
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reduction of stomach size within one of the diverse gastric bypass surgeries does neither lead to 
mayor absorption problems (8, 42). Anatomically the stomach can be roughly divided into three 
parts:  First the cardia is a region distal to the gastroesophageal sphincter, the fundus is the largest 
part of the stomach and the distal antrum separates the stomach from the small intestine by the 
pyloric sphincter. The most relevant functional aspects of the stomach can roughly be divided into 
secretory and motor functions. Both will be discussed in the next section.  
Gastric Secretion 
Gastric secretion affects the kinetics of digestion and absorption. The acid environment in the 
stomach provokes protein unfolding and leads to the autocatalytic activation of different gastric 
proteases. Furthermore the extent of secretion defines the concentration of nutrients and thereby 
indirectly contributes to nutrient absorption in the small intestine (23). Beyond digestion gastric 
secretion is critical to protect the upper gastrointestinal tract from bacterial colonization and 
infections. For instance patients with decreased gastric secretion are more prone to enteric 
infections by H. pylori, E. coli or V. cholera (22, 97). Gastric secretion is mediated mainly by two cell 
types - the chief cells, which secreted pepsinogens but not acid, and the parietal cells mediating acid 
secretion (135, 136, 157). Upon stimulation of the later, vesicle containing H,K-ATPase and K+ and Cl- 
channels fuse to the canalicular membrane.  H+ extrusion drives gastric secretion in exchange for K+, 
which is recycled to the stomach lumen by the K+ channels. Cl- moves passively into the stomach 
lumen. To energize the process parietal cells have a large amount of mitochondria performing 
oxidative phosphorylation and the Na,K-ATPase at the basolateral membrane uses ATP units to 
maintain/generate the electrochemical Na+, K+ gradient. Importantly the H,K-ATPase can be inhibited 
either directly using omeprazole or indirectly by inhibiting the Na,K-ATPase with ouabain. Both 
inhibitors are specific and do not interfere with each other. Stimulation of parietal cells can be direct 
or indirect via enterochromaffin-like cells (ECL) located in the lamina propria. The pathway by which 
a stimulus acts can be disentangled by inhibiting Histamine-2-receptors (cimetidine or ranitidine) as 
Histamine is the primary neurotransmitter released from ECL cells. Nevertheless parietal cells as well 
express a large number of receptors and therefore can be stimulated directly for instance by 
acetylcholine released from the enteric nervous system or different hormones such as CCK or gastrin. 
The most prominent inhibitor of gastric secretion is somatostatin. The number of hormones affecting 
gastric secretion is still increasing, however, for most it is still unclear if they can act as well by the 
enterogastric route and not only if administered intraperitonal.  Most probably there is a large 
redundancy within these pathways thereby guaranteeing robustness of this digestive mechanism. 
Gastric Motor Function 
Gastric motor activity serves three functions (23, 157). First, swallowed food has to be 
accommodated thereby the stomach serves as a nutritional reservoir. This is achieved by a neurally 
mediated reflex inducing a relaxation in the fundus with no change in intragastric pressure. Second, 
the ingested food has to be churned and digested – this is particularly true for solids. Solids move in a 
process termed propulsion from the fundus to the antrum following peristaltic waves, which are 
initiated by gastric pacemakers located in the great curvature. If solids did not reach a size smaller 
than 2 mm in humans, they cannot pass the pylorus and are trapped in the antrum. There the solids 
are grinded by arriving peristaltic waves and moved backward following the trough of the peristaltic 
wave, a process termed retropulsion. Third, the pylorus and the small intestine determine the rate of 
gastric emptying.  Solids empty similar to liquids, but describe a two phase process. An initial lag 
phase required for churning and grinding followed by a general emptying phase which is similar 
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between solids and liquids. Therefore several research teams focus on the effect of liquid emptying 
and do not assess solid emptying additionally. Gastric emptying is modulated by diverse signals, 
which are discussed in the next section.  
Regulation of Gastric Function 
Even though here gastric emptying and secretion were individually discussed both interact and 
synergize during digestion. Here, I aim to give a better integrated view of both processes upon meal 
ingestion and a focus is given to the impact of proteins and amino acids. The responses are complex 
and are historically separated into 3 phases: cephalic, gastric, and intestinal. Obviously this is a 
necessary simplification and considerable overlap exists. 
The cephalic phase is the initial phase, where different gustatory, olfactory and visual stimuli 
“prepare” the stomach for the ingested food. These sensory inputs are mediated solely by the vagus 
nerve and are thought to mediate up to >30-40 % of the overall secretory response to a meal, 
whereas the impact on motor function is less well understood (23).  
The gastric phase includes all mechanism induced within the gastric tract. The most critical function 
is the extent of gastric emptying. Non-nutrient liquids empty exponentially, whereas a more linear 
emptying is observed with increasing nutrient and caloric content of a meal. The rate of gastric 
emptying is primary determined by the caloric content of the ingested meal. It is generally accepted 
that a human stomach empties at a rate of ~200 kcal/h, whereas other meal properties such as 
volume, osmolality or macronutrient composition have a minor effect (70, 96). However, this view 
has been challenged by reports showing that high protein diets delay gastric emptying in an isocaloric 
setup in rats and humans (13, 44). Controversially other reports show no effect of a high protein load 
(58). Hence, the chemospecificity of gastric emptying remains debatable. Gastric secretion is known 
to be strongly induced by gastric distension and high protein diets (157). L-phenylalanine can induce 
gastric secretion indicating an even more amino acid specific effect (95). The most important 
hormone induced during the gastric phase of a meal is gastrin (136). Gastrin is responsible for at least 
50 % the meal induced gastric secretion and mediates its effect directly via CCK2 receptors on parietal 
cells and indirectly by stimulating histamine release from ECL cells. Gastrin was shown to be released 
upon stomach distension, but whether its release can be differentially induced by meals 
macronutrient content remains unclear.  The importance of the gastric phase for the intestinal 
absorption is highlighted by a study, which showed that gastric emptying determines to >30% of the 
variance observed after an oral glucose load (67). This potentially as well accounts for the strong 
variations observed after oral glucose tolerance tests (72). 
During the intestinal phase nutrients are absorbed by enterocytes, they can also stimulate the 
release of several hormones from endocrine cells along the intestinal tract and they can mediate a 
vagovagal reflex to modulate gastric emptying and secretion. Most prominently it was shown that 
the glucose infusion into the duodenum calibrates the gastric emptying rate so that ~200 kcal/h 
empty (21). However, it remains unclear to which extent portal glucose stimulates vagal afferents or 
if the release of insulin, GIP, CCK, GLP-1 or other gastrointestinal hormones contribute to this precise 
gastric emptying mechanism. Nevertheless it is clear that a protein rich meal in vivo or individual 
amino acids in vitro can stimulate specific hormone release as discussed above. Indeed it was shown 
that in rats proteins delay gastric emptying and that this effect can be antagonized by application of 
devazepide (CCK-antagonist) (126). Importantly, the inhibition was not complete suggesting other 
non-CCK mediated mechanism. Hence, GI hormones do play a role in adjusting gastric emptying and 
secretion. As they can be stimulated by different macronutrients (fats, carbohydrates and proteins), 
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there are considerable indications that gastric emptying is controlled by more than the caloric 
equivalent of a meal. Additionally it remains to be deciphered how these different endocrinel, 
paracrinel, neuronal and meal related signals interact to control gastrointestinal function.  
In summary, the stomach plays an important role for the accommodation, digestion and the release 
of nutrients into the small intestine. Gastric emptying and secretion are the main modulatory 
functions and their regulation integrates neuronal, paracrine, endocrine and meal-related signals.  
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3.7 Aim of this Study 
Essential for the understanding of this thesis is the knowledge that the side chains of amino acids are 
diverse leading to specific chemical characteristics. In fact, there are 20 proteogenic amino acids 
varying in size, charge, polarity and atomic composition. We hypothesize that based on these 
structural differences they may have distinct roles in the control of food intake and gastric 
function. 
Our overall strategy is to systematically test the impact of all proteogenic individual amino acids on 
food intake and on gastric function, compare their effect strength and decipher the mechanism of 
the most potent modulators.  
 
Aim 1 – Which amino acid most potently modulates food intake? 
We systematically tested the impact of all proteogenic amino acids on food intake and deciphered 
their neuronal afferent pathway. Additionally we showed that they distinctly alter gastrointestinal 
function and that the gastric and behavioral effects are dissociated. This data is summarized in the 
manuscript entitled: “Specific Amino Acids Inhibit Food Intake via the Area Postrema or Vagal 
Afferents.”. 
Aim 2 – Which amino acid most potently modulates gastric function? 
We aimed to systematically test the impact of all proteogenic amino acids on gastric function. Here, 
we encountered a technological hurdle as no current method can assess simultaneously gastric 
secretion and emptying in vivo (56, 144). Additionally current methods are lethal, invasive or 
technically limited and therefor disable systematic studies. To overcome this limitation, we 
developed a novel method based on computed tomography to assess these two functions. The 
method was extensively tested and validated leading to a manuscript entitled: “Simultaneous 
assessment of gastric emptying and secretion in rats by a novel computed tomography based 
method”. This method provided the basis to address the above question. We tested the impact of all 
proteogenic amino acids on gastric emptying and secretion in vivo. This data is shown in the 
unpublished result section of this thesis.   
Aim 3 – Can the effect of L-lysine be translated to humans? 
Within the systematic study “Specific Amino Acids Inhibit Food Intake via the Area Postrema or Vagal 
Afferents.” the amino acid L-lysine showed a remarkable effect on food intake, gastric emptying and 
secretion. We questioned whether these effects can be translated to humans. Therefore we 
conducted a dose depend study of the effect of L-lysine on food intake in rats and on visual analog 
scales in humans. Additionally we assessed gastrointestinal function in rats based on lethal 
methodology and magnetic resonance imaging in humans. The findings of this translational study are 
subject to publication in a manuscript entitled:  “L-Lysine dose dependently delays gastric emptying 
and increases intestinal fluid volume in humans and rats”.  
 
Overall we showed a remarkable amino acid specific impact on several important nutritional 
functions.  The underlying mechanism was deciphered within the physiological context. Still open 
remains the question for the cellular mechanism of specific amino acid detection at a molecular level.  
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4. Original Research Article: “Specific Amino Acids Inhibit Food Intake 
via the Area Postrema or Vagal Afferents.” 
 
This section contains an original research article that was published in the Journal of Physiology on 
July 29, 2013.  
 
My contribution to this paper includes the study design and data interpretation under the 
supervision of F. Verrey and T. Lutz. I performed all experiments including the surgeries and wrote 
the paper with the help of F. Verrey and T. Lutz. Additionally I supported S. Camargo writing the ZHIP 
grant prolongation.    
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Key Point Summary: 
 Proteins are more satiating than fats or lipids. Proteins are built by the 20 proteogenic 
amino acids.   
 Here, we identified L-arginine, L-lysine and L-glutamic acid as the most potent 
anorectic amino acids in rats.  
 L-arginine and L-glutamic acid require intact neurons in the area postrema to inhibit 
food intake, whereas L-lysine intact afferents fibers of the vagus nerve. All three 
mediate their effect by the blood stream.  
 All three amino acids induce gastric distension by delaying gastric emptying and 
inducing secretion. However, the gastric phenotype does not mediate the anorectic 
response.  
 These results unravel amino acid-specific mechanisms regulating digestion and eating 
behavior and thereby contribute to the understanding of nutrient sensing in vivo.   
Word count: 113 
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Abstract:  
To maintain nutrient homeostasis the central nervous system integrates signals that promote 
or inhibit eating. The supply of vital amino acids is tuned by adjusting food intake according 
to its dietary protein content. We hypothesized that this effect is based on the sensing of 
individual amino acids as a signal to control food intake. Here, we show that food intake was 
most potently reduced by oral Arg, Lys and Glu compared to all other 17 proteogenic amino 
acids in rats. These three amino acids induced neuronal activity in the blood-sensing area 
postrema and the nucleus of the solitary tract. Surgical lesion of the area postrema abolished 
the anorectic response to Arg and Glu, whereas vagal afferent lesion prevented the response to 
Lys. These three amino acids also provoked gastric distension by differentially altering gastric 
secretion and/or emptying. Importantly, these peripheral mechanical vagal stimuli were 
dissociated from the amino acids’ effect on food intake. Thus, Arg, Lys and Glu had a 
selective impact on food processing and intake suggesting them as direct sensory input to 
assess dietary protein content and quality in vivo. Overall, this study reveals novel amino acid 
specific mechanisms for the control of food intake and of gastrointestinal function. 
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Abbreviation List: 
4V, 4th ventricle; Ala, L-alanine; AP, area postrema; Arg, L-arginine; CCK, Cholecystokinin; 
DMX, dorsal motor nucleus vagus nerve; GLP1, Glucagon-like Peptide 1; Glu, L-glutamic Acid; 
GR, gracile nucleus; HK, high L-lysine dose (6.7 mmol/kg Lys); IG, intragastric; IP, 
intraperitonal; IV, intravenous; Leu, L-leucine; LK, low L-lysine dose (2 mmol/kg Lys); Lys, L-
lysine; mTOR, mamaliane target of rapamycin; NTS, nucleus of the solitary tract; Phe, L-
phenylalanine; PYY, Peptide YY; RLA, ringer lactate; Trp, L-tryptophane; Tyr, L-tyrosine. 
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Introduction: 
 Survival of an organism depends on its capability to adjust eating to its nutritional 
requirements. The brain ultimately controls this balance by integrating diverse signals 
related to the nutritional status of the body and the ingested meal both in terms of its 
energy- and macronutrient content (Morton et al. 2006). Meal born signals can be sensed 
centrally in specialized brain areas or be relayed from the periphery by abdominal vagal 
afferents, all finally leading to meal termination. The induction of these satiating signals 
might be triggered directly by circulating nutrients, indirectly by hormones released from 
enteroendocrine cells or via mechanical stimuli such as gastric distension as discussed in 
several reviews (Morton et al. 2006; Woods, 2009; Fromentin et al. 2012). In many cases, 
these mechanisms were studied for their role in energy homeostasis, whereas their 
macronutrient specificity was subject to less extensive research.  
Protein intake is a necessity to supply the organism with essential amino acids and species as 
diverse as insects, fish, rodents, and humans adjust food intake according to its dietary 
protein content (Morrison et al. 2012; Anderson et al. 2004). The sensory mechanisms 
eliciting this behavior are however debated. Taste, smell, sight and texture of a meal have 
been suggested to help identifying its protein content based on learned associations, but 
experimental alterations of these cues did not prevent the anorectic effect of a high protein 
diet in rodents (L'Heureux-Bouron et al. 2004). Physiological sensory mechanism detecting 
the protein content of a meal might therefore originate from the gut or be post-absorptive 
for instance in peripheral nerves or directly in the brain.  Indeed, the digestion of proteins to 
amino acids in the gastrointestinal tract stimulates vagal and endocrinal signals including 
CCK, GLP-1 and PYY release (Tome et al. 2009; Blom et al. 2006). However, total vagotomy 
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did not interfere with the anorectic effect of a high protein diet (L'Heureux-Bouron et al. 
2003) and the specificity of gastrointestinal hormones for protein intake is debatable as 
lipids and carbohydrates induce similar hormonal responses (Morrison et al. 2012). An 
alternative possibility is that amino acids may act directly on nutrient sensing neurons. 
Indeed, it was shown that the injection of the amino acid Leucine directly into the brain 
ventricles inhibits food intake via modulation of mTOR-signaling (Cota et al. 2006; Blouet & 
Schwartz, 2012; Morrison et al. 2007). However, the role of this effect was challenged by the 
observation that physiological changes in plasma Leu concentration did not inhibit food 
intake even though circulating amino acids have access to the brain (Laviano et al. 2006; 
Zhang et al. 2007; Purpera et al. 2012; Nassl et al. 2011; Potier et al. 2009; Morrison et al. 
2012). Importantly, all other 19 individual amino acids were so far not studied. Hence, the 
sensory mechanisms tuning ingestion of food to the dietary protein content remains elusive.  
Here, we hypothesize that specific individual amino acids act as a physiological signal to 
control food intake. First, we systematically investigated which individual amino acid given 
by oral gavage had a specific impact on food intake in rats. We showed that Arg, Lys, and Glu 
were significantly more active than all other proteogenic amino acids at an isomolar dose. To 
localize their respective sensory mechanism, we performed surgical invalidations that 
demonstrated in the case of Arg and Glu the involvement of area postrema neurons, and in 
the case of Lys of vagal afferents, respectively. Interestingly, in the gut all three amino acids 
induced gastric distension by specifically inducing secretion or delaying gastric emptying. 
However, these peripheral mechanical stimuli were not linked to the control of food intake 
as intravenously applied Arg and Lys inhibited food intake, but did not modulate 
gastrointestinal function. These results demonstrate for the first time the importance of Arg, 
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Lys and Glu for the independent adaptation of digestive functions and eating behavior 
probably as a direct sensory input to evaluate dietary protein content and quality.
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Methods: 
Ethical Approval 
All procedures for rat handling and experimental interventions were according to the Swiss 
Animal Welfare laws,approved by the Kantonale Veterinäramt Zürich and conform to the 
principles of UK regulations. 
Animal care 
Male Wistar rats (Janvier, France) were individually housed in wire-mesh hanging cages 
(room temperature 21 ± 1° C, artificial 12/12 h light dark cycle, water ad libitum, rat chow-
3430 Kliba Nafag, Kaiseraugst, Switzerland).  
Application and euthanasia 
Intragastrically administered L-amino acids (freshly prepared, Sigma-Aldrich, Buchs, 
Switzerland) were applied in 2 ml tap-water. 6.7 mmol/kg was selected as a single dose for 
the screen based on comparison to other previous publications (Ng and Anderson, 1992; 
Bialik et al. 1989). The plasma amino acid changes measured after individual amino acid 
administration (S. Tab. 2) are in the range observed after the intake of a high protein diet 
(Peters & Harper, 1987).Intravenously administered L-amino acids were dissolved in Ringer-
lactate and adjusted to pH 7.2. Animals were euthanized using pentobarbital (IP, 100 mg/kg, 
Kantonsapotheke Zürich, Switzerland) in combination with isoflurane (5 %) for quicker 
induction. 
Measurement of food and water intake 
Food/water intake was measured manually by weighing food containers/water bottles or 
using an automated system (BioDAQ, Research Diets, New Brunswick, USA). A meal was 
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defined by the intake of at least 0.25 g chow, and the intermeal interval criterion was set to 
10 min.  
Blood analysis 
Blood was collected into EDTA-coated tubes (Sarsted, Sevelen, Switzerland), inverted and 
centrifuged (1000 g, 10 min, 4 °C). Plasma amino acid concentration were measured by the 
Functional Genomics Center Zurich using high pressure liquid chromatography, plasma ions 
by enzymatic detection with Picollo Renal Functional Panel (Abaxis, Darmstadt, Germany) 
and plasma glucose by AccuCheck Aviva (Roche, Basel, Switzerland).  Gastric secretion was 
previously shown to correlate with base excess in blood, an effect termed alkaline tide (S J 
Rune, 1966; Niv et al. 1993). 
Phenol red quantification 
Phenol red (Sigma) was quantified as described by others (Tsurugizawa et al. 2009). Phenol 
red recovery was  57.5 ± 0.6 % (Fig. S3A), respectively 74.3 ± 0.9 % (Fig. S3B) of the 
administered oral dose with no significant differences between treatment groups, thereby 
enabling comparison.  
cFOS immunohistochemistry 
This time point after gavage was chosen, because cFOS expression is strongest 90-120 min 
post-stimulation(Watts et al. 2006). Animals were anesthetized with pentobarbital (no 
isoflurane) and perfused transcardially with ice-cold phosphate buffer (0.1 M PB), followed 
by 4 % paraformaldehyde in PB. After removal brains were kept in paraformaldehyde for 2 h 
to achieve proper tissue fixation. Following incubation in 20 % sucrose solution (in PB, 48 h, 
4°C) brains were snap frozen in hexane. Coronal sections (20 μm) were cut in a cryostat (CM 
3050 Leica, Germany) throughout the brain. Every slice was thaw mounted on microscopic 
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glass slides (SuperFrost Plus Faust, Switzerland). For the detection of cFos expression, frozen 
sections were air-dried at room temperature for 1 h and rehydrated in PBS. Unspecific 
binding was blocked by 2 h incubation in 1.5 % normal donkey serum. The primary antibody 
(1:5000, rabbit anti cFos, Ab-5, Calbiochem) was applied for 48 h at 4 °C. Sections were 
incubated with the secondary antibody (1:10’000, biotinylated donkey anti rabbit, Jackson 
711-065-152) for 2 h at room temperature. After incubation in ABC (Vectastain-Elite ABC Kit, 
Vector Laboratories), followed by 0.05 % DAB solution (in 0.05 M Tris-HCl with 0.009 % H2O2 
and color enhancement with 0.04 % NiCl2*6H2O and 0.08 % CoCl2*6H2O), the sections were 
dehydrated in graded alcohols, cleared in xylene and fixed with entellan. The rat brain atlas 
of Swanson was used to localize the cFOS expressing neurons (Swanson, 2004). In 3 adjacent 
sections cFos positive cells were counted manually ca. at Bregma -13.76 in the AP and the 
NTS by a treatment blinded investigator. 
AP-lesion surgery 
AP-lesion was conducted similar to a thermal lesion approach described previously, except 
that the AP was removed by vacuum aspiration to reduce damage in the NTS (Lutz et al. 
1998). Surgery success and specificity was verified functionally and histologically. The 
functional test was the absence of amylin induced satiation, which depends on an intact AP, 
and the presence of CCK induced satiation, which depends on intact vagal afferents (Lutz et 
al. 1998; Ruttimann et al. 2009).16 h food deprived rats were IP injected with amylin (10 
μg/kg, Bachem AG, Bubendorf, Switzerland), CCK-8 (4 μg/kg, Bachem AG) or saline, 
respectively in a cross over design. AP-lesioned animals that did not reduce 30 min post-CCK 
application food intake by at least 30% were excluded due to a damaged vagus nerve (6 of 
24 animals; food intake: sham NaCl 4.2 ± 0.3 g, sham CCK 2.1 ± 0.4 g, AP-lesion NaCl 2.9 ± 0.3 
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g, AP lesion CCK 0.9 ± 0.3 g). AP-lesioned animals that reduced 2 h post-amylin application 
food intake by more than 15% were excluded due to incomplete AP-lesion (7 of 24 animals; 
food intake: sham NaCl 8.6 ± 0.6 g, sham amylin 6.5 ± 0.5 g, AP-lesion NaCl 7.6 ± 0.6 g, AP 
lesion amylin 8.3 ± 0.7 g). Histological validation of the surgery included a test for the 
anterograde labeling capacity of vagal afferents to the NTS (Ruttimann et al. 2009). Rats 
were IP injected with 1 mg fluorogold (Fluorochrome, Denver, USA) in 1 ml saline 3 days 
before their brains were excised and fixed by a pH-switch protocol described by Khan et al 
(Khan et al. 2007). Brain sections were cut as described above, slides air dried and fixed with 
glycerol. An observer blind to surgery quantified the extent of the AP-lesion and counted 
fluorogold labeled neurons in the NTS. Only animals with histologically confirmed AP-lesion 
and similar numbers of fluorogold positive NTS neurons as sham lesioned animals were 
included for the final statistical analysis. 
Capsaicin vagotomy 
The local vagal capsaicin treatment was performed as previously described (Raybould and 
Tache, 1988). Surgery success and specificity was verified functionally and histologically. The 
functional test was the absence of CCK induced satiation, as described above. Capsaicin 
treatment was considered successful if CCK reduced eating 30 min post application by less 
than 30% compared to controls (3 of 13 animals excluded; food intake: sham NaCl 4.8 ± 0.2 
g, sham CCK 2.5 ± 0.3 g, Capsaicin-treated NaCl 3.9 ± 0.g g, Capsaicin-treated CCK 3.7 ± 0.3 
g). Histological validation of the surgery included a test for the anterograde labeling capacity 
of vagal afferents to the NTS as described above. Only animals with histologically confirmed 
fluorogold staining in the AP (as injection control) and decreased fluorogold staining in the 
NTS (due to damaged vagal afferents) were included into the final statistical analysis. 
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Conditioned taste aversion 
Water access is restricted during the 14 days of the conditional taste aversion test. 
Importantly animals received access to water or saccharine specific to the experimental day 
as specified below for a 30 min period at dark onset. In the first 4 days of the experiment 
rats received access to two water bottles to adapt animals to the drinking schedule. On day 5 
rats received access to two bottles saccharine (0.3 % in tap water, Sigma). Saccharine intake 
was equal between experimental groups on day 5 thereby showing equal preference for 
saccharine intake. Following the 30 min access to saccharine, amino acids (IG, 6.7 mmol/kg; 
IV 2 mmol/kg) or LiCl (IP, 76 mg/kg, Sigma), which was used as positive control, were 
administered. This conditioning paradigm was repeated on days 8 and 11; in between, i.e. on 
days 6-7, 9-10 and 12-13, respectively, water was offered as described for days 1-4. On Day 
14 rats were presented one bottle of water and one bottle of 0.3 % saccharine for 30 min at 
dark onset. Rats were offered water 4 h after dark onset for a 45 min period every day to 
ensure proper hydration. Liquid intake was measured throughout the entire experiment by 
weighting the bottles.  
Images  
Stomach images were captured with a digital camera (D50, Canon), brain slice images with 
the microscope (Axio Imager 2, Zeiss). Images were not altered except for minor 
adjustments in brightness and contrast. Fluorogold images were black/white inverted for 
better visibility.  
 
 
 
33 4. Original Research Article: “Specific Amino Acids Inhibit Food Intake via the Area 
Postrema or Vagal Afferents.” 
  
 
Statistics 
Rats were randomly allocated into treatment and/or surgical group. Application order was 
randomized. Results are presented as mean ± standard error of the mean. The data were 
analyzed using Graph Pad Prism 5.0. 
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Results:  
Identification of the most potent oral anorectic amino acids  
To identify the most potent anorectic individual amino acid, we administered isomolar doses 
of all 20 proteogenic amino acids individually to rats via the physiological gastrointestinal 
route and measured subsequent food intake. The amino acids were administered by gavage at 
an equal dose of 6.7 mmol/kg, corresponding in the case of Glu to 1g/kg and 27% of average 
daily Glu intake. Surprisingly the anorectic response induced by individual amino acids did 
not follow a rank order according to side chain structure, energy content, nutritional necessity 
(essential) or role as neurotransmitter (-precursor), but rather revealed a unique role for Arg, 
Lys and Glu (Fig. 1A). Each of these three amino acids significantly reduced food intake in 
the first hour after administration, whereas all other amino acids had no significant effect 
compared to water control (Fig. 1A). In the long term only Arg and Lys decreased food 
intake, whereas Glu treated animals compensated for the initial decrease in food intake in the 
following 48 h (Fig. 1B). Consistent with previous studies, oral Trp had a small effect on food 
intake which, however, was statistically not significant when testing for multiple comparisons 
(Fig. 1A, unpaired two-tailed t-test, p=0.03, Ng and Anderson, 1992); the other aromatic 
amino acids Phe or Tyr did not inhibit food intake as previously shown (Bialik et al. 1989). 
Meal pattern analysis indicated that oral Arg, Lys and Glu administration reduced eating only 
by an effect on the first meal size while the latency to meal initiation, meal number, meal 
duration or time between meals did not differ (Fig. 1C-F). Additional control experiments 
excluded that pH, osmolarity or the feeding state, hence the presence of nutrients, altered the 
anorectic effect of Lys (Fig.S1); dose response studies indicated a plateauing of the anorectic 
effect at 4.7 to 5.4 mmol/kg (Fig. S2A-C). Drinking behavior was not altered by Arg and Lys, 
but Glu reduced water intake in a dose dependent manner (Fig. S2D-F). These findings are 
35 4. Original Research Article: “Specific Amino Acids Inhibit Food Intake via the Area 
Postrema or Vagal Afferents.” 
  
 
striking because they identify Arg, Lys and Glu as the individual amino acids with the 
strongest anorectic effect.  
Neuronal pathways mediating the anorectic effect of Arg, Lys and Glu 
Eating behavior is ultimately controlled by the brain, which integrates a large array of 
sensory inputs projecting to specific areas (Berthoud, 2002). Therefore we investigated 
where in the brain Arg, Lys and Glu triggered neuronal activity by assessing the number of 
cells expressing cFOS, a neuronal activity marker induced by increases in intracellular Ca2+ 
(Watts et al. 2006).  Upon gavage with these three amino acids, an increased number of 
cFOS positive cells were detected in the nucleus of the solitary tract (NTS) and the area 
postrema (AP); two areas known to mediate the effect of specific anorectic signals (Fig. 2). 
Importantly, the AP is not protected by the blood brain barrier such that it may directly 
sense blood borne signals, and the NTS is the main projection site of vagal afferents (Morton 
et al. 2006). In contrast, the nucleus accumbens or the hypothalamus (arcuate nucleus, 
paraventricular nucleus of the hypothalamus, lateral hypothalamic area) did not display 
increased cFOS expression at this time point. To discriminate whether the anorectic effect of 
Arg, Lys and Glu was mediated via the AP or vagal afferents, we surgically lesioned both 
routes. The AP was vacuum aspirated, whereas vagal afferents were chemically lesioned by 
local sub-diaphragmatic capsaicin application. Surgery specificity and success was validated 
functionally and histologically (Fig. 3A). Arg and Glu lost their anorectic effect in AP-lesioned 
animals, but not in capsaicin-treated animals (Fig. 3B-C). Lys, on the other hand, showed an 
opposite response to the surgical interventions because its anorectic effect was dependent 
on intact vagal afferents but not on intact AP (Fig. 3). These findings suggest that the 
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anorectic response to Arg and Glu is induced centrally in the area postrema, whereas Lys 
response is relayed from the periphery to the NTS by abdominal vagal afferents.  
Satiation effects are dissociated from gastrointestinal actions 
Vagal afferents fire also in response to gastric distension, which may contribute to meal-
ending satiation (Woods, 2009).  Apart from the ingestion of food and water, gastric 
distension can also be due to gastric secretion or delayed gastric emptying, the latter 
described to depend mainly on the gastric caloric content (Camilleri, 2006). Arg, Lys and Glu 
increased gastric distension 0.5 h after their application, an effect which coincided with the 
time of decreased food intake (Fig. 4A). The increase in gastric volume by Arg and Lys 
administration appeared to be mediated by acidic gastric secretion as the alkaline tide 
increased plasma albumin-, and decreased plasma Cl- concentration (Tab. S1). Gastric 
emptying was delayed by Lys and Glu, as measured by phenol red retention in the stomach 
(Fig. S3A). For all three amino acids, wet weight of the stomach and/or cecum was still 
increased 1.5 h after amino acid administration (Fig. 4B). These findings demonstrate that 
specific amino acids differentially modulate gastrointestinal function, an important finding in 
light of the caloric focus in this field (Camilleri, 2006). We next tested whether the gastric 
and anorectic responses to Arg, Lys and Glu are functionally linked by bypassing the 
gastrointestinal lumen through intravenous amino acid administration. The dose of 2 
mmol/kg was selected, because it led to similar changes in plasma amino acid concentration 
as the oral dose (6.7 mmol/kg) given by gastric gavage (Tab. S2). Intravenous Arg, Lys and 
Glu reduced food intake similar as after oral application, but only intravenous Glu had an 
effect on gastric function (Fig. 5, Fig. S3B, Tab. S2). However, in AP-lesioned animals Glu 
delayed gastric emptying, but did not inhibit food intake (Fig. 3; Fig. S4). These data suggest 
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that all three amino acids Arg, Lys and Glu, inhibit food intake through circulation and that 
their effect on gastrointestinal function can be dissociated from their anorectic effect. 
Finally we tested if the three amino acids cause visceral discomfort. Therefore we conducted 
a conditioned taste aversion test after Arg, Lys and Glu administration by the intragastric 
respectively intravenous route. Oral Glu treatment did not alter the innate preference to 
saccharine of rats, whereas oral Arg and Lys did induce conditioned taste aversion (Fig. 6A). 
If Arg and Lys were given intravenously animals did not reduce their saccharine intake (Fig. 
6B). These data suggests that the gastrointestinal function changes caused by oral Arg and 
Lys, but not by intravenous Arg and Lys, induced conditioned taste aversion. Importantly the 
anorectic effect of Arg and Lys was equally prominent after oral or intravenous application 
suggesting limited importance of visceral discomfort for their anorectic effect.    
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Discussion:  
Our study establishes a novel role of the amino acids Arg, Lys and Glu in the control of food 
intake and gastrointestinal function. This expands the existing concept of gastrointestinal 
function modulation through the caloric content of meals by adding specific amino acids as 
novel calorie-independent signals (Camilleri, 2006).  By inducing gastric secretion these 
amino acids may favor acid-mediated denaturation of proteins and, by delaying gastric 
emptying, extend the time for enzymatic protein digestion. Hence, we suggest that the 
gastrointestinal tract recruits appropriate digestive capacity to cope with a high protein load 
based on specific amino acid detection. Future work should more systematically test the 
effect of individual amino acids on gastrointestinal function with an emphasis on translating 
animal findings to humans. Gastric distension is a mechanical stimulus, transmitted by vagal 
afferent to the NTS that may contribute to the control of food intake (Schwartz, 2006; 
Woods, 2009; Davis et al. 1993).Our experiments did however not support such a nutrient 
unspecific gut-brain axis and showed a clear dissociation of the gastric and the behavioral 
responses to Arg, Lys and Glu as schematically represented in Fig. 7. In agreement, gastric 
distensions in balloon inflation studies did not inhibit food intake in rats and humans (Oesch 
et al. 2006).  
Our data highlight the importance of circulating amino acids for the control of food intake 
and we identified Arg, Lys and Glu as the most effective ones, at least at isomolar doses. 
Naturally a complete dose-response relationship for all twenty amino acids would be 
desirable, nevertheless the here used single dose approach enabled the identification of the 
most potent anorectic amino acids. All three induced satiation by reducing first meal size, 
but not meal duration, unlike classical satiation-inducing peptides such as CCK or amylin 
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which proportionally reduce meal size and duration (Woods, 2009). Interestingly, the 
observed amino acid specificity is in marked contrast to the previously emphasized unique 
role of the amino acid Leu, which inhibits food intake by regulating mTOR signaling when 
administered directly to the third brain ventricle (Cota et al. 2006; Morrison et al. 2007). 
Indeed, consistent with others who showed that physiological changes in plasma Leu 
concentration do not lead to a reduction of food intake, our data also do not support a role 
of peripheral Leu for food intake control (Laviano et al. 2006; Zhang et al. 2007; Purpera et 
al. 2012; Nassl et al. 2011; Morrison et al. 2012). Importantly, so far no systematic study on 
the effect of the 20 proteogenic amino acids had been published (Fig. 1A). Here, we unravel 
an amino acid specificity that can be interpreted either as an evolutionary reductive strategy 
to detect the few amino acids that most accurately indicated protein supply or as a strategy 
to detect protein quality (Lamb, 2012). Supporting the latter possibility, high protein diets of 
different sources differentially alter satiation in rodents and humans (Faipoux et al. 2006; 
Anderson et al. 2004; Pichon et al. 2008). 
Interestingly two different afferent pathways respond specifically to one of the candidate 
amino acids. This redundancy may ensure accurate detection of protein intake in vivo. 
Others have already proposed the existence of a Lys sensor located on vagal afferents 
innervating the hepatic portal vein. However, the molecular identity of the sensor remained 
obscure (Torii K & Niijima, 2001). Similarly the molecular mechanism of Arg and Glu sensing 
by area postrema neurons is unknown, but other previously reported neurons able to sense 
specific amino acids (Cota et al. 2006; Blouet & Schwartz, 2012; Karnani et al, 2011). We 
identified here three novel amino acids as potent modulator of short-term food intake and 
suggest their neuronal site of action. They can contribute to the anorectic effect of a high 
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protein diet as Arg, Lys and Glu plasma concentrations were shown to raise proportionally to 
the protein content of a meal (Peters & Harper, 1987). Analogously dietary Arg 
supplementation was shown to reduce body weight gain in rats (Fu et al, 2005). Based on 
the aversive response rat exhibit to diets depleted from essential amino acids, we expect a 
diet depleted from Arg to be rejected but we are currently not aware of such a study 
(Morrison et al, 2012). One can speculate that a diet supplemented or partially restriction of 
the three candidate amino acids may mimic the effect of a high respectively of a low protein 
diet on feeding behavior. Taken together we propose that the central nervous system 
detects dietary protein content and quality to control food intake by sensing specific 
circulating amino acids, in particularly Arg and Glu via the AP and Lys via vagal afferents (Fig. 
7).  
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Figures & Figure Legends:  
Figure 1. Intragastric Arg, Lys and Glu inhibited food intake most potently of all 
proteogenic amino acids. After 12 h food deprivation rats were gavaged with isomolar doses 
of individual amino acids (6.7 mmol/kg, which in the case of Glu corresponds to 1 g/kg and to 
27 % of the daily average Glu intake) and their subsequent food intake measured for 1 (A), 2, 
4, 24 and 48 h (B); n = 12, mean ± sem; (A) unpaired one-way ANOVA, Dunnett post test; 
(B) unpaired two-way ANOVA, Bonferroni post test; *p < 0.05, **p < 0.01, ***p < 0.001. 
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mmol/kg) and their subsequent meal pattern analyzed in an automated BioDaq system; n = 
10, mean ± sem; unpaired one-way ANOVA, Dunnett post test; *p < 0.05. 
Figure 2; Intragastric Arg, Lys and Glu induced neuronal activity in the brainstem. 
After 16 h food deprivation, rats were gavaged with isomolar doses (6.7 mmol/kg) of 
individual amino acids and transcardially perfused with PFA 2 h later. Animals had no access 
to food between gavage and transcardial perfusion. Different brain areas were analyzed for 
cFOS expression. (A) Representative images showing cFOS positive cells in the AP and the 
NTS (located -13.76 from bregma). Scale bar, 100 μm. AP indicates the area postrema, NTS – 
nucleus of the solitary tract, 4V – 4th ventricle, DMX – dorsal motor nucleus vagus nerve, GR 
– gracile nucleus. Quantification of cFOS positive cells in the AP (B) and NTS (C); n = 6-8, 
mean ± sem;  unpaired one-way ANOVA, Dunnett post test; **p < 0.01, ***p < 0.001. 
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Figure 3. The AP mediated the anorectic effect of Arg and Glu, whereas abdominal 
vagal afferents are necessary for the anorectic effect of Lys. (A) Histological surgery 
validation showed complete removal of the AP and an intact vagus nerve, visualized by 
retrograded tracing of IP injected fluorogold to the NTS (primary vagal projection site), in 
AP-lesioned animals. Capsaicin treatment lesioned the vagus nerve and consequently less 
fluorogold reached the NTS in respective animals. The AP showed fluorogold labeling due to 
the absence of the blood brain barrier. Location -13.76 from bregma, 4V indicates the 4th 
ventricle, DMX – dorsal motor nucleus vagus nerve, GR – gracile nucleus, scale bar 100 μm. 
After 16 h food deprivation AP-lesioned (B), capsaicin-treated (C) and the respective sham 
animals were gavaged with individual amino acids (6.7 mmol/kg) and their subsequent food 
intake measured for 1 h; n = 7-11, mean ± sem; repeated measures two-way ANOVA, 
Bonferroni post test; *p < 0.05, **p < 0.01, ***p < 0.001. 
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Figure 4. Arg, Lys and Glu induced gastric distension by distinct mechanisms. (A) After 
16 h food deprivation rats were gavaged with an isovolumic (2 ml) dose of individual amino 
acids (6.7 mmol/kg), 30 min later their stomach was excised and weighted; n = 6, mean ± 
sem;  unpaired one-way ANOVA, Dunnett post test; *p < 0.05, ***p < 0.001. Representative 
images are shown; scale bar, 4 mm. (B) After 16 h food deprivation rats were gavaged with 
individual amino acids (6.7 mmol/kg), 30 min later received access to 3 g rat chow and 1.5 h 
post-administration the gastrointestinal tract was excised and the wet weight measured; n = 6, 
mean ± sem; unpaired two-way ANOVA, Bonferroni post test; *p < 0.05, **p < 0.01, ***p < 
0.001.  
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Figure 5. Intravenous Arg, Lys and Glu inhibited food intake, but only intravenous Glu 
delayed gastric emptying. (A) After 16 h food deprivation rats were anesthetized, received a 
Ringer lactate (RLA) or amino acid (2 mmol/kg) injection into the lateral tail vein, were 
gavaged with water or amino acid (HK, 6.7 mmol/kg Lys; LK, 2 mmol/kg Lys) and their 
subsequent food intake was measured for 1 h; n = 9-11, mean ± sem; unpaired one-way 
ANOVA, Dunnett post test; *p < 0.05, **p < 0.01, ***p < 0.001.  (B) After 16 h food 
deprivation rats were anesthetized, received a Ringer lactate (RLA) or amino acid (2 
mmol/kg) injection into the lateral tail vein, were gavaged with water or amino acid (HK, 6.7 
mmol/kg Lys; LK, 2 mmol/kg Lys), 30 min later their stomach was excised and weighted; n = 
6, mean ± sem; unpaired one-way ANOVA, Dunnett post test; *p < 0.05, ***p < 0.001. (C) 
After 16 h food deprivation rats were anesthetized, received a Ringer lactate (RLA) or amino 
acid (2 mmol/kg) injection into the lateral tail vein, were gavaged with water, 30 min later 
received access to 3 g rat chow and 1.5 h post-administration the gastrointestinal tract was 
excised and the wet weight measured; n = 6, mean ± sem; unpaired two-way ANOVA, 
Bonferroni post test; *p < 0.05. 
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Figure 6. Conditioned taste aversion test following different routes of amino acid 
administration. (A) Rats received an amino acid (6.7 mmol/kg) or water gavage during the 
conditioning days. (B) Rats received an amino acid (2 mmol/kg) or Ringer lactate (RLA) 
injection into the lateral tail vein and were gavaged with water or amino acid (HK, 6.7 
mmol/kg Lys) during the conditioning days. IP injected LiCl is the positive control. n = 6 
(LiCl n = 3), mean ± sem; unpaired one-way ANOVA, Dunnett post test; *p < 0.05, **p < 
0.01, ***p < 0.001. 
 
Figure 7. Schematic representation of main findings. Arg, Lys and Glu were identified as 
the most potent oral anorectic amino acids. After gastric delivery, they specifically stimulate 
gastric secretion and/or delay gastric emptying thereby facilitating digestion. After absorption 
only Glu can inhibit gastric emptying. Importantly all three amino acid also inhibit food 
intake when administered intravenously but by different neuronal mechanism. Lys is detect by 
vagal afferents projecting to the NTS, whereas Arg and Glu centrally in the area postrema - a 
brain areas not protected by the blood barrier. Thus, Arg, Lys and Glu selectively impact on 
food processing and intake suggesting them as direct sensory input to assess dietary protein 
content and quality.  
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Supplementary Figures 
Supplementary Figure 1. The anorectic effect of Lys was independent to feeding state 
and pH. (A) Rats were fed ad libitum, food deprived for 12 h or 16 h and gavaged with 
isomolar doses (6.7 mmol/kg) of Lys at dark onset. Food deprivation was used to synchronize 
food intake and thereby reduce variation. Food intake of the 12 h or 16 h food deprived 
animals was measured for 1 h (n = 10), and the ad libitum fed group for 6 h (n = 20); mean ± 
sem; unpaired two-tailed student t-test; ***p < 0.001. (B) After 12 h food deprivation rats 
were gavaged with 6.7 mmol/kg Lys adjusted to pH 2.8, 7.5 and 10.3 (n = 7) and their 
subsequent food intake measured for 1 h; mean ± sem; unpaired two-tailed student t-test; *p < 
0.05. 
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Supplementary Figure 2. Dose response of Arg, Lys and Glu. After 16 h food deprivation 
rats were gavaged with different doses (as indicated) of individual amino acids and their 
subsequent (A-C) food and (D-F) water intake measured for 1 h; n = 10, mean ± sem; 
unpaired one-way ANOVA, Dunnett post test; *p < 0.05, **p < 0.01, ***p < 0.001.  
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Supplementary Figure 3. Arg, Lys and Glu differentially altered gastrointestinal 
function dependent on route of application. (A) After 16 h food deprivation rats were 
gavaged with isomolar doses (6.7 mmol/kg) of individual amino acids including phenol red 
(1.5 mg). Thirty minutes later they received access to 3 g rat chow and 1.5 h post-
administration, the gastrointestinal tract was excised and phenol red content quantified; n = 6, 
mean ± sem; unpaired two-way ANOVA, Bonferroni post test; *p < 0.05, **p < 0.01, ***p < 
0.001. (B) After 16 h food deprivation rats were anesthetized, received a Ringer lactate (RLA) 
or amino acid (2 mmol/kg) injection into the lateral tail vein and were gavaged with water 
including phenol red (1.5 mg). Thirty minutes later they received access to 3 g rat chow and 
1.5 h post-administration, the gastrointestinal tract was excised and the phenol red content 
quantified; n = 6, mean ± sem; unpaired two-way ANOVA, Bonferroni post test; *p < 0.05, 
***p < 0.001. 
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Supplementary Figure 4. Glu delayed gastric emptying in AP-lesioned animals. (A) After 
16 h food deprivation rats were gavaged with water or 6.7 mmol/kg Glu, 30 min later received 
access to 3 g rat chow and 1.5 h post-administration the gastrointestinal tract was excised and 
the wet weight measured; n = 4-6, mean ± sem; unpaired two-way ANOVA, Bonferroni post 
test; **p < 0.01, ***p < 0.001. (B) After 16 h food deprivation rats were gavaged with water 
or 6.7 mmol/kg Glu including 1.5 mg phenol red. Thirty minutes later they received access to 
3 g rat chow and 1.5 h post-administration the gastrointestinal tract was excised and phenol 
red content quantified; n = 4-6, mean± sem; unpaired two-way ANOVA, Bonferroni post test; 
*p < 0.05, ***p < 0.001. 
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Supplementary Tables 
Supplementary Table 1. Blood plasma parameters 30 min after gavage.  
IG
£ 
H2O Ala Arg Lys Glu 
Chloride [mmol/l] 91.0±1.2 92.7±0.9 83.8±1.4[***]
 
88.3±1.3 94.8±0.9 
Albumine [g/dl] 1.56±0.03 1.68±0.02 1.70±0.04[*] 1.75±0.03[**] 1.58±0.04 
Sodium [mmol/l] 145.7±0.5 144.8±0.9 146.2±1.3 145.7±0.8 145.4±1.2 
Glucose [mg/dl] 209±29 200±17 214±11 211±18 199±13 
£
After 16 h food deprivation rats were gavaged with isomolar doses (6.7 mmol/kg) of amino acids and 
30 min later blood collected by heart puncture; n = 6, mean ± sem; unpaired one-way ANOVA, 
Dunnett post test, *p < 0.05, **p < 0.01, ***p < 0.001. 
Supplementary Table 2. Blood plasma parameters 30 min after intravenous 
administration. 
IV
£ 
RLA RLA Ala Arg Lys Glu 
IG H2O HK H2O H2O H2O H2O 
Lys [μmol/l] 150±13 770±100[***] 178±20 144±8 856±50[***] 127±89 
Chloride [mmol/l] 89.8±0.5 90.8±0.5 93.2±0.7 92.8±1.8 93.0±0.7 91.0±1.1 
Albumine [g/dl] 2.06±0.04 2.28±0.05[*] 2.07±0.03 1.92±0.09 2.05±0.03 2.10±0.10 
Sodium [mmol/l] 148.0±1.2 149.2±2.1 152.0±1.6 145.8±2.2 146.5±1.3 149.8±0.5 
Glucose [mg/dl] 135±4 146±3 136±3 134±4 132±3 145±5 
£
After 16 h food deprivation rats were anesthetized, received a Ringer lactate (RLA) or amino acid (2 
mmol/kg) injection into the lateral tail vein, were gavaged with water or amino acid (HK – 6.7 
mmol/kg Lys) and 30 min later blood was collected from the tongue in short-term anesthetized 
animals (isoflurane); n = 6, mean ± sem; unpaired one-way ANOVA, Dunnett post test; *p < 0.05, 
***p < 0.001. 
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My contribution to this paper includes the study design and data interpretation under the 
supervision of F. Verrey and T. Lutz. I performed all experiments and wrote the paper with the help 
of F. Verrey and T. Lutz.  
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Abstract  
Gastric emptying and gastric secretion are two major physiological functions of the stomach. 
The assessment of these functions in particular in small animals is challenging; no method 
currently available allows the simultaneous measurement of both functions, and methods used 
are lethal or invasive and often limited by spatial, temporal or quantitative resolution. Here, 
we report the establishment and validation of a quantitative non-invasive high-throughput 
computed tomography based method to measure simultaneously gastric emptying and 
secretion in rats in vivo. The imaging strategy enables to visualize stomach anatomy and 
quantify stomach volume and stomach contrast agent content. The method was validated by 
comparing the results to classical lethal methods (stomach phenol red content and stomach 
wet weight). Additionally, we showed that the use of a mild anesthetic does not interfere with 
normal gastric emptying and secretion thereby enabling high-resolution temporal studies in 
the same animal. These combined advantages were applied to reevaluate the impact of 
cholecystokinin (CCK), histamine and oral glucose solutions on gastric function with high 
temporal resolution. CCK inhibited gastric emptying completely for 20 min leading to the 
accumulation of gastric juice in the stomach. The CCK antagonist Devazepide blocked this 
effect. Histamine stimulated both gastric secretion and delayed emptying. Oral glucose 
solution emptied at a fix rate of 24-31 cal/min and stimulated gastric secretion. These results 
confirmed previous observations and added volumetric changes as a new dimension. As 
computed tomography scanners become broadly available this method is an excellent 
approach to measure the combined gastric functional readout and to reduce animal 
interventions. 
 
 
59 5. Original Research Article: “Simultaneous assessment of gastric emptying and 
secretion in rats by a novel computed tomography based method” 
  
 
Introduction 
Gastrointestinal (GI) transit, nutrient digestion and absorption are highly controlled functions. 
Each of them is to some extent autonomously regulated by neuronal and endocrinal 
mechanisms but also controlled by the central nervous system (3). Based on the multifactorial 
control mechanism, it is not surprising that impaired GI function is associated with a broad 
spectrum of pathologies (Diabetes Type 1/2, Parkinson, etc) (10, 17, 21). Due to the multiple 
involved signals, GI function needs to be studied in vivo, ideally with non-invasive methods.  
The present study focuses on two main functions of the stomach, i.e. gastric secretion and 
gastric emptying. Gastric secretions participate in nutrient digestion but acid secretion is also 
an important component of the body’s defense mechanisms. For instance, patients with 
decreased gastric secretion are more prone to enteric infections by H. pylori, E. coli or V. 
cholera (15, 21). The rate of gastric emptying determines nutrient release into the small 
intestine, which is particularly important to maintain postprandial nutrient homeostasis. Our 
understanding of stomach functions evolved rather slowly due to the lack of suitable in vivo 
methods applicable to high-throughput studies in rodents.  
One challenge in measuring stomach secretion and motility is the high speed of these 
functions thereby requiring methods with high temporal resolution [see recent reviews (7, 
22)]. A classical method to assess gastric emptying compares the residual gastric dye content 
(e.g. radioactive compounds or phenol red) between treatment groups at specific time points 
(12, 24). This method requires stomach excision and therefore is lethal for the experimental 
animal. Alternatively, gastric fistulas can be implanted to aspirate gastric content (13, 18). 
Experimental success depends strongly on fistula positioning, because it determines 
localization and extent of aspiration. Apart of its invasive nature, surgery may also interfere 
with normal gastric function. Non-invasive alternatives are paracetamol absorption or breath-
tests (
13
C acetate) (4, 16). Both methods are indirect and are limited by the fact that 
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unchanged metabolism and absorption kinetics across experimental groups have to be 
assumed. Currently the most promising avenue might be the use of in vivo imaging strategies 
including ultrasound, positron-emission-tomography or bioluminescence among others (1, 2, 
11, 19). However, so far their use remained limited due to difficulties with time- or spatial-
resolution, throughput or quantitative measures. Apart from these technical limitations, these 
imaging strategy are also unable to assess gastric secretion and emptying within the same 
measurement. Nevertheless they are critical components in the efforts to reduce lethal and 
invasive animal experiments and thereby important in context of the current 3R (replacement, 
refine, reduce) goals anchored in most national guidelines on animal welfare. 
Advancements in small animal X-ray technology led to a reduction of the scanning times for 
computed tomography (CT) to few seconds while the image quality increased markedly in 
spatial resolution (8). Hence, X-ray exposure was markedly reduced enabling several hundred 
scans per animal before reaching critical doses (>4 Gy for rats). A disadvantage of X-ray-
based techniques is the poor absorption of radiation in soft tissue such as the stomach 
epithelium and intestinal content. This can be compensated by the oral application of contrast 
agents such as barium sulfate or sodium diatrizoate (SDH). Hence, the quantitative detection 
of stomach contrast agent content and  volume might provide an alternative imaging method 
to visualize stomach function in vivo. 
Here, we report the establishment and validation of a quantitative non-invasive high-
throughput computed tomography based method to measure simultaneously gastric emptying 
and secretion in rats in vivo. The contrast agent based strategy enables visualization and 
quantification of the total stomach volume and the residual contrast agent with high temporal 
resolution. The method was extensively validated using known modulators of gastric 
emptying and secretion.  
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Glossary 
GI – gastrointestinal 
CT – computed tomography 
SDH – sodium diatrizoat hydrate (contrast agent) 
IP - intraperitonal  
SC – subcutaneous 
CCK - cholecystokinin 
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Materials and Methods 
Animals 
Male Wistar rats (Janvier, France) were group housed (room temperature 21 ± 1° C, artificial 
12/12 h light dark cycle, water ad libitum, rat chow ad libitum [3433 Kliba Nafag, 
Kaiseraugst, Switzerland]). Body weight increased throughout the study by 3-4 g/day. All 
procedures for rat handling and experimental interventions were according to the Swiss 
Animal Welfare legislation and approved by the Kantonales Veterinäramt Zürich.   
Contrast Agent 
Sodium diatrizoate hydrate (SDH, Sigma-Aldrich, Buchs, Switzerland) was solubilized in tap 
water and adjusted to pH 7.2, if not stated differently. A liquid contrast agent was selected 
because we assumed more accurate detection of the total stomach volume compared to a solid 
contrast agent (barium sulfate). We selected SDH instead of Meglumine diatrizoat, because 
SDH generated a stronger contrast and is less expensive. Both agents are used in clinics 
(gastrografin) and side effects are at most mild and transitory (FDA rev.10/11, NDC 0270–
0445–40). 
In vitro quantification of SDH concentration and liquid volume by micro-CT 
Different solutions were prepared in vitro and of each solution one CT image acquired. First, 
SDH was diluted to different concentrations (50, 100, 200, 300, 400, 500 mg/ml) with tap 
water. 120 μl of each of these solutions were used for imaging in a 1.5 ml tube. Second, 125 
mg of SDH was dissolved in 0.5, 0.6, 0.7, 0.9, 1.3, 2.1 ml tap water in a 15 ml tube 
(concentrations of 250, 208, 179, 139, 96, 60 mg/ml). The entire tube and volume was imaged 
using the CT scanner.  Third, 200 mg SDH were dissolved in 1 ml tap water, pH adjusted to 3, 
5, 7, 9, 11 with HCl or NaOH respectively and one CT image acquired of each solution in a 
1.5 ml tube.   
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In vivo quantification of SDH concentration and liquid volume by micro-CT 
Food deprivation was used to ensure similar initial stomach contents between animals. 4 h 
food deprived rats were anesthetized with isoflurane (5 %), gavaged with different solutions 
and immediately scanned by CT under isoflurane anesthesia. In the first set of experiments 2 
ml of solutions were orally applied with different SDH concentrations (2 ml/animal; 30, 50, 
70, 100, 150, 200 mg/ml; 60, 100 140, 200, 300, 400 mg/animal).  In the second set of 
experiments 200 mg SDH was applied in different volumes of tap water (1, 1.1, 1.2, 1.4, 1.8, 
2.5, 3 ml/animal; 200, 181, 167, 143, 111, 80, 67 mg/ml; 200 mg/animal).  
mCT validation against the classical phenol red method 
4 h food deprived rats received an intraperitonal (IP) injection of CCK-8 (4 μg/kg, Bachem 
AG, Switzerland) or saline (vehicle), immediately followed by 2 ml gavage of 200 mg/ml 
SDH and 0.75 mg/ml phenol red (Sigma).  Animals were returned to their home cages, but did 
not have access to water or food. 20 min post-application animals were euthanized using 
pentobarbital (IP, 100 mg/kg, Kantonsapotheke Zürich, Switzerland) in combination with 
isoflurane (5 %) for quicker induction. Immediately after anesthesia induction CT images 
were acquired and the stomach excised. The stomach wet weight was measured and the 
residual stomach phenol red content extracted and quantified spectroscopically at 560 nm as 
described before (24). 
Stomach function under anesthesia 
One groups of 4 h food deprived rats were anesthetized using Zoletil (Zoletil = Tiletamine 
base : Zolazepam base , IP or subcutaneous (SC), 20 mg/kg, Virbac, Glattbrugg,  
Switzerland). After anesthesia induction, the rats’ eyes were covered with Vitamin A 
ointment (Kantonsapotheke Zürich), rats gavaged with 2 ml SDH (200 mg/ml) and 
subsequently imaged immediately after gavage and then every 5 min. Animals were kept on a 
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heat-plate during the experiment to limit heat loss. The second group was not anesthetized 
during the experimental time enabling normal gastric function thereby reflecting the non-
anesthetized condition. After a specific time window these animals were anesthetized to 
image one single time point. Hence, each time point is one animal not exposed to anesthesia 
before and therefor termed endpoint anesthesia. Animals undergoing the endpoint anesthesia 
protocol were 4 h food deprived, received a gavaged with 2 ml SDH (200 mg/ml) and 
returned to their home cage, where they did not have access to food or water. After a defined 
time interval, the animals were anesthetized using 5 % isoflurane and immediately imaged.  
Pharmacological modulation of gastric emptying and secretion by CCK and histamine 
In the first experiment, 4 h food deprived rats received an IP injection of devazepide (1 
mg/kg, Sigma) or vehicle (10 % DMSO 10 % Tween 80 in 0.9 % NaCl, all Sigma). After 10 
min rats received an IP injection of CCK-8 (4 μg/kg) or saline and Zoletil (IP, 20 mg/kg). In 
the second experiment, 4 h food deprived rats received and IP injection of histamine (5 
mg/kg, Sigma) or vehicle (10 % DMSO 10 % Tween 80 in 0.9 % NaCl, all Sigma) and Zoletil 
(IP, 20 mg/kg). In both experiments, eyes were covered with Vitamin A ointment after 
anesthesia induction, then rats were gavaged with 2 ml SDH (200 mg/ml) and subsequently 
imaged immediately and every following 5 min. Animals were kept on a heat-plate during the 
experiment to limit heat loss. 
Oral glucose empties at a rate of 24-31 cal/min 
4 h food deprived rats received an IP Zoletil injection (20 mg/kg). After anesthesia induction 
eyes were covered with Vitamin A ointment, rats gavaged with 2 ml of different glucose 
solutions (0, 0.2, 0.4 g/ml D-(+)-glucose and 200 mg/ml SDH, pH 7.2, all Sigma) and 
subsequently imaged immediately and every following 5 min. Animals were kept on a heat-
plate during the experiment to limit cooling. 
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Imaging acquisition 
Images were acquired using Quantum FX microCT (Perkin Elmer, Massachusetts, USA). 
Rats were imaged in a prone position using a field of view sized 73 mm. Respiratory gating 
was used to reduce motion artifacts. The radiation dose was 26 mGy / scan enabling a voxel 
size of 148 µm
3
. Scan time was 34 s / scan.  
Image analysis 
Images were analyzed using Caliper Analyze 11.0 (Analyze Direct, Kansas, USA). All 
images were treated equally i.e. no changes to contrast or intensity were applied nor any filter 
to enhance image quality. Original images were subject to a semi-automatic object extraction 
algorithm which is part of the software package. Briefly, a seed point was selected within the 
object of interest which, in our case, was the contrast agent within the stomach; a threshold 
was set to the intensity 2000 based on  the in vitro experiments (see Fig. 1A). The algorithm 
automatically assigned every voxel connected to the seed point above the threshold to the 
object. The extracted object was visually inspected by a treatment blinded investigator. If the 
algorithm had falsely assigned voxels within the esophagus or the small intestine to the object, 
they were manually removed. Subsequently object volume and mean intensity were extracted. 
The displayed stomach images are 3D-volume renderings of representative stomachs for the 
specified condition. For the mathematical analysis of the results, see equation section.  
Statistics 
Rats were randomly allocated to treatment groups, and the order of application was 
randomized. Results are presented as mean ± standard error of the mean. The data were 
analyzed using Graph Pad Prism 5.0. Statistical significance between the means was tested 
using unpaired Student t-test or two-way ANOVA and a Bonferroni post-test as appropriate. 
Differences were considered significant at P < 0.05. 
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Results 
In vitro quantification of SDH concentration and liquid volume by micro-CT 
To test if SDH can be detected quantitatively we diluted SDH to different concentrations and 
quantified the signal intensity and the liquid volume with the CT method. In vitro SDH 
concentrations correlated in a linear manner with signal intensity until 200 mg/ml (Fig. 1A). 
At higher concentrations the signal intensity tended to plateau but volume detection remained 
accurate. To test if the CT method can detect volume changes, we measured different liquid 
volumes containing equal amounts of SDH with the CT method. Volume changes showed an 
excellent linear correlation without a loss in signal intensity in vitro (Fig. 1B). To exclude that 
pH such as a low pH in the stomach affected SDH quantification, we measured SDH signal 
intensity at different pH values in vitro. pH did not affect signal intensity down to pH 3 (Fig. 
1C). However, at more acid pH SDH precipitated. 
In vivo quantification of SDH concentration and liquid volume by micro-CT 
To test SDH quantification and volume detection in vivo we performed similar experiments as 
described above for in vitro measurments. Briefly, 4 h fasted rats were anesthetized and 
different concentrations or volumes of SDH were applied orally. Animals were immediately 
imaged by CT and stomach total volume and signal intensity assessed (Fig. 2A). Image 
resolution enables even to distinguish the anatomical difference of the stomach wall between 
the antrum and the body. Applied SDH concentration and stomach intensity correlated 
linearly R
2 
= 0.99 (Fig. 2B). Stomach volume detection, which is based on the presence of 
SDH, is accurate when the stomach SDH content is larger than 100 mg (Fig. 2B). When 
different volumes containing the same amount of SDH were given by gavage, the applied 
volumes correlated linearly with the measured stomach volume R
2 
= 0.96 (Fig. 2C). 
Importantly, the stomach was not completely empty after 4 h fasting and there was a residual 
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gastric volume of 0.81 cm
3 – here termed non-administered stomach volume. Hence, in vitro 
and in vivo SDH concentration and volume changes were accurately detected by the applied 
CT method. Therefore all following experiments were conducted with a fixed oral 
administration volume of 2 ml and a SDH concentration of 200 mg/ml i.e. 400 mg/animal.  
mCT validation against the classical phenol red method 
Next we validated the CT method by comparing it to classical lethal methods (12). Gastric 
emptying was inhibited in half of the animals by pre-treating them with CCK (4 µg/kg IP) and 
after 20 min the extent of gastric emptying was quantified by different methods. Stomach wet 
weight, total stomach volume, phenol red and SDH content were increased in the CCK treated 
animals compared to saline control (Fig. 3). Importantly, the methods measuring stomach 
content showed similar relative increases after CCK administration. 
Stomach function under anesthesia 
A major advantage of in vivo imaging is the capability to assess the same phenomena in the 
same animal repeatedly. CT imaging requires an immobilized animal, but certain anesthetics 
such as isoflurane were shown to delay gastric emptying (23). Here, we compared stomach 
SDH content, total volume and non-administered volume in animals treated with a light 
anesthetic (Zoletil) to non-anesthetized animals. All animals received an oral SDH gavage. 
After application the non-anesthetized animals were returned to their home cage and not 
exposed to anesthesia. After a specific time window one CT image was acquired of these 
animals (here, termed endpoint anesthesia). Zoletil treated animals were under constant 
anesthesia, hence sequential imaging of the same animal over time was possible. Zoletil was 
administered IP and SC to test if the exposure of the GI tract to the anesthetic altered gastric 
function. Under all conditions, stomach SDH content, total volume and the non-administered 
volume decreased similar over time (Fig. 4). Noteworthy, the endpoint anesthesia group had a 
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higher variability due to intra-individual differences in gastric function. This demonstrates 
that Zoletil anesthetized animals have similar gastric function as non-anesthetized animals and 
therefor bear the advantage to allow repeated measures of stomach content over time in the 
same animal. Importantly the gastric emptying curve was similar to the exponentially 
emptying of non-caloric meals observed by MRI in humans or phenolred in rats (12, 20). This 
indicates that SDH did not interfere with normal gastric emptying. 
Pharmacological modulation of gastric emptying and secretion by CCK and histamine 
To further validate our method, we pharmacologically altered gastric function by applying 
CCK or histamine. Their impact was monitored at a high temporal resolution. CCK was 
previously reported to delay gastric emptying and devazepide is a known CCK antagonist (12, 
18). Indeed, CCK (4 µg/kg IP) completely inhibited stomach SDH release for 20 min (Fig. 
5A). Additionally, CCK induced an increase of the stomach total and non-administered 
volume presumably due to enhanced secretion (Fig. 5B & 5C). Devazepide (1 mg/kg IP) 
completely antagonized the effect of CCK, but alone did not differ from vehicle control. Next, 
we pharmacologically induced gastric secretion by administering histamine (5 mg/kg IP) (5). 
Histamine injection delayed SDH and total stomach volume decreased (Fig. 6A & B). 
Importantly, non-administered volume increased after 20 min indicating gastric secretion 
(Fig. 6C). Together, these results show that the CT method can detect the expected 
pharmacological effects of CCK and histamine on gastric emptying and secretion with an 
excellent temporal resolution.  
Oral glucose empties at a rate of 24-31 cal/min 
Finally, we evaluated if physiologically induced meal-born signals can modulate gastric 
function. Most prominently orally applied glucose solutions were shown previously to 
calibrate gastric emptying to a fix rate of 30-45 cal/min in rats (14). To test these phenomena, 
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we orally administered 0.2 and 0.4 g/ml glucose, respectively, in combination with the 
contrast agent and monitored gastric function by CT over time. Indeed, glucose delayed the 
release of SDH content and induced an increase of total and non-administered stomach 
volume (Fig. 7A, 7B & 7C). When plotting the energy (in kJ) emptied from the stomach over 
time, a linear regression could be fitted which suggests a linear gastric emptying rate of 24-31 
cal/min (Fig. 7D; not statistically different). This highlights that our CT method can detect 
and reproduce the expected effect of oral glucose on gastric emptying.  
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Discussion 
Gastric emptying and secretion are two key functions of the stomach. The current 
methodology does not allow the assessment of both simultaneously in small mammals like 
rats in vivo (7, 22). Here, we demonstrate that based on CT, it is possible to accurately 
measure the volume and concentration of SDH, a liquid contrast agent, in vitro but also in the 
stomach of living animals (Fig 1 & 2). Gastric emptying therefore can be quantified by 
measuring changes of the absolute SDH content in the stomach over time, and gastric 
secretion can be calculated based on stomach SDH concentration and volume. Changes of the 
total stomach volume depend on the volumes emptied, secreted or ingested within the 
specified time frame. The ingested volume can be neglected when animals have no access to 
food or drinking water during the study. The emptied volume can be calculated based on the 
changes in the total SDH content. Therefore, the remaining volume reflects the volume which 
has not been administered and which can therefore be approximated as gastric secretion. This 
assumes proper and rapid mixing of the contrast agent with the secreted volume, emphasizing 
the importance of a liquid nature of a contrast agent. Similar reasons to assess gastric 
emptying and secretion have also been made in respect to human MRI data sets (20). 
Furthermore, we show a good correlation between classic lethal methods and our CT 
approach as validation (Fig. 3). Additionally image resolution is excellent enabling to 
distinguish anatomical stomach features.   
Non-lethal in vivo methods provide the major advantage to measure a function in the same 
animal over time. Here, we validated the use of a light anesthetic that does not inhibit gastric 
emptying and can be used for high temporal resolution studies (Fig 4). These technical 
advantages were applied to validate the method with pharmacological modulators of GI 
function and physiologically induced meal born signals.  Among them are several GI 
hormones which contribute to proper GI function. CCK, for example, stimulates the 
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relaxation of the proximal stomach, increases its reservoir function and inhibits gastric 
emptying. This has been documented as delayed phenol red release upon CCK treatment that 
is antagonized by devazepide (12, 18). Our data confirmed this effect with high temporal 
resolution (Fig. 5). Interestingly, CCK inhibited stomach SDH release completely for 20 
minutes which might lead to the accumulation of basal gastric acid secretion. This would also 
explain the observed increase of the total stomach volume and non-administered volume. 
Alternatively, CCK might induce gastric secretion based on its structural relationship to 
gastrin (3). Histamine stimulates gastric secretion but it can also delay gastric emptying by 
interacting with the H1-receptor (5, 6). Our data clearly support both effects and confirm its 
action to inhibit gastric emptying and to increase gastric secretion (Fig. 6). Endocrine and 
neuronal signals are physiologically induced by the ingested meal itself. Most prominently 
gastric emptying is described to be modulated mainly by the caloric equivalent of the ingested 
meal. Glucose solutions were shown to empty at a fix rate of 2-2.5 kcal/min in humans and at 
a rate of 30-45 cal/min in rats (9, 14). We confirmed this finding and additionally showed an 
increase in gastric secretion upon glucose ingestion possibly due to an insulin effect (Fig. 7).  
Taken together, we developed and validated a method to simultaneously measure gastric 
secretion and emptying in rats in vivo based on non-invasive CT.  This enables paired 
experiments and reduces future harmful animal experiments.  Furthermore, we tested a light 
anesthetic strategy to increase temporal resolution of gastric experiments. As new CT 
scanners are getting broadly available, this method should be exploited for future efforts that 
may aim of measuring intestinal or colonal transit motility and volume.   
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Figures 
Figure 1 – In vitro calibration of SDH concentration and solution volume measurement by 
micro CT. (A) CT measurement of in vitro signal intensity and volume of solutions with 
different SDH concentrations but equal volume (120 µl). Linear regression accounts for all 
data until 200 mg/ml. (B) In vitro signal intensity and volume of solutions with different 
volumes but equal SDH content (125 mg). (C) In vitro signal intensity of solutions with equal 
volume and SDH content but at different pH. Mean ± SEM, n = 3. 
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Figure 2 – In vivo calibration of SDH concentration and solution volume measurement by 
micro CT. (A) Workflow of in vivo experiments starting with image acquisition. Next, the 
stomach is semi-automatically segmented (red line) and objects volume and mean intensity 
extracted. This object is subject to 3D volume rendering for image presentation. (B) In vivo 
signal intensity and volume obtained from the stomach immediately after oral application of 
different SDH concentrations with equal gavage volumes (2 ml). (C) In vivo signal intensity 
and volume recorded from the stomach immediately after oral application of different 
volumes with equal SDH content (200 mg). Mean ± SEM, n = 4-5. 
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Figure 3 – Comparison of micro CT and phenol red method. Animals were treated with CCK 
(IP, 4 μg/kg) and received a 2 ml oral SDH (200 mg/ml) and phenol red (0.75 mg/ml) 
application. Stomach volume and SDH content was measured by CT 20 min post-application. 
The same stomachs were then excised and their wet weight and phenol red content assessed. 
Mean ± SEM, n = 5, unpaired two-tailed student t-test, ***p<0.001. 
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Figure 4 – Comparison of stomach function under continuous Zoletil and endpoint isoflurane 
anesthesia.The effect of different anesthetics on stomach SDH content (A), volume (B) and 
secretion (C) was analyzed after oral SDH application. The endpoint anesthesia group is 
composed of animals just anesthetized after a specific time point to acquire one image (n = 6 / 
time point; total = 54 animals). In contrast, the Zoletil groups are the same animals imaged 
every 5 minutes as indicated by the connecting lines (n = 6). (D) Representative 3D volume 
renderings of stomachs are shown. Mean ± SEM, no statistical significant differences were 
found.  
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Figure 5 – Effect of CCK application on stomach function measured by micro CT. Animals 
were treated with CCK (IP, 4 μg/kg) and the effect of CCK antagonized applying devazepide 
(IP, 1 mg/kg). Stomach SDH content (A), volume (B) and secretion (C) was recorded over 
time in the same animal after oral SDH application. (D) Representative 3D volume renderings 
of stomachs are shown. Mean ± SEM, n = 5, unpaired two-way ANOVA, Bonferroni post 
test; *p < 0.05, **p < 0.01, ***p < 0.001.    
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Figure 6 – Effect of histamine application on stomach function measured by micro CT. 
Animals were treated with histamine (IP, 5 mg/kg). Stomach SDH content (A), volume (B) 
and secretion (C) were recorded over time in the same animal after oral SDH application. (D) 
Representative 3D volume renderings of stomachs are shown. Mean ± SEM, n = 4-5, unpaired 
two-way ANOVA, Bonferroni post test; *p < 0.05, **p < 0.01.      
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Figure 7 – Effect of glucose application on stomach function measured by micro CT. Animals 
received different oral glucose solutions including SDH. Stomach SDH content (A), volume 
(B) and secretion (C) was recorded over time in the same animal after application. kJ emptied 
form the stomach calculated based on the emptied SDH content are plotted over time in panel 
D and a linear regression fitted. (E) Representative 3D volume renderings of stomachs are 
shown. Mean ± SEM, n = 4, unpaired two-way ANOVA, Bonferroni post test; *p < 0.05, **p 
< 0.01, ***p < 0.001 
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Equations 
SDH concentration in vitrot = x min [mg / ml] = (mean intensity – 1867) / 18.57 (see Fig. 1A) 
SDH content in vivot = x min [mg] = {(SDH concentration in vitrot = x min [mg / ml] * total 
volumet = x min [ml]) + 15} / 0.063 (see Fig. 2A)  
Gastric emptying: % of initial SDH content = SDH content in vivot = x min [mg] / SDH content 
in vivot = 0 min [mg] * 100 
% of initial total volume = total volumet = x min [ml] / total volumet = 0 min [ml] * 100 
Gastric secretion: % of initial non-administered volume = Non-administered volume t = x min 
[ml] / Non-administered volume t = 0 min [ml] * 100 
Non-administered volume t = x min [ml] = total volumet = x min [ml] – SDH volumet = x min [ml] 
SDH volumet = x min = 2 ml * SDH content in vivot = x min [mg] / 400 mg (we initially apply 2 ml 
of SDH 200 mg/ml) 
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This section contains an original research article, which is under internal review of the co-auhors. The 
article will be submited to the Journal of Physiology until the end of September.  
 
My contribution to this paper includes aspects in the study design, data interpretation and 
preliminary experiments in humans. I performed all animal experiments. C. Baruffol performed all 
human experiments, together we wrote the paper and therefore we share 1st authorship. A. 
Steingötter, T. Lutz and F. Verrey supervised all aspects of the project.  
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Abstract:  
Novel sensory inputs for the control of food intake and gastrointestinal (GI) function are of 
increasing interest due to the rapid increase in nutrition related diseases. The essential amino 
acid L-lysine, along with L-arginine and L-glutamic acid, was demonstrated to have a 
selective impact on food intake and GI processing in rats thus indicating a potential novel 
direct sensory input to assess dietary protein content and quality. The aim of this study was to 
assess the translational aspects of this finding and to investigate the dose-dependent effect of 
L-lysine on human and rat GI function. L-lysine doses from 0-800 mg in rats and 0.5-7.5 g in 
humans were analyzed for their effect on gastric emptying and gastrointestinal secretion. 
Human GI function was non-invasively assessed using magnetic resonance imaging (MRI) 
whereas rat data was acquired using standard lethal measurement methods. L-lysine dose-
dependently delayed gastric emptying and stimulated gastrointestinal secretion in rats as 
reflected by increased gastric wet weight and residual phenol red content (0.4g and 3% per 
0.1g L-lysine, p<0.001). The dose-dependent delay in gastric emptying was confirmed in 
humans with an increase in half-time of gastric emptying of 4 min/g L-lysine, p<0.01. 
Moreover, a dose-dependent increase in intestinal fluid accumulation was observed (0.4 
ml/min/g L-lysine, p<0.0001). No effect on blood gas parameters or visceral sensations was 
detected. This translational study demonstrates comparable dose-dependent effects of 
intragastric L-lysine on GI function in humans and rats. This conserved chemospecificity 
supports a broader role for individual amino acids in the control of gastrointestinal motility 
and secretion in vivo.    
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Abbreviation List: 
CCK, Cholecystokinin; GI, gastrointestinal; MRI, Magnetic Resonance Imaging;  
LMH – L-lysine monohydrate 
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Introduction:  
The worldwide rapid increase in nutrition related diseases stimulated efforts to understand 
how a meal impacts on various physiological processes including gastrointestinal (GI) 
function. Upon food intake, GI function adapts quickly to the ingested meal presumably to 
control efficient digestion and absorption of the vital nutrients. This dynamic plasticity is 
regulated by mechanisms responding to properties specific to the ingested meal among them 
are caloric content, volume and consistency. This multiple signalling input is integrated to 
some extent by the autonomous nervous system but also by the central nervous system via 
vagal and endocrinal signals to control proper GI function (Camilleri, 2006).  
The macronutrient composition of a meal is historically not considered to have a major impact 
on GI function (Cummings & Overduin, 2007; Boron & Boulpaep, 2012). This is in contrast 
to newly emerging concepts demonstrating macronutrient specific control of different vagal 
and endocrinal signals. For instance, specific individual amino acids induce vagal afferent 
firing or stimulate the release of different GI hormone ex vivo (Tanaka et al., 1990; Niijima, 
1991; Niijima & Meguid, 1995; Niijima, 2000; Torii & Niijima, 2001). The in vivo relevance 
of these findings in context of GI function control can only be extrapolated from studies 
showing that high protein diets delayed gastric emptying to a larger extends than their 
isocaloric control in both humans and rats (Blom et al., 2006; Faipoux et al., 2006). 
Controversially others could not confirm these observations including us (Goetze et al., 
2007). As high protein diets are composed of different individual amino acids and thereby 
considerably vary between laboratories, this might obscure amino acid specific effects. So far, 
no study systematically tested the impact of all the 20 individual amino acids on GI function 
in humans or rats. Therefore the selection of a candidate amino acid was based on a recent 
study in rats revealing that L-arginine, L-lysine and L-glutamic acid induced the most potent 
anorectic effect compared to all other proteogenic amino acids (Jordi et al., 2013). Within this 
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study L-lysine was shown to delay solid gastric emptying, induce gastric secretion and 
increase intestinal motility thereby revealing an amino acid specific impact on GI function in 
vivo. Still several aspects remained elusive. Neither the dose-dependent effect nor the 
temporal dynamics of L-lysine were resolved and which both are relevant for the 
characterization of the pharmacokinetic effect of L-lysine. Most important it remained unclear 
if humans show a similar gastrointestinal response to a gastric load of L-lysine. This is 
relevant, as humans and rodents significantly differ in GI anatomy and physiology even 
though from an ingestive perspective both are omnivores. For instance, rats eat 10-20 % of 
their body weight equivalent as food every day, whereas healthy humans at best 2 %. 
Moreover, rats do not have a gallbladder and lack the vomiting reflex.  
The aim of this study was to identify the dose-dependent effect of L-lysine on human and rat 
GI function after intragastic infusion or gavage, respectively. Animal experiments were 
restricted to the 30 min time point due to lethal methods. GI function was analysed by 
measurements of wet weight and residual phenol red content. In humans, magnetic resonance 
imaging (MRI) and blood sampling was applied to repeatedly assess gastric meal, secretion 
and intestinal fluid content volume as well as blood gas parameters every 15 min for over 90 
min. Human experiments were performed within a randomized, double-blind, three-armed, 
cross-over study design. The study revealed a conserved impact of L-lysine on GI function in 
humans and rats.  
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Methods: 
Ethical approval  
All procedures for rat handling and experimental interventions were according to the Swiss 
Animal Welfare laws and approved by the Kantonale Veterinäramt Zürich. The human study 
was performed between April and September 2012 in a single centre, randomized, double-
blind, 3-armed, unbalanced, cross-over study design and in accordance with the Declaration 
of Helsinki, Good Clinical Practice. It was registered at ClinicalTrial.gov with identifier 
NCT01212614. The local Ethics Committee approved the study and all volunteers gave 
written informed consent. 
Animal care 
30 male Wistar rats (Janvier, Saint Berthevin Cedex, France) were grouped housed (room 
temperature 21 ± 1° C, artificial 12/12 h light dark cycle, water ad libitum, rat chow ad 
libitum - 3433 Kliba Nafag, Kaiseraugst, Switzerland).  
Animal dose preparation 
0, 25, 50, 100, 200 and 400 mg/ml L-lysine (Sigma-Aldrich, Buchs, Switzerland) was 
solubilized in tap-water and 80, 75, 70, 60 and 40 mg/ml NaCl (Sigma) proportionally added 
to correct for molarity differences. pH was adjusted to 7.2 using HCl (Merck, Zug, 
Switzerland). The applied volume was 2 ml for each of these solutions supplemented with 1.5 
mg phenol red (Sigma).  
Animal experiment design 
Animals were food deprived for 4 h prior oral L-lysine administration to ensure similar 
residual stomach content.  Rats received intragastric application of 2 ml of the respective L-
lysine dose and were returned to their home cage, where they did not have access to food or 
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water. 30 min post application animals were euthanized using pentobarbital (IP, 100 mg/kg, 
Kantonsapotheke Zürich, Switzerland) in combination with isoflurane (5 %) for quicker 
induction. The GI tract was excised and segmented into stomach, small intestine, cecum and 
colon based on anatomical landmarks using clamps to limit liquid loss. The wet weight of 
each segment was immediately measured. Phenol red was extracted from each segment and 
quantified by optical spectroscopy at 560 nm wavelength as described previously (Jordi et al., 
2013).  
Animal Statistics 
Rats were randomly allocated into the six treatment groups. Application order was 
randomized and statistical analysis performed as described for the human data set below.  
Human Subjects 
A total of six healthy subjects aged between 18-50 years (four male, two female) were 
recruited via a public advertisement. Prior study inclusion, all subjects underwent a clinical 
assessment and were tested for negative helicobacter pylori.  The following exclusion criteria 
were applied: BMI (kg/m
2
) <19 or >24, no history of systemic and psychiatric disease 
especially GI disease or surgery (excludes appendectomy, hernia repair and anorectal 
disorders), lysineuria, galactosaemia, medication intake of any kind, drug or alcohol abuse, 
presence of metallic implants, devices or metallic foreign bodies, claustrophobia, pregnancy 
and lactation, known allergy or intolerance against locus bean gum, L-lysine, Gadolinium 
(DOTAREM®), Methylparaben (E218), Fructose, Gluten, Galactose and also allergic 
reaction after prior injection of Lidocain (e.g. at the dentist). To assure an approximately 
similar concentration of L-lysine per kg of body weight the included subjects had similar 
body mass indices (22 ± 1 kg/m
2
). 
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Human Test Meal 
L-lysine was administered as L-Lysine monohydrate (LMH, Fagron GmbH & Co.KG, 
Barsbuettel, Germany) at doses of 0.5, 1.2, 3.0 and 7.5 g in four different 300 ml test meals. 
The ingredients and properties of the four LMH test meals that had negligible caloric content 
(<25 kcal) are listed in table 1. NaCl was proportionally added to each test meal to correct for 
molarity differences. All meals were prepared directly before each study session, heated to 37 
°C and infused within 1-2 min while volunteers were lying in the MRI scanner.  
Human measurement protocol 
All six subjects underwent three study sessions of 2.5 hours including subject preparation and 
repeated MRI and venous blood measurements. Sessions were performed on three different 
days separated by minimum 5 and maximum 21 days. Subjects were asked to refrain from 
special foods (chocolate, banana, pineapple, nuts, tomatoes, eggplant, mirabelle, gooseberry, 
avocados, plums, currant, melon, kiwis, alcohol, coffee, tea and nicotine) for 2 days prior to 
each study session. Each session followed the same procedure depicted in Figure 1. Subjects 
arrived at the MR centre in the morning or at noon after fasting overnight (or at least for 8 h). 
A nasogastric tube (Freka® Tube CH/FR 12) was placed 50-60 cm from the nares after 
previous local anaesthesia of the nasal cavity with Lidocain-HCl 2 % (prepared in house) and 
Vibrocil® (Novartis, Basel, Switzerland) nose gel. A venous vascular cannula 
(Vasofix®Braunüle®) was placed on the right or left cubital vein for subsequent blood 
sampling and continuous 0.9 % NaCl infusion. MR image data were acquired with subjects 
positioned in right decubitus before and directly after test meal infusion and then every 15 
min until 90 min. Visceral sensations scores were recorded after each MRI scan and in 
addition at 105 min after meal infusion. Blood samples were collected before (baseline) and at 
10, 25, 40, 55, 70, 85 and 100 after meal infusion. The first blood sample in fasted state and 
last blood samples at 100 min were taken in sitting position, all the others were obtained while 
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the subject was lying on the MR patient table. The nasogastric tube was always removed at 
~60 min with subjects in sitting position. 
Human MRI and visceral sensations scores 
Subjects were positioned in right decubitus inside the clinical MRI scanner (1.5 T Achieva, 
Philips Healthcare, Best, NL). An abdominal phased-array surface coil (SENSE body coil, 
four elements) was used for image acquisition. MR imaging consisted of three imaging 
sequences to visualize gastric content volume, gastric secretion, gallbladder volume and 
intestinal fluid content.  The MRI scan parameters for gastric content volume measurement 
were: balanced steady state free precession sequence, 26 - 34 transverse slices, 6 mm slice 
thickness, no slice gap, 360 mm field of view,  1.6/3.3 ms echo/repetition time, one breath 
hold, 16 – 24 sec scan duration (depending on slice number). For assessing gastric secretion, 
MRI scan parameters were: radial T1-weighted gradient echo sequence with profiles acquired 
in golden angle view order, 18 coronal slices, 6 mm slice thickness, 0.6 mm slice gap, 360 
mm field of view, 1.8/12 ms echo/repetition time, free breathing, 2:24 min scan duration. To 
visualize gallbladder volume and intestinal fluid content, MRI scan parameters were: T2-
weighted turbo spin echo sequence with fat suppressions, 26 coronal slices, 5 mm slice 
thickness, 1 mm slice gap, 375 mm field of view, 80/1200 ms echo/repetition time, two breath 
holds, 31 sec scan duration. 
After MRI scans, subjects had to report their visceral sensations, i.e. hunger, fullness, nausea, 
bloating, abdominal cramps and urge to defecate using a self-assessed sensations scale 
ranging from 0 – 10 (0 – no sensations, 10 – extremely prominent sensations). 
Human blood sampling and analysis 
For blood gas measurements (pH, bicarbonate, pCO2, chloride, glucose, haematocrit), blood 
was first collected with a serum vacutainer, then filled within 1-3 minutes in heparinized 
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capillaries and analysed using the ABL 700 blood gas analyser (Radiometer GmbH, Thalwil). 
For measurements of albumin and L-lysine blood concentration, Li-heparin vacutainer and 
EDTA-vacutainer were used, respectively. Albumin was measured to assess a potential shift 
in fluid from intravasal to Intraintestinal. Blood samples were directly centrifuged and ~ 1 ml 
of plasma was pipetted for storage at -20 °C for L-lysine and 8 °C for albumin. 50 μl of each 
L-lysine plasma sample was mixed with 50 μl of 10 % SSA/NVal solution and centrifuged at 
15’000 rpm for 5 min. 60 μl borate/NaOH buffer and 20 μl reagent (2AMT) was added to 20 
μl of the resulting supernatant and 1/100 μl of this mixture was injected on a HPLC column 
using the cell culture gradient, according to the manufacture’s protocol. The plasma for the 
albumin measurement was processed with a Cobas 8000 modular analyser (c701 module, 
Roche, Mannheim) subsequent a colour test method (Bromocresol green) with endpoint 
measure. 
Data analysis 
MR image analysis was performed by a radiologist in training (TR) and a research assistant 
with one year of training in analysing abdominal MR image data (CB). Purpose built software 
tools implemented in MATLAB (The MathWorks, Natick, MA) and IDL (Exelis Visual 
Information Solutions) were applied for extraction of gastric content volume, gastric 
secretion, gallbladder volume and intestinal fluid content. Gastric content contours were 
segmented in each transverse image by a semi-automated algorithm. Respective 3D gastric 
content volumes were computed from 3D isosurfaces of the contours (Sauter et al., 2012). 
Gallbladder contours and small intestinal areas excluding blood vessels and visceral tissues 
were manually contoured in each T2-weighted coronal image slice. To assess intestinal fluid 
content, a signal threshold was selected to segment the bright luminal fluid content from air 
and surrounding soft tissue. Intestinal fluid volume was calculated by summing all segmented 
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pixels. Gastric secretion volume was analysed from reconstructed T1 maps according to a 
previously established analysis method (Sauter et al., 2012).  
MR parameters were smoothed using function loess (with smoothing parameter  = 1) in 
program R (R Development Core Team, 2008)  and plotted over time and LMH dose. Half-
times of gastric emptying (t50) were calculated from smoothed curves by solving the locally 
smoothed interpolation for 50% using the Newton method (Brent, 1973). 
Dose response of t50 was analysed by linear mixed model with t50 and LMH dose as fixed 
effects and subject as random effect. Dose response of gallbladder and intestinal fluid 
volumes was analysed by linear mixed model with volume, time and LMH dose as fixed 
effects and subject as random effect.  
The density functions of individual mean visceral sensations scores were plotted. Since the 
resulting distributions were dominated by zero values, visceral sensations scores were divided 
into two categories, i.e. 0 and ≥1, to only test for a dose dependent increase in scores not zero. 
The dose dependent effect of L-lysine on the binomial visceral sensations scores was analysed 
using generalised linear models with a binominal link function. 
Deltas over baseline (DOB) values were calculated for L-lysine and albumin concentrations, 
all blood gas parameters and base excess. Baseline was defined as the values detected at 
fasted state. DOB values were smoothed using function loess and plotted over time and LMH 
dose. Dose response was analysed by linear mixed models with DOB of blood gas 
parameters, time and LMH dose as fixed effects and subject as random effect. Estimated 
model parameters are presented as estimate ± standard error. A p-value of < 0.05 was 
considered significant.  
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Results:  
Animal experiments 
To identify a dose dependent impact of L-lysine on rat GI function, we administered different 
isomolar doses of L-lysine intragastrically and measured GI tract wet weight and phenol red 
transit 30 min post-application. The doses applied ranged from 0 – 800 mg L-lysine per 
animal covering the span of daily L-lysine intake in rats. Rat stomach and cecum wet weight 
dose-dependently increased by 0.4 ± 0.04 g / 0.1 g L-lysine (p < 0.0001) and 0.2 ± 0.01 g / 0.1 
g L-lysine (p = 0.03) respectively (Figure 2a, b). No other GI segment showed a dose 
dependent change in wet weight. As animals did not have access to water or food these wet 
weights changes reflect alterations in secretion or absorption. To access GI motility more 
specifically, we tracked the transit of a dye (phenol red) along the GI segments 30 min post 
application. By measuring residual phenol red in the stomach, we observed delayed gastric 
emptying by increased gastric phenol red content of 3 ± 0.8% per 0.1 g L-lysine (p < 0.001) 
and decreased small intestinal phenol red content of also 3 ± 0.4% per 0.1 g L-lysine (p < 
0.0001, Figure  3a, b). In accordance, also colon phenol red content decreased by 0.03/g L-
lysine (p < 0.001, Figure 3c). The gastric and intestinal phenol red content plateaued at the 
two higher L-lysine doses. This data shows that L-lysine dose-dependently delayed gastric 
emptying and stimulated gastric secretion in rats. Additionally, cecum wet weight increased 
dose dependently indicating alterations in intestinal, pancreatic or biliary secretion. This data 
is limited to the 30 min time point thereby potentially obscuring lower dose effects of L-
lysine.  
Human experiments 
To assess the translational aspects of L-lysine impact on GI function, we conducted a MRI 
based study in healthy human subjects. Briefly, we administered different isomolar doses of 
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L-lysine nasogastrically and measured the impact on GI function and blood gas parameters 
every 15 min over a time course of 90 min. The administered doses were between 0.5 g and 
7.5 g L-lysine per test meal, which is considered physiological relevant as the daily L-lysine 
intake varies between 2 to 9 g/day (Flodin, 1997). In one subject, measurements of one dose 
had to be dismissed due to subject non-compliance of the study protocol (subject PB1_1991, 3 
g L-lysine dose). After L-lysine application blood L-lysine concentration increased dose-
dependently over time by 0.54 ± 0.1 μM/min/g L-lysine (p < 0.0001, Figure 4a, b) 
demonstrating proper application and absorption. No dose dependent differences were found 
for albumin and all blood gas parameters. (Figure S1, a-c). At the level of the stomach L-
lysine dose dependently delayed gastric emptying by an increase in t50 of 4.2 ± 1.4 min/g L-
lysine (p = 0.01, Figure 5a, b), but no changes in gallbladder volume or gastric secretion were 
detected based on MRI. In the small intestine, L-lysine dose- and time-dependently increased 
fluid volume by 0.37 ± 0.1 ml/min/g L-lysine (p < 0.0001, Figure 6a, b). This effect and its 
dynamics were clearly detectable in the MR image data (Figure 7). Defecation was altered 
after the intake of 7.5 g L-lysine, as 5 of 6 subjects reported self-limiting diarrhoea within one 
to six hours after L-lysine application. No other side effects or dose dependent changes in 
self-reported visceral sensations were found during the experiments. Original data of all 
visceral sensations scores and corresponding density functions are summarized in 
supplemental Figure S2a, b. These findings confirm the dose-dependent delay in gastric 
emptying and demonstrate an increase in intestinal liquid content with high temporal 
resolution in humans.   
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Discussion:  
This study revealed several similar functional responses of the GI tract to L-lysine stimulus in 
humans and rats. In both species, gastric and small intestinal functions were effectively 
modulated after intragastric infusion of L-lysine. 
L-lysine delayed gastric emptying revealing a conserved amino acid specific effect in rats and 
humans. This delay did not trigger a temporal delay of L-lysine absorption into the blood 
stream in humans thereby enabling a post-gastric regulatory mechanism. Gastric emptying is 
generally accepted to be primarily controlled by the volume and the caloric equivalent of the 
gastric load (Camilleri, 2006). The negligible caloric content and differences between the 
lowest and highest L-lysine dose in humans (< 23 kcal) and rats (< 5 kcal), however, suggest 
a novel caloric independent mechanism for the regulation of gastric emptying. This amino 
acid specific mechanism for the control of GI function has been recently proposed for L-
lysine, L-arginine and L-glutamic acid in rats (Jordi et al., 2013) and is herewith confirmed 
for humans. Beyond that the rat study showed that intravenous L-arginine and L-lysine did 
not modulate GI function indicating a potential GI luminal mechanism of action (Jordi et al., 
2013). Nevertheless, the underlying regulator mechanism might also involve vagal signaling 
or a paracrine action of GI hormones. Several ex vivo electrophysiological studies revealed 
amino acid specificity of vagal firing as different amino acids excite or inhibit vagal afferent 
activity dependent on the exposed vagal branch (Tanaka et al., 1990; Niijima, 1991; Niijima 
& Meguid, 1995; Niijima, 2000; Torii & Niijima, 2001). Interestingly of all amino acids 
tested only intragastric L-glutamic acid induced vagal signaling ex vivo indicating the 
necessity for amino acid absorption (Uneyama et al., 2006; Kitamura et al., 2011). Hepatic 
vagal afferents fire specifically to an L-lysine stimulus and they were shown to mediate the 
anorectic effect of L-lysine in rats (Torii & Niijima, 2001; Jordi et al., 2013). Apart of 
neuronal signaling L-lysine might stimulate the release of specific GI hormones. For instance 
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the release of the gut hormone GLP-1 from primary murine intestinal cells was shown to be 
induced by L-glutamic acids (Tolhurst et al., 2011). Similar L-phenylalanine and L-
tryptophan were reported to stimulate CCK secretion from primary cells (Wang et al., 2011). 
Hence, this demonstrates remarkable amino acid specificity for the secretory function of 
endocrine cells ex vivo.  However, the specific impact of L-lysine on GI hormone release and 
their relevance for the modulation of GI function in vivo is currently unknown. Taken 
together, L-lysine dose dependently delayed gastric emptying revealing a caloric independent 
mechanism for the control of GI function also in humans.   
Gastric secretion was dose dependently induced in animals but not in humans.  Importantly, 
delayed gastric emptying and secretion had a different dose response curve in rats. This 
indicates that the here applied L-lysine doses in humans might not be sufficient to extensively 
stimulate gastric secretion. A formerly more invasive study by Sackler et al. applying repeated 
extraction of gastric content with subsequent titration reported increased gastric HCl secretion 
after application of 5 g L-lysine combined with a solid test meal (Sackler & Sophian, 1957). 
Hence, the test meal composition and the sampling method might have synergized with L-
lysine to induce increased gastric secretion. It is understood, that gastric secretion is mainly 
mediated by parietal cells. Here, it was not assessed if L-lysine stimulated parietal secretion 
directly or induced Histamine secretion by enterochromaffin cells, but as Histamine not only 
induces gastric secretion but also delays gastric emptying this might be an alternative 
mediatory mechanism of the observed L-lysine action (Bertaccini & Scarpignato, 1982; 
Furutani et al., 2003). The missing effect of L-lysine on gastric secretion in humans was 
reflected and supported by the absence of any differences in blood gas parameters and base 
excess. Gastric secretion was previously shown to correlate with base excess in blood, an 
effect termed alkaline tide (Niv & Fraser, 2002). In sum, L-lysine induced gastric secretion at 
high doses in rats.  A similar effect might be probable in humans; however, its analysis is 
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hampered by the diarrhea inducing side effect of L-lysine doses ≥ 7 g. The reported side 
effects of self-limiting diarrhea for the highest Lys dose of 7.5 g in humans were accompanied 
by an increase in intestinal fluid volume. In both humans and rats, a dose dependent increase 
in intestinal fluid volume, respectively cecum wet weight, was observed. The origin of this 
fluid accumulation is currently unclear, but might arise either from increased bile and 
pancreatic secretion, reduced luminal absorption and/or active intestinal fluid influx. A simple 
osmotic effect can be excluded, because we applied isomolar L-lysine solutions. Since no 
dose dependent effect on gallbladder volume was detected in humans, and because rats have 
no gallbladder the latter two possibilities are currently the more likely reasons for this 
phenomenon.  
In healthy humans, the apparent impact of L-lysine on gastric and small intestinal function did 
not translate into changes in visceral sensation scores. Hunger and fullness were the only 
scores to exhibit density functions with modes different from zero. Therefore, a simplified 
ordinal, i.e. binomial, model analysis had to be applied to test for a dose dependent increase in 
scores ≥ 1. This finding might not be surprising given the low numbers of study participants 
and the multitude of determinants of visceral sensitivity (Mulak, 2003) . A larger number of 
volunteers would be needed to conclude on the effect of L-lysine on human satiation.  
In conclusion, this translational study demonstrates comparable dose-dependent effects of 
intragastric L-lysine on GI function in humans and rats, in particular stomach and small 
intestinal function. This conserved chemospecificity supports a broader role for individual 
amino acids in the control of gastrointestinal transport and secretion in vivo.    
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Tables 
 
Table 1 
 
Ingredients and properties of the four L-lysine test meals for human application 
Ingredients/properties units values 
LMH [g] 0.5 1.2 3.0 7.5 
NaCl [g] 1.24 1.12 0.8 0.0 
Evian® (still water)   [ml] 300 
Locus beam gum (E410)   [g] 3 
MR contrast agent (Dotarem®) [µl] 350 µl(≙175 µmol ≙583.3 µM) 
Osmolarity [mOsm/l] 152.52 
pH pH 9.2 9.6 9.6 9.85 
Caloric load [kcal] 2.3 4.5 10.4 25.1 
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Figure captions 
 
Figure 1 
 
Schematic of the human study protocol. The schematic depicts the sequence of MRI 
measurements, venous blood sampling and visceral sensation ratings as performed in all three 
study sessions. 
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Figure 2 
 
Dose dependent effect of intragastric L-lysine administration on GI wet weight in rats. 
L-lysine dose-dependently increased stomach (A) and caecum wet weight (B) in rats. 
Individual dots represent wet weight measurements of individual animals treated with the 
respective L-lysine dose. The predicted linear dose-response curve is presented as black solid 
line. 
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Figure 3 
 
Dose dependent effect of intragastric L-lysine administration on phenol red content in 
rats. Phenol red content is expressed as percentage of the initially administered total phenol 
red amount. L-lysine dose-dependently increased gastric phenol red content (A) and 
decreased small intestinal (B) and colon (C) phenol red content in rats. Individual dots 
represent residual phenol red content measurements of individual animals treated with the 
respective L-lysine dose. The predicted linear dose-response curve is presented as black solid 
line. 
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Figure 4 
 
Dose dependent L-lysine concentrations in venous blood after intragastric application of 
L-lysine in humans. Data is expressed as delta over baseline (DOB) with baseline values 
measured before intragastric L-lysine infusion. (A) Smoothed DOB L-lysine concentration 
curves (lines) overlaid on the individual measurements (dots) of all human subjects each 
treated with three (of the total four) different L-lysine doses. L-lysine concentration data of 
one dose in subject PB1_1991 had to be dismissed due to subject non-compliance of study 
protocol. (B) The linearly predicted L-lysine concentration increase per dose (solid lines) 
overlaid on the individual measurements (dots).  
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Figure 5 
 
Dose dependent effect of intragastric L-lysine application on gastric emptying in 
humans. (A) Smoothed gastric emptying curves (lines) overlaid on the individual volume 
measurements (dots) of all human subjects each treated with three (of the total four) different 
L-lysine doses. (B) L-lysine dose-dependently increased t50 (computed from smoothed 
gastric emptying curves) in humans. Values of t50 (y-axis) are plotted in log10 scale, while L-
lysine doses (x-axis) are plotted in log2.5 scale. 
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Figure 6 
 
Dose dependent effect of intragastric L-lysine application on intestinal fluid volume in 
humans. (A) Smoothed intestinal fluid volume curves (lines) overlaid on the individual 
volume measurements (dots) of all human subjects each treated with three (of the total four) 
different L-lysine doses. (B) The linearly predicted intestinal fluid volume increase per dose 
(solid lines) overlaid on the individual measurements (dots).  
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Figure 7 
 
MR image data highlighting the dose dependent effect of intragastric L-lysine 
application on gastrointestinal fluid volume in humans. The difference in the accumulation 
of intestinal fluid volume and the delay in gastric emptying between L-lysine doses 1.2 g and 
7.5 g is depicted over 60 min in representative MR image data of one subject (RH1_1988). 
Imaged GI organs and anatomical landmarks are indicated. 
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7. Unpublished Results  
7.1 The Impact of L-arginine, L-lysine and L-glutamic acid on Circulating 
Gastrointestinal Hormone and Metabolite Concentrations 
Rational 
Important factors in the modulation of food intake and gastrointestinal function are gastrointestinal 
hormones as discussed in the introduction. They can act in a paracrine and/or endocrine manner. 
Locally they can directly alter gastrointestinal function and/or modulate vagal afferent firing. By 
circulation they can directly act on hormone sensitive central neurons and the vagus nerve among 
many others. The paracrine and the endocrine mechanism can regulate gastrointestinal motility 
and/or eating behavior. Hence, we hypothesized that L-arginine, L-lysine and L-glutamic acid 
differentially stimulate the release of gastrointestinal hormones and thereby indirectly inhibit food 
intake and modulate gastrointestinal motility. We assessed circulating gastrointestinal hormones in 
the portal vein and in general circulation. The portal vein is of particular interest because of its 
unique anatomical localization and the therefore expected high nutrient and hormone concentration 
as discussed in the introduction. 
Methods 
Animal housing, amino acid administration and dosing was performed as described in “Specific 
Amino Acids Inhibit Food Intake via the Area Postrema or Vagal Afferents”. To test the above 
hypotheses we conducted a terminal experiment focusing on one time point (30 min post 
application). Rats were food deprived for 12 h and received at dark onset an oral administration of a 
candidate amino acid. Glucose (isomolar) served as a positive control. Rats were returned to their 
home cage and had no access to food. 30 min post-administration rats were anesthetized and blood 
collected from the portal vein, the tongue and the heart by puncture with a syringe.  Blood was 
collected into two EDTA-coated tubes. The tube for amino acid analysis was not supplemented, 
whereas the tube for hormone analysis was supplemented with 1 μl / 100 μl blood protease inhibitor 
(Sigma), 1 μl / 100 μl DPP IV (EMD Millipore) and 0.1 mg / 100 μl blood Perfabloc (Roche). We 
showed that supplementation interfered with amino acid analysis, but improves gastrointestinal 
hormone stability according to the kit manufacture. Blood was gently inverted, immediately 
centrifuged for 10 min at 1000 g and 4 °C. Plasma was collected and stored at -20 °C. Plasma amino 
acid concentrations were measured by the Functional Genomics Center Zurich using high pressure 
liquid chromatography, plasma glucose by AccuCheck Aviva (Roche) and plasma hormones using the 
Milliplex Map Kit – Rat Metabolic Magnetic Bead Panel based on the Luminex xMAP technology. 
Manufacture procedures were followed and magnetic sorting performed with a hand-held magnetic 
separation block. Importantly all samples were detected in the linear range of the standards and all 
quality control samples were in the manufacture target range. Amylin was below the detection range 
in all samples.  
Results  
All the data was listed and statistically analyzed comparing to water control (Table 1). Under all 
conditions the orally applied metabolites (glucose and individual amino acids) were absorbed, 
appeared in plasma of the portal vein and in general circulation (tongue/heart), and increased by 
several folds in concentrations indicating proper experimental application. The concentration in the 
portal vein was higher compared to common circulation for most applied metabolites. Different 
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metabolic products were as well detected dependent on the applied metabolite. For instance, L-
arginine application increased the ornithine concentration. However, in our experimental conditions 
neither L-arginine, L-lysine nor L-glutamic acid triggered a measurable change in the concentration of 
a specific gastrointestinal hormone in the portal vein, heart or tongue plasma. Specifically, no 
significant change in the concentration of insulin, glucagon, glucose-dependent insulinotropic 
peptide (GIP), glucagon-like peptide-1 (GLP-1), amylin, ghrelin, leptin, pancreatic polypeptide (PP) 
and peptide tyrosine tyrosine (PYY) were detected after amino acid administration (Tab. 1). Glucose, 
the positive control, stimulated the release of GIP and a general reduction of circulating amino acids 
was observed compared to water control.  
Conclusion 
We conclude that the measured circulating hormones do not play a central role in mediating the 
anorectic and gastrointestinal responses reported for L-arginine, L-lysine and L-glutamic acid. This 
conclusion does not include a paracrine action of the hormones on vagal afferents or on the 
gastrointestinal tract. The power of this experiment is limited as it assessed only one time point and 
therefore neglects the temporal aspect of metabolite absorption and hormone release. Nevertheless 
the 30 min time point was a good choice, because after a meal most gastrointestinal hormones were 
elevated for at least 30 min and detectable with the here used method as shown by Shin et al. (138). 
Additionally our observed gastrointestinal hormone concentrations were in a comparable range to 
the basal concentrations measured by Shin et al. Our positive control, oral glucose application, 
stimulated the release of GIP but no change in insulin concentration was detected. This might have 
been expected as plasma insulin peaks 15 min after an oral glucose tolerance test, but returns to 
baseline quickly within 30-60 min (2). The here used glucose dose is “only” 25 % of the one used in a 
classical oral glucose tolerance test (4 g/kg), hence, differences might be explainable. Indeed insulin 
concentration drop to baseline after the application of 1 g/kg glucose in the rat. Nevertheless the 
increase in GIP concentration and the general decrease of amino acid concentration indicate a post-
insulinic phase. Insulin is generally described to increase peripheral amino acids absorption in text 
books (157). Taken together, the data quality indicates a proper experimental approach but no 
amino acid induced release of circulating hormones.  
This conclusion has to be taken with sufficient care, because negative data are difficult to interpret. 
Therefore next I briefly discuss specific limitations. First of all a defined set of hormones and 
metabolites was measured therefore an unknown compound or peptide may mediated the effect to 
the specific amino acids. Second, the measurement of hormones is a technical challenge. Normally, 
several splicing variants of one hormone exist and they might act by different receptors. They differ 
in stability, activity, half-life, etc. These differences were not accounted for by our measuring 
technique. Third, hormones are difficult compounds not only for measurement but as well for 
application. The problematic is best illustrated, if one considers that intraperitonal injection of even 
well-known anorectic hormones such as leptin, insulin, PYY or CCK do not always inhibit food intake. 
The mystery is why and was recently reviewed by two respected seniors in the field (168). Fourth, to 
correctly assess the above hypothesis feeding behavior and gastrointestinal function study should 
have been performed within hormonal inhibitor studies or even better within the specific 
gastrointestinal hormone knock-out mice if available. We did not follow this route because we did 
not find any indications for a candidate hormone to test in more detail. In sum, we did not detect 
amino acid induced changes in gastrointestinal hormones in the circulation. Therefore we propose  
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Table 1 – Plasma hormones and metabolites 30 min after individual amino acid administration.   
Oral gavage of
Measured Compound Location Mean SEM p-value Mean SEM p-value Mean SEM p-value Mean SEM p-value Mean SEM p-value Mean SEM p-value
Hormones
GIP tongue 25 9 28 4 67 10 ** 24 4 13 5 18 2
[pg/ml] portal vein 67 14 56 15 127 23 *** 39 6 36 4 * 57 9
heart 45 9 40 7 109 5 *** 28 2 25 4 39 5
Leptin tongue 278 109 409 70 309 84 687 210 * 316 118 253 59
[pg/ml] portal vein 630 141 757 197 773 189 970 316 841 100 905 215
heart 714 161 807 175 1029 173 1121 224 1084 187 912 89
Glucagon tongue 1 0 na nd nd na 1 0 na 2 1 na 5 4 na 1 0 na
[pg/ml] portal vein 26 9 19 8 16 1 31 11 43 12 22 8
heart 12 0 2 0 3 1 13 9 13 7 3 0
Insulin tongue 942 540 963 282 468 74 1358 570 2157 731 1536 500
[pg/ml] portal vein 4594 1331 1922 811 2378 1527 4782 1664 5013 1163 6268 1431
heart 1394 486 1275 666 693 110 2365 1091 3377 1036 3044 743
PP tongue nd nd na nd nd na nd nd na nd nd na nd nd na nd nd na
[pg/ml] portal vein 63 15 50 13 33 13 50 24 38 12 59 15
heart nd nd na nd nd na nd nd na nd nd na nd nd na 30 0 na
PYY tongue nd nd na nd nd na nd nd na nd nd na nd nd na nd nd na
[pg/ml] portal vein 78 18 na nd nd 77 15 na 130 22 na 136 33 na 70 4 na
heart 41 0 na nd nd nd nd na 86 7 na 84 22 na 37 0 na
Grehlin tongue 90 18 62 11 74 8 98 26 103 25 64 14
[pg/ml] portal vein 47 7 52 11 24 5 71 27 90 15 53 13
heart 55 16 43 8 32 15 80 30 67 18 51 14
GLP-1 tongue nd nd na nd nd na nd nd na nd nd na nd nd na nd nd na
[pg/ml] portal vein 177 58 87 20 73 35 264 61 301 96 196 47
heart 63 10 na nd nd na 21 0 na nd nd na nd nd na nd nd na
Amino Acids
Alanine tongue 602 28 3433 115 *** 571 36 703 62 658 24 862 91
[μmol/l] portal vein 833 80 3374 113 *** 829 60 1093 104 918 106 1311 86 ***
heart 678 43 3546 212 *** 665 66 774 37 647 41 953 73
Arginine tongue 123 12 120 8 77 18 922 62 *** 140 10 110 12
[μmol/l] portal vein 69 19 47 14 39 12 1000 178 *** 118 18 89 9
heart 122 14 124 15 94 11 787 115 *** 134 11 113 9
Asparagine tongue 107 8 133 6 80 4 96 7 115 5 93 8
[μmol/l] portal vein 116 12 143 10 107 9 116 11 158 20 ** 107 10
heart 116 10 146 8 93 7 97 6 110 3 103 5
Aspartic Acid tongue 12 1 25 3 16 3 15 2 15 1 66 13 **
[μmol/l] portal vein 41 7 99 10 ** 42 4 57 14 32 10 130 29 ***
heart 29 4 54 11 28 8 36 7 22 3 98 26 ***
Cysteine tongue 7 2 8 2 4 1 10 2 12 2 8 2
[μmol/l] portal vein 11 3 8 2 6 2 15 2 15 3 13 2
heart 11 3 10 2 7 1 12 0 14 2 12 2
Glutamine tongue 1101 58 1223 54 886 48 1040 89 993 46 1144 104
[μmol/l] portal vein 1158 114 1084 80 1039 58 1041 121 923 94 1373 128
heart 1428 110 1478 80 1148 89 1167 56 1204 37 1464 67
Glutamic Acid tongue 133 10 211 17 148 28 186 18 163 11 775 174 **
[μmol/l] portal vein 585 123 1140 97 * 695 131 781 217 484 200 1527 341 ***
heart 204 30 358 57 227 57 340 52 277 39 964 260 ***
Glycine tongue 512 36 538 28 315 62 ** 447 45 555 40 433 27
[μmol/l] portal vein 472 91 466 36 445 18 525 50 662 77 * 513 28
heart 566 42 577 38 436 14 479 32 593 40 518 21
Histidine tongue 65 7 74 5 51 4 53 3 56 3 57 4
[μmol/l] portal vein 77 10 80 7 65 4 67 4 70 2 70 6
heart 78 10 86 7 59 5 58 5 63 2 69 4
Isoleucine tongue 83 4 64 2 57 8 75 4 84 5 90 25
[μmol/l] portal vein 160 20 120 4 137 15 151 22 157 13 132 23
heart 106 10 86 4 80 12 104 9 101 6 92 11
Leucine tongue 155 7 116 5 106 15 155 6 159 9 163 43
[μmol/l] portal vein 287 36 219 9 251 26 301 38 302 26 241 42
heart 198 19 160 7 150 22 212 15 197 12 171 18
Lysine tongue 327 46 372 44 261 27 372 39 2804 146 *** 368 57
[μmol/l] portal vein 403 39 432 41 316 32 407 52 3953 358 *** 423 61
heart 354 48 434 50 306 44 403 57 2835 191 *** 389 43
Methionine tongue 45 2 40 2 36 2 47 2 55 3 41 4
[μmol/l] portal vein 60 7 50 2 51 4 60 4 73 3 * 52 4
heart 54 4 48 2 42 4 51 4 57 2 46 2
Phenylalanine tongue 50 5 42 3 41 6 48 1 48 2 51 9
[μmol/l] portal vein 94 19 78 8 85 8 89 12 88 8 77 14
heart 65 9 56 4 51 6 61 9 62 4 60 7
Proline tongue 161 11 195 11 128 6 218 14 ** 172 14 163 11
[μmol/l] portal vein 169 15 187 13 142 6 276 18 *** 217 22 * 197 14
heart 175 17 206 12 139 9 217 14 172 9 178 10
Serine tongue 286 26 382 23 173 34 * 255 18 270 13 259 18
[μmol/l] portal vein 276 66 354 31 242 14 267 25 303 27 307 25
heart 313 42 409 30 233 9 249 24 276 12 297 16
Threonine tongue 242 16 276 15 173 14 217 17 256 29 223 23
[μmol/l] portal vein 274 29 286 21 206 8 244 24 308 34 268 24
heart 269 27 303 19 191 8 * 218 20 266 21 251 17
Tryptophan tongue 60 10 56 5 47 3 57 8 67 4 53 4
[μmol/l] portal vein 67 12 64 5 54 3 66 7 75 5 64 7
heart 63 12 61 5 50 3 56 7 68 4 61 8
Tyrosine tongue 53 7 45 4 36 4 49 3 57 3 53 9
[μmol/l] portal vein 90 19 72 7 68 7 84 10 86 7 78 14
heart 66 11 57 5 44 4 61 4 65 3 61 9
Valine tongue 187 6 158 6 134 10 175 9 185 11 192 41
[μmol/l] portal vein 307 36 237 7 247 22 291 32 292 20 259 34
heart 225 17 193 6 168 19 221 12 217 10 197 13
H2O L-alanine D-(+)-glucose L-arginine L-lysine L-glutamic acid
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that L-arginine, L-lysine and L-glutamic acid inhibit food intake and modulate gastrointestinal motility 
independent of circulating hormones. This conclusion is as well supported by the behavioral data 
shown in the research article”Specific Amino Acids Inhibit Food Intake via the Area Postrema or Vagal 
Afferents.”. All three amino acids induced satiation by reducing first meal size, but not meal duration. 
This is in contrast to classical satiation-inducing peptides such as CCK or amylin which proportionally 
reduce meal size and duration (167). Additionally, the anorectic effect of CCK for instance is 
compensated by hyperphagia as soon as the hormone loses its activity (degradation, stability,…). In 
contrast, L-arginine and L-lysine decreased food intake as well in the long term, whereas L-glutamic 
acid treated animals compensated for the initial decrease in food intake in the following 48 h. Lastly 
several gastrointestinal hormones mediate their anorectic effect by vagal afferents (see 
introduction). L-arginine and L-glutamic acid still induced an anorectic behavior in capsaicin de-
afferented rats. Hence, several lines of experiments indicate no involvement of circulating 
gastrointestinal hormones for the anorectic effect induced by L-arginine, L-lysine and L-glutamic acid. 
This conclusion is only valid for the anorectic effect and not for the amino acid specific impact on 
gastrointestinal function.    
Oral gavage of
Measured Compound Location Mean SEM p-value Mean SEM p-value Mean SEM p-value Mean SEM p-value Mean SEM p-value Mean SEM p-value
Non-Amino Acids
Glucose tongue 156 13 159 14 103 9 179 11 197 7 286 66
[mg/dl] portal vein 171 44 441 45 *** 395 75 ** 244 16 318 81 299 72
heart 203 39 230 29 205 42 281 22 258 27 243 28
1-Methylhistidine tongue 1.0 0.2 1.5 0.1 0.8 0.1 1.4 0.1 1.7 0.2 2.2 0.5 *
[μmol/l] portal vein 1.9 0.3 1.7 0.2 1.2 0.2 1.2 0.3 2.0 0.3 2.2 0.8
heart 1.1 0.2 1.8 0.2 1.0 0.1 1.3 0.3 2.0 0.3 1.5 0.3
3-Methylhistidine tongue 3.9 0.5 5.0 0.3 3.5 0.3 3.3 0.1 0.8 0.3 3.5 0.6
[μmol/l] portal vein 3.3 0.6 5.0 0.4 3.3 0.4 8.6 4.2 ** 1.1 0.5 4.1 0.6
heart 4.2 0.4 5.2 0.4 3.7 0.4 4.2 0.7 1.5 0.5 4.5 0.6
Alpha-Amino-N-Butyric Acid tongue 14 2 14 1 9 1 12 2 12 3 12 3
[μmol/l] portal vein 24 5 16 2 11 1 *** 17 3 20 3 15 3 *
heart 15 3 16 2 10 1 16 3 16 3 13 2
Alpha-Aminodipic Acid tongue 1.0 0.4 2.2 0.1 0.9 0.4 2.0 0.6 14.7 1.9 *** 3.6 0.8 *
[μmol/l] portal vein 3.2 0.4 4.2 0.1 3.3 0.4 3.8 0.7 16.7 1.1 *** 6.2 1.1 *
heart 2.1 0.1 2.8 0.3 1.3 0.6 3.2 0.6 16.1 1.4 *** 5.2 0.8 *
Beta-Alanine tongue 10 1 11 2 11 2 12 2 14 1 11 1
[μmol/l] portal vein 10 2 11 2 10 1 13 3 12 2 13 2
heart 11 2 12 2 12 2 13 2 14 1 13 1
Carnosine tongue 4.1 1.6 4.6 1.7 3.5 1.0 8.6 1.4 2.4 0.3 3.2 0.6
[μmol/l] portal vein 5.2 1.6 4.9 0.8 9.4 2.0 24.3 6.4 *** 7.2 2.6 8.1 1.8
heart 4.2 0.7 2.7 0.3 3.7 0.7 10.9 1.0 4.9 1.6 4.1 0.7
Citrulline tongue 115 9 145 11 91 7 115 11 107 10 108 10
[μmol/l] portal vein 141 14 182 13 ** 115 3 154 11 135 7 137 11
heart 124 13 157 11 96 2 117 8 113 8 111 7
Cystathionine tongue 1.7 0.2 2.0 0.3 1.7 0.1 1.6 0.3 1.8 0.1 2.4 0.3
[μmol/l] portal vein 2.0 0.2 2.3 0.3 1.9 0.1 2.0 0.2 2.0 0.4 2.9 0.6
heart 2.0 0.2 2.6 0.4 1.9 0.1 1.9 0.3 1.8 0.3 3.1 0.4 *
Ethanolamine tongue 16 1 18 1 17 2 14 2 16 1 22 5
[μmol/l] portal vein 33 6 40 4 38 3 31 8 27 4 36 7
heart 24 2 28 3 24 3 25 3 22 2 27 3
GABA tongue 1.8 0.4 2.4 0.3 1.6 0.3 2.0 0.5 1.6 0.5 2.0 0.4
[μmol/l] portal vein 2.0 0.4 3.4 0.5 2.2 0.5 3.0 0.6 2.4 0.1 3.0 0.3
heart 1.8 0.5 2.8 0.3 1.9 0.4 2.7 0.2 2.1 0.5 2.4 0.5
Hydroxyproline tongue 62 7 84 6 52 3 60 3 71 10 59 8
[μmol/l] portal vein 43 10 70 7 * 47 3 53 5 59 10 66 6
heart 69 8 91 8 56 4 57 2 68 7 57 12
Ornithine tongue 75 6 90 4 84 15 567 62 *** 59 10 121 25
[μmol/l] portal vein 169 16 212 19 170 26 1081 126 *** 84 17 186 24
heart 97 9 109 12 83 15 688 32 *** 85 14 129 12
Phospohoethanolamine tongue 15 2 19 5 17 2 15 1 18 1 23 3
[μmol/l] portal vein 25 3 35 4 29 6 31 6 23 4 36 6
heart 16 1 18 3 16 2 17 1 17 1 25 3
Sarcosine tongue 15 1 13 2 9 3 13 2 13 2 15 2
[μmol/l] portal vein 20 3 16 2 14 1 21 2 20 5 17 2
heart 11 1 12 2 13 1 13 3 15 2 17 1
Taurine tongue 187 17 230 27 208 24 212 19 222 22 232 49
[μmol/l] portal vein 233 40 276 46 288 56 284 19 232 24 216 25
heart 434 75 300 22 379 90 281 24 269 31 * 339 47
Unknown Compound tongue 49800 5170 60522 6069 41531 4326 52656 5149 401341 52757 *** 56616 8642
[area under the peak] portal vein 74355 9288 85102 9147 49259 11141 64734 6702 570966 96183 *** 89575 9108
heart 55138 5162 68650 8624 42458 4237 64253 10153 356618 28216 *** 61986 3152
n= 6; statistical comparison made to H2O; unpaired two-way ANOVA, Bonferroni post test nd=not detected na=not accessed
L-glutamic acidH2O L-alanine D-(+)-glucose L-arginine L-lysine
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7.2 The Impact of L-arginine, L-lysine and L-glutamic acid on Defecation 
Rational 
The data presented in the manuscript “Specific Amino Acids Inhibit Food Intake via the Area 
Postrema or Vagal Afferents.” could as well be interpreted in the following manner as proposed in 
the 1.5 year committee meeting. The amino acid L-arginine and L-lysine stimulated a putative alarm 
system controlling amino acid homeostasis, which protects the milieu interieur from an amino acid 
overload. The applied doses of L-arginine and L-lysine were relatively high (Table 2 – see discussion, 
113 %, 104 % of their specific daily intake), which led to a strong raise in their plasma concentration 
(Table 1; fold changes relative to H2O– L-alanine [4-6x],L-arginine [6-15x], L-lysine [8-10x], L-glutamic 
acid [2.5-6x]) and these could be detected by a alarm mechanism. The immediate protective 
mechanism induced will target to reduce nutrient absorption in the small intestine. Luminal nutrients 
would be removed by increased intestinal motility, their concentration diluted by increased secretion 
and their delivery to the small intestine delayed by reduced gastric emptying. Additionally, food 
intake would be restricted and the animal will learn to avoid this nutrient sources reflected in the 
positive conditioned taste aversion test after oral application. Indeed L-arginine and L-lysine did 
trigger the above response. Additionally in humans’ high doses of L-lysine induced diarrhea. L-alanine 
and L-glutamic acid (Table 2, 66 %, 27 % of daily consumption) did not elicit the alarm system 
because they are key energetic shuttling molecules between organs and had no malaise effect in oral 
conditioned taste aversion test. If there is such a putative protective mechanism aiming to avoid 
nutrient absorption by altering gastrointestinal functions, one would expect altered defecation 
specifically triggered by L-arginine and L-lysine as a mean to release over-counting nutrients. To test 
this hypothesis, we assessed defecation after individual amino administration. 
Methods 
Animal housing, amino acid administration and dosing was performed as described in “Specific 
Amino Acids Inhibit Food Intake via the Area Postrema or Vagal Afferents.”. Animals were adapted to 
a feeding schedule enabling food intake only in the first 8 h after dark onset. Water was available ad 
libitum. After 16 h food deprivation rats were gavaged with an isomolar dose of individual amino 
acids including phenol red (1.5 mg) and 30 min later received access to food. Food intake was 
measured every 2 h. Feces were individually collected and counted every 2 h, weighted, and dried at 
80 °C. Phenol red (Sigma) was extracted and quantified as described by others (153). 
Results 
L-arginine, L-lysine and L-glutamic acid reduced food intake in the first 2 h after amino acid 
application (Fig. 3A). No significant differences between treatment groups were found on feces 
number, wet weight or water content (Fig. 3B, C, E). A higher dry feces weight between 6-8 h was 
measured after L-lysine administration, but no other time point or treatment showed a significant 
effect (Fig. 3D). The administered phenol red, a spectroscopically detectable dye, was mainly 
recovered within feces samples after 4-8 h of administration and no treatment differences were 
found (Fig. 3F).      
Conclusion 
L-arginine, L-lysine, and L-glutamic acid inhibited short-term food intake as previously described in 
our manuscript entitled “Specific Amino Acids Inhibit Food Intake via the Area Postrema or Vagal 
Afferents.”. No significant impact of L-arginine, L-lysine, and L-glutamic acid was found on defecation 
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or on the water content in the rat feces, which could indicate a very mild form of diarrhea. 
Interestingly the orally administered dye, phenol red, is recovered in the feces sample mainly after 4 
h showing no faster gastrointestinal dye transit between treatment groups. This is in agreement with 
previous reports showing that an orally applied randomly labeled 14C protein and a non-absorbable 
marker 51CrCl3 reached the colon within 4 h (36). This collectively indicates that L-arginine, L-lysine 
and L-glutamic acid did not induce accelerated defecation nor changed total gastrointestinal dye 
transit time. The alternative interpretation of the gastrointestinal phenotype induced by L-arginine, 
L-lysine and L-glutamic acid is that they serve as direct sensory input to assess dietary protein 
content and quality in vivo enabling to adapt food processing and intake accordingly. This 
interpretation is part of the manuscript entitled “Specific Amino Acids Inhibit Food Intake via the 
Area Postrema or Vagal Afferents.”. 
Figure 3 – Food intake and defecation following amino acid administration. After 16 h food 
deprivation animals were gavaged with an isomolar dose of individual amino acids including phenol 
red and 30 min later received access to food. Every following 2 h food intake was measured (A), feces 
collected and counted (B), weighted (C), dried (D) and water content calculated (E). Phenol red 
content of feces was measured (F). Values are mean ± sem; n = 10-12, unpaired two-way ANOVA, 
Bonferroni Post-Test, **P<0.05, **P<0.01, ***P<0.001. 
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7.3 The Impact of L-arginine, L-lysine and L-glutamic acid on Body Weight in 
the Short Term 
Rational 
As L-arginine, L-lysine and L-glutamic acid are potent inducer of satiation, we hypothesized they 
could be applied to reduce or limit body weight gain. As discussed in the introduction, high protein 
diets such as the Atkins diet are of broad interest, because they seem to selectively reduce fat mass 
and not alter lean body mass or energy expenditure (3, 75). Dietary supplementation with L-arginine 
revealed promising results in Zucker rats reducing body weight by 6 %, 10 %, and 16 % after 4, 7, and 
10 weeks after treatment initiation (51, 98).  The dietary supplementation with monosodium-
glutamate or L-lysine was not successful in reducing body weight in rats (18, 152). Obviously these 
conclusions are restricted to the applied doses and to a constant increase of the supplemented 
amino acid. In this work, we always assessed the acute impact of a single amino acid dose on food 
intake. Hence there is a peak of amino acid concentration in plasma and not a constant 
supplementation potentially marking a conceptual difference. Therefore, we hypothesized that L-
arginine, L-lysine and L-glutamic acid can limit body weight gain acutely.  
Methods 
Animal housing, amino acid administration and dosing was performed as described in “Specific 
Amino Acids Inhibit Food Intake via the Area Postrema or Vagal Afferents.”. Animals were adapted to 
a feeding schedule enabling food intake in the first 8 h after dark onset. Water was available ad 
libitum. At dark-onset animals were weighted and gavaged with an isomolar dose of individual amino 
acids. 30 min post application animals received access to food. Food intake was measured after 1 h 
to assess the short-term impact and after 8 h to assess the daily intake. During the first 3 days of the 
experiment all animals received a water gavage followed by 5 days of treatment with the respective 
amino acid.  
Results 
All animals allocated to the different treatment groups increased body weight by around 4.5 g/day 
during the initial treatment with water (Fig. 4A). Short-term and daily food intake did neither differ 
between treatment groups during the initial water treatment. Oral L-arginine and L-lysine reduced 
short term food intake in the first hour after application on every treatment day expect on day 4 (Fig. 
4B). Daily food intake was not significantly reduced between treatment groups nor did we observe a 
significant impact on body weight gain (Fig. 4A, 4C).  
Conclusion 
L-arginine and L-lysine inhibited short-term food intake as previously described in our manuscript 
entitled “Specific Amino Acids Inhibit Food Intake via the Area Postrema or Vagal Afferents.” on day 1 
and the following days expect for day 4.  Surprisingly L-glutamic acid did not reduce food intake 
significantly. This divergence from previous findings might emerge, because the water and L-alanine 
group did eat less compared to previous experiments (normally +- 8 g in the first hour; +- 30 g/day). 
An intuitive explanation might be the stress induced by daily gavaging, however we did not find that 
oral applications impaired normal rat feeding or drinking behavior in our experience. Nevertheless, 
no significant impact of L-arginine, L-lysine, and L-glutamic acid was found on total food intake or on 
body weight gain thereby limiting the potential for an anti-obesity treatment. Even though this 
intervention for 5 days was not successful a more long-term application might be an alternative 
120 7. Unpublished Results 
  
 
strategy. The option would range from supplementing the water bottles with the candidate amino 
acids to the use of mini-pumps for a constant increase in plasma L-arginine, L-lysine and L-glutamic 
acid concentration. We did not continue on this avenue because the data was for us not promising 
enough. We concluded that the effect of the three individual amino acids most probably is limited to 
the short-term. 
Figure 4 – Body weight gain and food intake of animals treated every day with a single individual 
amino acid. (1) Animals were orally gavaged with H2O from day 0 to day 2 and with the indicated 
amino acid from day 3 to day 7. (B) Food intake measured 1 h after amino acid application. (C) Food 
intake measured 8 h after amino acid application. Values are mean ± sem; n = 10, unpaired two-way 
ANOVA, Bonferroni Post-Test, *P<0.05, **P<0.01. 
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7.4 The Impact of All Different Combinations of L-arginine, L-lysine and L-
glutamic acid on the Control of Food Intake 
Rational 
From the experiment assessing the impact of L-arginine, L-lysine and L-glutamic acid on body weight 
we concluded that the effect of the three individual amino acids most probably is not strong enough 
to reduce food intake to the extent required for an impact on body weight. This raised the question, 
what high protein diets contain to mediate their long-term effect. We proposed that the combination 
of all individual amino acids might generate a combined effect. We therefore tested, if combinations 
of L-arginine, L-lysine and L-glutamic acid effect induce a stronger anorectic effect than an individual.   
Methods 
Animal housing, amino acid administration and dosing was performed as described in “Specific 
Amino Acids Inhibit Food Intake via the Area Postrema or Vagal Afferents.”. Animals were adapted to 
a feeding schedule enabling food intake only in the first 8 h after dark onset. Water was available ad 
libitum. At dark-onset animals were weighted and gavaged with a combination of individual amino 
acids. 30 min post application animals received access to food. Food intake was measured as 
indicated after 1 h, 24 h and 48 h.  
Results 
To test this hypothesis we administered all three candidate amino acids in all possible combinations. 
The combination of L-arginine + L-lysine reduced short-term and long-term food intake and 24 h 
body weight gain most potently compared to all other combinations tested (Fig. 5A, 5B). Counter 
intuitively the addition of L-glutamic acid buffered or inhibited the anorectic effect of L-arginine, L-
lysine and their combination. To further characterize the combined effect of L-arginine + L-lysine we 
conducted a dose response study (Fig. 5C). The combination did induce an anorectic effect at lower 
doses compared to the single. At higher doses no significant difference between single and the 
combination were measured. As all experiments so far ignored the osmolarity differences, we 
conducted a study under isomolar conditions. Isomolarity was achieved by adding L-alanine, an 
amino acids with no apparent effect on food intake.  Only the combination L-arginine and l-lysine 
reduced food intake at the low dose of 5.4 mmol/kg, whereas the combination seemed to induce a 
similar effect as the single individual amino acid at the high dose of 13.6 mmol/kg (Fig. 5D, 5E).  
Conclusion 
We hypothesized that L-arginine, L-lysine and L-glutamic acid may combine to generate a stronger 
anorectic effect. Indeed the combination of L-arginine and L-lysine seemed to be more efficient in 
reducing body weight compared to other combinations. Further efforts aimed to characterize this 
combination and experimentally demonstrate synergism (53). Unfortunately these efforts were not 
successful at high doses (Fig. 5E). However, most striking and confusing was the finding that L-
glutamic acid inhibits or even buffered the anorectic effect of L-arginine, L-lysine or their 
combination. We currently do not have a good explanation for this finding.   
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Figure 5 – The combined effect of L-arginine, L-lysine and L-glutamic acid on food intake. (A-B) 
Animals were orally gavaged with a combination of individual amino acids each at a fix dose of 6.7 
mmol/kg. Food intake and body weight was measured. Values are mean ± sem; n = 10, unpaired one-
way ANOVA, Dunnett Post-Test, *P<0.05, **P<0.01, ***P<0.001. (C)  Animals were orally gavaged 
with different doses of individual or combination of amino acids and their subsequent food intake 
measured for 1 h. Values are mean ± sem; n = 10. (D-E) Animals were orally gavaged with a 
combination of individual amino acids at a isomolar dose of 5.4 mmol/kg or 13.4 mmol/kg and their 
subsequent food intake measured for 1 h.  Values are mean ± sem; n = 11, unpaired one-way 
ANOVA, Dunnett Post-Test, *P<0.05.  
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7.5 Systematic Study of the Impact of Individual Amino Acids on Gastric 
Secretion and Emptying – a Novel Computed Tomography Study 
Rational 
Upon meal ingestion, gastrointestinal function can quickly adapt to the meal. This dynamic plasticity 
is based on mechanisms responding to meal born signals. They are to some extent autonomous but 
also controlled by the central nervous system via intertwined neuronal and endocrine signals. The 
afferent input can be mechanic or chemospecific. Most prominently gastric emptying was suggested 
to be calibrated to a fix emptying rate of 2-2.5 kcal/min in humans and of 0.03-0.045 kcal/min in rats 
(70, 96). However, others suggested an even more chemo-specific control of gastrointestinal 
function. For instance, a high protein diet delayed gastric emptying to a larger extends than the 
isocaloric control in humans and rats (13, 44). So far no study systematically addressed the effect of 
all 20 proteogenic amino acids on gastrointestinal function, but our recent efforts demonstrated a 
distinct impact of L-arginine, L-lysine and L-glutamic acid on gastric emptying, secretion and intestinal 
motility in rats. Here, we tested the impact of the other 17 proteogenic amino acids. 
Methods 
Animal housing, image acquisition and data analysis was performed as described in “Simultaneous 
assessment of gastric emptying and secretion in rats by a novel computed tomography based 
method”. Intragastrically administered L-amino acids and D-(+)-glucose (freshly prepared, isomolar, 
6.7 mmol/kg) were applied in 2 ml tap-water containing 400 mg Sodium-diatrizoate. After 4 h food 
deprivation rats were gavaged with their respective dose and after application rats were returned to 
their home-cage. They did not have access to water or food after application. In the first experiment 
animals were imaged after 20 min and in the second experiment after 30 min using the computed 
tomography method described in the manuscript.  
Results 
H2O is known to empty exponentially and significantly faster compared to caloric liquids. Therefore in 
this experiment D-(+)-glucose served as a negative control. The statistical comparison was made to L-
alanine, because it is an amino acid which showed no impact on gastric secretion and emptying 
compared to glucose. Gastric emptying is delayed only by L-cysteine 20 min after administration, 
whereas L-methionine, L-arginine, L-tryptophan, L-lysine and L-cysteine showed increased stomach 
contrast agent content after 30 min (Fig. 6A, 6D). Total stomach volume and non-administered 
stomach volume increased after L-arginine and L-lysine administration and decreased after H2O 
application after 20 min indicating altered gastric secretion (Fig. 6B & C). Total stomach volume was 
increased by L-methionine, L-arginine, L-tryptophan, L-lysine and L-cysteine and decreased for L-
tyrosine and H2O 30 min after their application (Fig. 6E). The non-administered stomach volume was 
increased only by L-arginine and L-lysine and decreased after L-tyrosine and H2O administration 30 
min post administration (Fig. 6F). 
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Figure 6 – Systematic study of the impact of individual amino acids on gastric function. Fasted 
animals were gavaged with Sodium-diatrizoate (SDH, contrast agent) containing an individual amino 
acid. After 20 (A, B, C) or 30 min (D, E, F) animals were imaged using computed tomography and the 
contrast content in the stomach and the total stomach volume quantified. The SDH content reflects 
the extent of gastric emptying and the non-administered stomach volume gastric secretion. L-alanine 
served as a negative control and was used for statistical comparison. Values are mean ± sem; n = 11, 
unpaired one-way ANOVA, Dunnett Post-Test, *P<0.05, **P<0.01, ***P<0.001. 
   
Conclusion 
This study confirmed our previous reported impact of L-arginine and L-lysine on gastric emptying and 
secretion by classical lethal techniques. Beyond these it identified other interesting amino acids. L-
tyrosine seemed to accelerate gastric emptying and inhibit gastric secretion. L-cysteine selectively 
blocked gastric emptying, but did not alter gastric secretion. L-tryptophan behaved similar to L-
cysteine and is particularly interesting, because it was shown to regulate CCK release most potently 
of all amino acids ex vivo (37). This study raised several questions on the underlying endocrine and 
vagal mechanism, which will be subject to future efforts. 
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8. Discussion and Outlook 
My thesis builds around the hypothesis, that specific individual amino acids have a distinct impact on 
the control of food intake and gastric function. We tested this hypothesis by systematically assessing 
the individual impact of all proteogenic amino acids on food intake and gastric function; identifying 
their different effect strength and deciphering the mechanism of action of the most potent 
modulators. The two functional readouts are particularly relevant in context of the regulation of 
short-term nutrient intake. The amount of ingested food determines the maximal amount of 
ingested nutrients. Gastric function, namely emptying and secretion, dictates the concentration and 
the timing of nutrient release into the small intestine thereby directly impacting on plasma nutrient 
concentrations and their temporal appearance upon meal ingestion. Liver-, muscle metabolism, urine 
excretion among other functions may buffer the extent of plasma nutrient concentration changes 
after a meal, but they cannot directly alter absorption. In this thesis we showed a remarkable amino 
acid specific impact on eating behavior and gastric function. These findings are directly discussed in 
the respective paper and I will not repeat here these conclusions. Instead I aim to briefly discuss 
overall limitations of the performed studies, reveal some promising future avenues specific to each 
topic and finish with a general discussion about cellular amino acid sensing mechanisms.  
Individual Amino Acid Administration & Dose 
The main experimental intervention in my thesis was the administration of individual amino acids. 
They were applied orally by gavage in the two screens conducted for food intake and gastric 
function. Intragastric application was chosen because it follows the physiological route of a meal and 
the stomach is the primary place where the body is exposed to the individual amino acids contained 
in a meal. Correctly one can argue that the use of an individual amino acid is an artificial condition 
and the stomach in nature never encounters individual amino acids. Indeed a meal contains not only 
one but rather all the 20 proteogenic amino acids and additionally carbohydrates, fats, fibers, 
vitamin, salts, minerals, etc as individual molecules but also as part of higher order structure for 
instance membrane fragments, extracellular matrix components among others. Theoretically each of 
these molecules can generate a physiological signal by itself and their combination may trigger 
multiple potentially synergizing or neutralizing signals. To reduce the complexity of this multi 
nutrient matrix, we assessed the impact of only one individual amino acid on food intake and gastric 
function. Additionally, we showed that different feeding states and therefore the presence of other 
nutrients did not interfere with the individual anorectic impact of L-arginine, L-lysine or L-glutamic 
acid. Still, concluding that solely the three candidate amino acids mediate the anorectic effect of a 
high protein diet might be too simplistic. Following this argument the combination of individual 
amino acids i.e. L-arginine, L-lysine and L-glutamic acid should be more anorectic compared to the 
individual. The conducted combinatory experiments did not support this conclusion. Particularly 
intriguing was that L-glutamic acid inhibited the effect of L-arginine, L-lysine or their combination. 
Hence, the combination of different nutrients and macronutrients clearly contributes to the 
anorectic effect of a high protein diet. Still our data proposes a prominent role for specific individual 
amino acids namely L-arginine, L-lysine and L-glutamic acid.  
To identify the most potent individual amino acids, we conducted our screens for food intake and 
gastric function at an isomolar dose of 6.7 mmol of each individual amino acid/kg body weight.  
Isomolar conditions were selected to enable comparison, but different alternatives exist and are 
briefly discussed. Naturally different combinations of the approaches are also possible, but they will 
not be discussed here. The first alternative is to use isocaloric doses. This approach would exclude 
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energetic differences between the applied doses to affect the outcome of the screens. The 
disadvantage is the use of different molarities and thereby comparing the effect of different numbers 
of chemical molecules. Isomolar conditions prevent this pitfall and were also favored by use, because 
the largest energy difference is 8 kJ ≈ 2 kcal between the applied doses in the isomolar screen for a 
300 g rat (Table 2). This difference is very small considering the daily intake of ca. 400-500 kJ in a 
healthy rat (daily intake of ±28 g rat chow of KLIBA NAFAG 3430, gross energy 16.1 kJ/g). A second 
alternative is to assess the daily intake of individual amino acids in a healthy animal. This was done by 
measuring the daily food intake of a specific diet (here, 28 g of KLIBA NAFAG 3430). The amino acid 
content of the diet can be analytically determined (here, according to manufacturer’s information) 
and thereby the daily intake of individual amino acids calculated (Table 2). This specific individual 
amino acid intake could then be applied as a single oral dose. However, several questions arise. 
Should the daily amino acid intake, the first meal or the intake in the first two hours of the dark 
phase be used as reference? What is the reference diet? Is the reference diet low or rich in proteins? 
What protein source is the reference – casein, peptone, albumin or another? Hence, several 
unknowns complicate this approach apart of the same limitations already described for the isocaloric 
approach above. The third alternative would be to base the dose on the circulating blood levels of 
individual amino acids. Here, it is unclear if fasting or postprandial levels are relevant, if portal or 
common circulating blood levels should be considered and if equal or multiple factors of the blood 
levels should be applied. The fourth alternative is to measure the changes in portal blood levels of 
single amino acids after the intake of a defined meal and subsequently mimicked by the application 
of a single amino acid dose. Naturally this approach is very laborious and the same limitations as 
described above are here also relevant. Overall a satisfactory compromise to include all potential 
factors seems to be difficult and at some point all approaches to determine a reasonable dose are 
arbitrary. Our aim was to compare the effect of individual amino acids against each other, hence 
applying the same amount of an amino acid seemed conceptually critical. Therefor we decided to use 
the same single isomolar dose for all amino acids of 6.7 mmol/kg. This corresponds in the case of L-
glutamic acid to 1 g/kg and is in the range used by other previous publications (12, 107). Obviously, a 
more complete dose-response relationship for all 20 amino acid would be desirable but is not 
realistic from a work feasibility perspective. To consider if a dose is in a physiological range, we 
compared the individual doses to the daily dietary intake of an individual amino acid. As no universal 
standard lab diet exists and dietary protein content and source vary between labs, the comparison 
needs to be considered not as a fix threshold but rather as a range (Table 2).  
Table 2 shows that for instance for L-glutamic acid the applied dose of 6.7 mmol/kg in a 300 g rat 
reflects 27 % of the normal daily L-glutamic acid intake. Most doses for individual amino acids range 
between 27 to 250 % of their specific daily intake. This might reflect a physiological range as for 
instance animals fed a high protein diet ( ~40 % protein) easily double their amino acid intake. The 
exception is L-tryptophan with a relatively high dose reflecting 729 % of the daily L-tryptophan 
intake, which therefore is rather a pharmacological dose. The doses are relatively similar concerning 
caloric or energy content and contain only 3-11 kJ. This calculation is based on the combustion 
energy and therefor reflects an entirely chemical measurement. Alternatively ATP equivalent or 
other biological energy forms could be calculated, but they are determined based on metabolic flow 
charts and thereby reflect as well at best an approximation.  We performed correlation analysis to 
compare the properties of each individual amino acid dose (% daily intake, energy content, ATP 
equivalents, etc.) to its specific impact on food intake, gastric emptying and secretion, but no 
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correlation was found. In sum, we consider our approach physiological meaningful even though 
every dose or strategy has limitations.    
Table 2 – Applied individual amino acid dose relative to the dietary intake. 
 
Neuronal Activity 
Feeding behavior is ultimately controlled by the brain within specific neuronal circuits. We assessed 
neuronal activity using immunohistochemistry to stain for the expression of the widely and 
commonly used early gene cFOS, which is expressed upon regulation of intracellular Ca2+. Other 
classical but less used alternatives to cFOS are in-situ hybridization for Arc or Homer 1a gene 
products or immunohistochemistry against the phosphorylated form of ERK or CREB proteins (160). 
The advantage of cFOS is the higher stability of a protein compared to mRNA and that it does not 
require double labeling for the non-phosphorylated protein variant. From a methodological 
perspective immunohistochemistry is limited because complete brain staining is extremely laborious 
and therefor temporal and treatment resolution is restricted to few conditions. Additionally antibody 
sensitivity and specificity may differ between labs. The main disadvantage is that the correlation 
between neuronal activity meaning single neuronal spiking and the expression of a protein 90 min 
later may not be linear and it is unclear if cFOS expression is required for the observed behavioral 
phenotype. Nevertheless it enables to assess neuronal activity with good spatial resolution. We 
detected more cFOS positive cells in the area postrema and the nucleus of the solitary tract after oral 
L-arginine, L-lysine and L-glutamic acid administration, but not in any other brain region related to 
eating behavior namely the hypothalamus and the nucleus accumbens.  Interestingly an acute high 
protein diet intake increased cFOS expression as well in the nucleus of the solitary tract but also in 
the arcuate nucleus of the hypothalamus reflecting a specific difference to our study (39, 45). 
Methodologically the papers measuring the acute effect of a high protein diet on cFOS expression are 
Amino acid Dietary amino Amount of food intake Applied dose Applied dose relative Molar mass Energy
4
acid content1 in a 16h fasted rats2 in a 300 g animal3 to normal intake
Daily - 28g 1h - 8g energy
4
Daily 1h
% mg mg mg kJ % % g/mol kJ/g AA
Alanine 0.97 272 78 178 3 66 230 89.09 17.7
Arginine 1.1 308 88 348 7 113 396 174.2 21.5
Asparagine - - - - - - - 132.12 14.6
Aspartate 1.67 468 134 266 3 57 199 133.1 12
Cystein 0.28 78 22 242 5 309 1082 121.16 18.6
Glutamate 3.93 1100 314 294 5 27 94 147.13 15.3
Glutamine - - - - - - - 146.14 17.6
Glycine 0.84 235 67 150 2 64 223 75.07 13
Histidine 0.47 132 38 310 6 236 825 155.15 20.7
Isoleucine 0.78 218 62 262 7 120 420 131.17 27.3
Leucin 1.5 420 120 262 7 62 219 131.17 27.3
Lysine 1 280 80 292 7 104 365 146.19 25.2
Methionine 0.39 109 31 298 7 273 956 149.21 23
Phenylalanine 0.83 232 66 330 9 142 498 165.19 28.1
Proline 1.43 400 114 230 5 58 201 115.13 23.7
Serine 0.87 244 70 210 3 86 302 105.09 13.7
Threonine 0.65 182 52 238 4 131 458 119.12 17.2
Tryptophan 0.2 56 16 408 11 729 2553 204.23 27.6
Tyrosine 0.52 146 42 362 9 249 871 181.19 24.4
Valine 0.93 260 74 234 6 90 315 117.15 25
1 Kliba Nafag 3430 diet
2 see feeding data of baseline H2O group 
3 6.7 mmol/kg BW
4 Combustion energy - Amino acids: metabolism, functions and nutrition; Guoyao Wu, Texas, 2009
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similar to ours. We reasoned that this difference might have a biological explanation. First, a high 
protein diet contains carbohydrates and fats, which are absorbed, enter circulation and therefor can 
stimulate the glucose and fat sensitive central neurons located in the arcuate nucleus previously 
described in the introduction (34). Second, a high protein diet was shown to stimulate the release of 
gastrointestinal hormones and several of them are known to mediate their effect via arcuate neurons 
(167). Third, a high protein diet as well modulates body weight gain and therefor interacts with long 
term signals, which are thought to mainly induce their anorectic effect via the hypothalamus (103).  
Hence, there are several different reasons to expect different neuronal activity after the intake of a 
high protein meal compared to an individual amino acid. 
We showed the specific importance of area postrema neurons and vagal afferents in context of the 
anorectic effect of L-arginine, L-lysine and L-glutamic acid by surgical lesion of the two afferent 
pathways. We suggest in our manuscript that L-arginine and L-glutamic acid directly act on area 
postrema neurons, whereas L-lysine directly on vagal afferents. This conclusion is based on the 
presented evidence in the manuscript and supported by the literature indicating hepatic vagal 
afferents recordings sensitive to L-lysine ex vivo (150). Direct electrophysiological recordings from 
area postrema neurons would be a desirable method to test, if L-arginine and L-glutamic acid but not 
for instance L-lysine application alters the neuronal firing rate. However, this brain region is 
unfavorable for electrophysiological studies due to its spongy structure caused by the strong 
vascularization, but still it is possible (24, 50). Alternative approaches could aim to culture area 
postrema neurons and perform ex vivo Ca2+ signaling under different conditions. These efforts and 
potential positive findings would strongly support our conclusion. Additionally they would enable to 
investigate the biochemical identity of neurons activated by individual amino acids and thereby on 
the molecular mechanism enabling neurons to distinguish between individual amino acids. 
Interestingly amino acids seem to be detected by two different afferent pathways indicating 
redundancy. To test the broader relevance of this amino acid specific finding, area postrema and 
vagal afferent lesion animals should be exposed to a high protein diet and their food intake recorded. 
Our data may be interpreted to predict that a high protein diet should lose its anorectic effect in 
these double-lesion animals compared to control.  
Gastrointestinal Function 
The study of gastrointestinal function is particularly challenging from a methodological perspective. 
Gastrointestinal function is fast i.e. gastric peristaltic waves have a frequency of 3 contractions per 
minute in humans, and the 3D convolute of the intestinal segments requires high spatial resolution 
for visualization. Even though several methods exist to study specifically the diverse functions, all of 
them are limited by throughput and do not allow to assess different gastrointestinal functions 
simultaneously. Currently most approaches are lethal and are very laborious apart of being limited by 
temporal, spatial and/or quantitative resolution. Hence, it would be desirable to develop methods 
enabling to assess gastric motility and secretion, pancreatic and biliary acid secretion, intestinal and 
colon motility, among others simultaneously. Here, we initially focused on the stomach. The novel 
computed tomography method is non-invasive and enables high throughput studies as demonstrated 
by screening for the impact of individual amino acids on gastric emptying and secretion.  
The computed tomography screen outcome supported our previous data suggesting an L-arginine 
and L-lysine specific impact on gastric function but additionally revealed novel interesting amino 
acids namely L-tryptophan, L-tyrosine and L-cysteine. The previous reported effect of L-glutamic acid 
was as well confirmed when comparison is made to water control. The effect of L-glutamic acid is less 
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spectacular if compared to other amino acids but this was already apparent in the previous study 
(Fig. 6 and Manuscript: Specific Amino Acids Inhibit Food Intake via the Area Postrema or Vagal 
Afferents.). The remarkable amino acid specificity at isomolar conditions does exclude a simple 
osmotic effect and as well a solely calorie dependent mechanism (see small energy differences 
between applied doses in Table 2; max. Δ = 8 kJ ≈ 2 kcal). So far no study systematically studied the 
individual impact of amino acids on gastric secretion and emptying in rats. Nevertheless one study 
compared the effect of all individual amino acids on gastric emptying in dogs (143). The authors 
highlighted the effect of L-tryptophan delaying gastric emptying even though they detected as well a 
significant but smaller gastric emptying delay induced by L-lysine. They did not report any effect for 
L-arginine or L-tyrosine on gastric emptying. L-cysteine neither altered gastric emptying, but induced 
vomiting in dogs. Potentially these differences in amino acid specific effects arise due to species 
differences between rodents and dogs. This might be problematic for future translational studies as 
dogs are considered as the best animal model for human gastrointestinal function and may even be 
superior to monkeys (60). The authors of the dog study concluded that L-tryptophan may mediate its 
effect via CCK and noted that they surprisingly did not detect an effect after L-phenylalanine 
administration. Both amino acids were reported to potently induce CCK secretion and these rather 
classic studies were recently confirmed by novel ex vivo approaches (37). Therefore, it would be 
interesting to test if L-arginine, L-lysine, L-tryptophan, L-tyrosine or L-cysteine stimulated the release 
of gastrointestinal hormones. As we did not detect any hormonal concentration differences in 
circulation, future work should aim to disentangle their paracrine role. Hence, the effect of oral L-
arginine, L-lysine, L-tryptophan, L-tyrosine or L-cysteine application on gastric secretion and 
emptying could be tested after the application of different gastrointestinal hormone antagonists in 
rats.  
As gastric emptying and secretion are thought to be controlled by an intricate feedback mechanism 
based on vagovagal reflexes and/or gastrointestinal hormones, it may be interesting to test if 
secretion and emptying are controlled by the same regulatory mechanism (23). First indication could 
be drawn after performing dose response studies. Differences in the dose-response curve may 
indicate different underlying mechanisms.  For L-lysine we already showed a different dose response 
curve for gastric emptying and secretion in rats and in humans, which may indicate independent 
regulatory mechanisms. Second, gastric emptying and secretion may be stimulated by signals 
emerging in the gastric and intestinal lumen and/or the blood stream. To improve our understanding, 
it is relevant to assess where amino acids induce their effect on gastric emptying and secretion. Rats 
could be equipped with duodenal and/or portal-vein catheters and the elicited gastric effect monitor 
after candidate amino acid application at both locations. All these studies may determine and 
improve our understanding of how L-arginine, L-lysine, L-glutamic acid, L-tryptophan, L-tyrosine and 
L-cysteine induce their effect on gastric emptying and secretion. They will help to identify which cell 
types are potentially involved and highlight the physiological important site of action.  
Amino Acid Sensing 
Our efforts have revealed that L-arginine and L-glutamic acid mediate their anorectic effect via area 
postrema neurons, whereas L-lysine by vagal afferents. Which cell type and regulatory mechanism is 
stimulated by L-arginine, L-lysine, L-glutamic acid, L-tryptophan, L-tyrosine or L-cysteine to modulate 
gastric function is under current investigation. Intuitively the identified cells are localized at a specific 
anatomical position to exert their function and additionally express a specific set of proteins enabling 
them to do so. Both studies ultimately lead to the question, what are the proteins that enable amino 
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acid sensing? Do they explain the basis for the observed amino acid specificity? Next I will speculate 
about cellular amino acid sensing mechanisms emphasizing that it is difficult to propose an 
“educated guess” for the underlying cellular mechanism of the here described physiological effects. 
One needs to consider that here probably different sensory mechanisms overlap and thereby 
complicate the systemic understanding of the regulatory effect induced by L-arginine, L-lysine, L-
glutamic acid, L-tryptophan, L-tyrosine and L-cysteine.   
A general amino acid sensor able to detect the amino group shared by all amino acids was 
characterized in S. cerevisiae highlighting the existence of unspecific amino acid sensing mechanisms. 
The plasma membrane permease-like protein Ssy1 stimulates the activation of the Ssy5 protease 
upon extracellular amino acid binding. Ssy5 cleaves Stp1 and Stp2 transcription factor N-terminally 
enabling their translocation into the nucleus, where they drive the expression of specific amino acid 
induced genes mainly amino acid transporters (91). This general sensing system is not conserved in 
higher eukaryotes presumably because sensing individual amino acid might be a more significant 
evolutionary advantage (80). The detection of individual amino acids might give a more accurate 
indication of protein quantity and quality intake compared to a broadly tuned amino acid sensor. This 
interpretation is supported by the loss of the Ssy1 mechanism in the course of evolution.  
Specificity for amino acid sensing appeared as well early in evolution. Most prominent is the 
aspartate and arginine receptors in E. coli, which enables bacterial motor function (“swimming”) 
directionality towards an amino acid rich localization (46). As these pathways do not have eukaryotic 
homologs they are not discussed here in further detail. Still they demonstrate the simplest 
mechanism for detecting the presence of a single amino acid by a “ligand receptor” interaction. An 
alternative strategy is to detect the lack of individual amino acids instead of their presence. Here, the 
GCN2 pathway plays the pivotal role as described in in the introduction. The GCN2 kinase is activated 
in response to binding of uncharged tRNA and was first described in S. cerevisiae but is also 
conserved in higher eukaryotes. Nevertheless functionally they differ between species. In yeast GCN2 
activation stimulates the transcription of genes involved in amino acid synthesis and absorption and 
does not inhibit general translation. Additionally in yeast, which can synthesize all 20 amino acids, 
GCN2 is activated by the starvation of all individual amino acids (66). In contrast, in the rat anterior 
piriform cortex GCN2 activation is only induced upon starvation of essential amino acids, inhibits 
general translation and leads to the rejection of the specific diet (57). Hence, this evolutionary 
conserved amino acid sensing mechanism can detect amino acid depletion in both species, the 
specificity was adapted to the available anabolic pathways and importantly the induced response 
seems to be contrary. As lesion to the anterior piriform cortex did not abolish the anorectic effect of 
a high protein diet, it is very likely that the lack of an individual amino acid is sensed by a different 
mechanism compared to their presence (85). The challenge in sensing the presence of individual 
amino acid arises from their multiple functions. They are not only signal transmitters like insulin with 
its specific receptor family, but they are also metabolic substrates, protein building-blocks, 
neurotransmitters and so on. Due to this multi-functionality amino acids may be sensed by several 
most probably redundant mechanisms making identification difficult. Next, the currently available 
concepts will be briefly discussed starting with the simple receptor – ligand interaction, transceptors 
and finishing with intracellular nutrient kinases. A focus to amino acids is given in particular to the 
ones inducing either a gastric or anorectic effect in the here presented thesis.  
The most prominent receptors directly responding to amino acids in mammals are several G-protein 
couple receptors (128). The Ca2+ - sensing receptor (CaSR) does not only sense Ca2+ but also several 
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amino acids among other molecules (132). In culture L-phenylalanine and L-tryptophan mobilized 
Ca2+ most potently compared to all other amino acids in the presence of Ca2+. Generally charged 
amino acids were much less effective compared to aromatic amino acids and nearly no effect had 
branch chain amino acids (31). CaSR knockout mice died early after birth demonstrating the general 
importance of this receptor (163). Endothelia specific CaSR-knockout animals did not show 
differences in eating behavior or body weight gain (personal communication – Pascal Houillier). The 
CaSR is strongly expressed in the area postrema suggesting a potential role in feeding behavior, but 
this was so far not specifically tested (47). The high expression in the area postrema could as well be 
linked to other functions of the area postrema, particularly in the context of sodium, potassium or 
calcium homeostasis. For instance it was shown that AP lesion animals have a supernormal desire for 
NaCl intake without apparent impact on NaCl loss (33). The low affinity for L-arginine, L-lysine and L-
glutamic acid suggests no role of the CaSR in the control of their anorectic effect due to differences in 
amino acid specificity. In context of gastrointestinal function the CaSR is expressed in several 
endocrine cells along the gastrointestinal tract and associated with their secretory functions (30, 54). 
For instance CCK-secretion from murine intestinal I cells was shown to depend on the CaSR and was 
most potently induced by L-tryptophan (90). Additionally gastrin and somatostatin co-localize with 
the CaSR indicating another potential secretory role (61). In summary, the CaSR is relevant for 
chemosensing in the gut and might be relevant for the delay of gastric emptying observed after L-
tryptophan administration. An evolutionary neighbor of the CaSR is the G-protein coupled receptor 
group 6 family A (GPRC6A) protein. GPRC6A is an osteocalcin receptor which is stimulated by basic 
amino acids particularly L-arginine, L-lysine and L-ornithine (162). The receptor is broadly expressed 
including in the brain but no study so far addressed its expression in the area postrema specifically 
(161). Interestingly knockout animals of GPRC6A have osteopenia, feminization and metabolic 
syndrome. They show reduced body weight, increased body fat and glucose intolerance (120). Based 
on the broad functional impact, the authors suggest that GPRC6A may coordinate the anabolic 
response of multiple tissues to amino acids. In the gastric tract GPRC6A was shown to co-localize 
with gastrin and somatostatin (61). Hence, it might be tempting to speculate that GPRC6A mediates 
some of the effects induced by L-arginine and L-lysine. Another receptor, the T1R1/T1R3, might be 
another interesting candidate for amino acid detection as discussed in the introduction. Taken 
together several G-protein couple receptors respond to individual amino acids. They were shown to 
play a prominent role for different endocrine functions, but their role in mediating neuronal firing is 
unclear. Nevertheless we do not expect them to mediate the anorectic effect of L-arginine, L-lysine 
and L-glutamic acid because of their broad specificity. Concerning the gastric effect observed, it 
might be that L-arginine, L-lysine, L-tryptophan, L-tyrosine and L-cysteine mediate their effect 
indirectly by stimulating endocrine cells to release gastrointestinal hormones by one of the above or 
a still unknown receptor. One could test for the involvement of a receptor by administering amino 
acids coupled to polyethylenglycol, which renders amino acid still accessible but not absorbable. 
Conceptually a receptor should be able to bind this form similar to the non-modified amino acid and 
induce its downstream effect.  
Intestinal enterocytes and endocrine cells express a large variety of amino acid transporters at the 
apical surface and presumably area postrema neurons do so as well.  The precise expression pattern 
is most probably cell type specific and thereby may reveal interesting differences. The transporters 
ensure efficient amino acid absorption thereby altering the specific intracellular amino acid pool 
relevant for intracellular amino acid sensing mechanisms (discussed below). The newly emerging 
concept of “transceptors” suggests, that transporters not only shuttle specific nutrients but are as 
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well able to signal specifically relatively to the transported nutrient (69, 99). Secondary active 
transport couples amino acid transport with the inward movement of for instance sodium following 
the electrochemical gradient. The induced ionic current could trigger voltage sensitive signaling 
mechanism. For instance the release of GLP1 was shown to be triggered by membrane depolarization 
caused by calcium entry after sodium dependent glutamine uptake (127, 129). However, so far 
knockout experiments for the voltage dependent calcium influx transporters are missing to show the 
in vivo relevance of this mechanism. Other gradients such as potassium or even tertiary transport 
could be coupled to alter membrane potential and thereby alter intracellular calcium stores. Clearly 
the difficulty of this concept is to separate transport from signaling function. Unfortunately the 
“transcepter” concept does not clarify how to interpret the overlapping substrate specificity of 
several amino acid transporters, the interaction of different transport proteins with distinct 
accessory proteins, the different role of the apical and the basolateral membrane and the potential 
importance of intracellular membranes. From the perspective of L-arginine, L-lysine, L-glutamic acid, 
L-tryptophan, L-tyrosine or L-cysteine “transcepting” the number of potential transporters is large. 
To formulate a hypothesis for the involved transport proteins it would be clearly beneficial to know 
their expression profile in the area postrema respectively of vagal afferent fibers and ideally from the 
cells activated by the candidate amino acids.    
The most prominent intracellular nutrient sensing/signaling mechanism is the mTORC1 pathway as 
briefly mentioned in the introduction. mTORC1 not only regulates protein but also lipid synthesis 
which are both coupled to the availability of the respective nutrient (133). Amino acid limitation 
inhibits protein synthesis and induces autophagy via the mTORC1 kinase, presumably to maintain 
intracellular amino acid pools (14, 115). The most potent inducer of mTORC1 signaling are the amino 
acids L-arginine and L-leucine in different cell culture system, but there impact is limited if all other 
amino acids are depleted (63).  This might arise as they are not efficiently transported in the absence 
of other amino acids. For instance, L-leucine induced mTORC1 signaling was shown to be driven by 
the anti-port of intracellular glutamine for extracellular L-leucine (108). What the upstream 
mechanism is to detect L-leucine and L-arginine is part of current research effort and therefore the 
selectivity to L-arginine and L-leucine is not well understood (80). mTORC1 is ubiquitously expressed 
in the rat brain including the nucleus of the solitary tract (35). Injection of L-leucine into the nucleus 
of the solitary tract did not induce phosphorylation of mTOR in the area postrema (15). 
Unfortunately we never tested for mTORC1 activation after L-arginine, L-lysine or L-glutamic acid 
administration in the area postrema or the nucleus of the solitary tract by immunohistochemistry or 
by other means. A definite role of mTORC1 could have been validated by administration of 
rapamycin intravenously as a specific mTOR inhibitor. Overall mTORC1 is the best characterized 
intracellular nutrient sensing pathway and potentially an interesting future avenue.  
Our efforts revealed specific physiological effects of L-arginine, L-lysine, L-glutamic acid, L-
tryptophan, L-tyrosine and L-cysteine on animal behavior and also on gastrointestinal function. The 
main question arising of all the studies is which cellular mechanism enables to mediate this 
remarkable amino acid specificity. Different potential candidate proteins were suggested above and 
a future safe avenue would be to test specifically for their involvement. The main argument against 
all the candidate mechanism is that it is unclear how they should mediate the specificity to the 
individual amino acids. Here attention has to be taken – neither the screen for the impact of 
individual amino acids on food intake nor on gastric function has revealed a binary result. Only 
statistical analysis based on multi-condition comparison suggests this outcome, but reality suggests a 
certain continuity of responses to individual amino acids. Hence, it might be that one of the above 
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receptors is involved in mediating some of the here reported in vivo functions even though there is a 
non-perfect receptor specificity match. In the long term it would be desirable to establish a system, 
where we could specifically test for the role of candidate proteins respectively systematical screen 
the rat genome. Ex vivo cultures of area postrema neurons combined with Ca2+ imaging might 
provide such a system for systemically probing the regulation of neuronal activity in the near future. 
Still mayor logistic and methodological hurdles need to be taken before genome wide screening is 
possible. In context of the regulation of gastrointestinal function it is still unclear, which cell types are 
relevant for the response. Most probably the effects are a systemic and therefor finding a suitable 
model for systematic testing is a formidable challenge. In sum, the identification of the molecular 
machinery responsible for the here reported physiological effects induced by individual amino acids 
is a fascinating and also an ultimate challenge not only in respect of the current available technology.    
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